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Deciphering the “language” of the genome is a crucial step to understand life on earth. The 
Human Genome Project (HGP) initiated the era of Omics, and the rapid method development 
has greatly improved our knowledge of genome. Epigenomics, one of the active Omics fields, 
has largely increased our genomic vocabulary of the genomic and functional DNA elements. 
It has revealed that amongst others the local chromatin configuration at these DNA elements 
plays a pivotal role in generating cell types and modulating cell functions (Bernstein et al., 
2007; Consortium, 2012; Ernst et al., 2011; Goldberg et al., 2007; Kouzarides, 2007; Neph et 
al., 2012a), and has been linked to health and disease (Arrowsmith et al., 2012; Calvanese et 
al., 2009; Egger et al., 2004; Feil and Fraga, 2012; Kelly et al., 2010; Portela and Esteller, 2010). 
Most recently, studies of the three-dimensional (3D) genome, which can be analogized to 
genomic syntax, has progressively drawn our attention to chromatin physical communication 
and begun yielding exciting insights into the hierarchical chromatin organization and its 
contribution to gene regulation by facilitating the contacts between separated genomic 
regions (Dekker et al., 2013; Denker and Laat, 2016; Dixon et al., 2012; Lieberman-Aiden et 
al., 2009). This chapter introduces the general conceptions, existing techniques and the aims 
of our studies.
General conceptions
How a genome governs phenotypic plasticity, has long been the subject of research. 
The genome that encodes the genetic blueprint of an organism consists of linear polymers 
comprising a colossal amount of deoxyribonucleotides (ribonucleotides in some viruses) 
ranging from thousands in viruses to billions in eukaryotes. 
It is extremely fascinating and mind boggling that multicellular eukaryotes, such as the 
metazoans, are composed of a multitude of different cell types that have virtually the same 
genomic information yet have distinct morphologies and functions. In addition, the cells of 
a metazoan and for that matter unicellular organisms have the ability to respond to cues 
from the environment. Thus, differentiation and other cellular responses must be carried 
out and maintained by a precisely spatiotemporal regulation of genes, yet remain plastic 
to respond to a changing environment. Genome sequencing has revealed that, in most 
eukaryotic genomes, only very a small part of the genome (~2% in human and mouse) is 
used to encode proteins (Goldberg et al., 2007; Harrow et al., 2012; Venter et al., 2001). 
This raises the question what the rest is used for. Originally, a major part of the genome was 
thought to be junk. It has become clear however, that non-coding genomic regions likely 
have a function in regulation of the transcriptional activities of genes. The non-coding part of 
the genome, like the coding part, is modified with specific chemical tags that mark different 
regions with specific functions and instruct the cellular machinery to execute a particular 
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cellular function. Such modifications define so called cis-regulatory DNA elements (CREs). A 
variety of techniques have been developed to identify the distinctly marked CREs and assess 
the function of these genomic DNA elements. CREs are often found at a large distance from 
the genes and yet appear to regulate gene expression. This begs the question how such 
distant elements communicate with the transcriptional machinery located at the start site 
of the gene, the promoter. The development of chromosome conformation capture (3C) and 
genome-wide derivatives enable to link CREs to their target regions, and unveiled a complex 
hierarchical compaction and organization of eukaryotic genomes (Table 1). Epigenomics 
and 3D genomics opened the door to study how phenotypes are created and sustained 
in populations over time. Yet, due to the high diversities of cell types and the requirement 
of abundant starting material, in depth genome-wide study have mainly been performed 
in depth on cell lines and a handful of primary cell types from mammals over the last few 
years (Bernstein et al., 2005; Consortium, 2012; Marks et al., 2012; Roadmap Epigenomics 
Consortium et al., 2015; Saeed et al., 2014; Stunnenberg et al., 2016). 
Epigenome — primary structure of chromosome
Until the discovery of the molecular basis of epigenomes, the inheritable information which 
defines different cell types remained a puzzle long after the establishment of primary structure 
of DNA, the double-helix model, in the early 1950’s. Epigenome refers to the functionally 
relevant changes to the genome that do not alter the nucleotide sequences but are inheritable 
upon cell division (Bernstein et al., 2007; Margueron and Reinberg, 2010). In eukaryotic 
cells, the nucleosome which provides the first layer of DNA compaction is the basic unit of 
chromatin consisting of a segment of DNA wrapped around a histone octamer containing two 
copies each of the core histones H2A, H2B, H3, and H4 (Khorasanizadeh, 2004). Both the DNA 
and histone proteins are decorated with various reversible chemical modifications to set up 
a localized chromatin configuration which has a major influence on transcriptional activities 
of genes (Bannister and Kouzarides, 2011). Taken together, the double-helix DNA of genome 
provides an elegant way to accurately transfer genetic information to the next generation, 
whereas the reversible and inheritable chemical modifications to chromatin add the ability to 
construct diverse gene expression programs for distinct phenotypes and functions.  
DNA modification
In nature, DNA is made up from four nucleotides, each known by its own letter—A, G, C, 
and T. Several DNA nucleotide modifications are often found on the usual letters in the 
DNA sequences (Plongthongkum et al., 2014).  Generally, these modified nucleotides are 
not considered as usual nucleotides, because the DNA replication machinery itself could not 
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preserve those variants in the daughter strands after every cellular DNA replication cycle 
(Chen and Riggs, 2011; Smith and Meissner, 2013). 
DNA methylation is the most common DNA modification by which methyl groups are added 
to nucleotides. In mammals, methylation at the 5th carbon position of cytosine is the most 
abundant DNA modification (Suzuki and Bird, 2008). Most 5mCs are found in the context 
of CpG dinucleotides, where the C residues on the two strands of this short palindromic 
sequence are usually both methylated. 5mC can be found throughout vertebrate genomes. 
Its patterns are stable during replication and discriminate different cell types. The DNA 
methyltransferase DNMT1 is responsible for maintenance of DNA methylation patterns 
following DNA replication, whereas DNMT3A and DNMT3B are involved in deposition at a 
new site (Wu and Zhang, 2014). 
DNA methylation often acts like switches of genes controlling which genes are turned on 
and off (Suzuki and Bird, 2008). It mainly affects gene activities by its interplays with other 
proteins. Methylated DNA can be recognized and bound by proteins known as methyl-CpG-
binding domain proteins (MBDs) which then recruit additional proteins such as the polycomb 
group proteins to create an inactive chromatin configuration for gene repression (Zhu et al., 
2016). Alternatively, but rarely, the DNA methylation itself may physically impede the binding 
of certain transcription factors (TFs) (Choy et al., 2010). 
It has been widely accepted that 5-methylcytosine (5mC) is essential for normal development 
and is associated with a number of key processes including genomic imprinting (Bartolomei 
and Ferguson-Smith, 2011), X-chromosome inactivation (Sharp et al., 2011) and repression of 
repetitive elements (Habibi et al., 2013; Smith et al., 2014). Hence, abnormal changes in DNA 
methylation patterns may link to human diseases (Bernstein et al., 2007; Heyn and Esteller, 
2012). Using bisulfite sequencing and other techniques, a number of genomic regions have 
been associated with cancer and aging showing local hypomethylation and hypermethylation 
at specific genes (Berman et al., 2012; Bernstein et al., 2007; Jones et al., 2016; Varley et al., 
2013). Although the precise mechanism is not completely understood, these regions such as 
differential methylated regions (DMRs) can be potentially used as biomarkers for the diagnosis 
of disease progression. Some other DNA modifications such as 5-hydroxymethylcytosine 
(5hmC) are also found in vertebrate genomes (Ito et al., 2011; Tahiliani et al., 2009; Whalen 
et al., 2016; Yu et al., 2012). However, their roles in gene regulation have not been extensively 
explored. 
Chapter 1
18
DNA accessibility
While nucleosomes help in DNA compaction, they also provide protection to DNA from access. 
To utilize the information stored in the genome, DNA sequences have to be accessible by 
other molecules residing in the nucleus such as transcription factors (TFs). To systematically 
measure DNA accessibility, several techniques have been developed based on the idea that 
DNA at nucleosome free regions can be cleaved or modified by enzymes such as DNase I and 
transposase Tn5 (Meyer and Liu, 2014). Despite certain observed biases, these techniques 
produced strong cross-validation showing 1~2% of the genome as accessible regions (often 
called open chromatin regions) in individual cell types (He et al., 2014). 
Exposed DNA has long been believed to indicate activated regulatory regions such as 
promoters and enhancers. Hence, DNA accessibility assay provides a highly effective way to 
study transcriptional regulation at genome wide level. Indeed, it has been shown by ChIP–
seq that transcription factor binding displays high correlation with DNA accessibility (Neph 
et al., 2012a; Thurman et al., 2012; Whalen et al., 2016). Open chromatin regions likely are 
created by a special class of transcription factors called pioneer factors. These factors bind 
to nucleosomal DNA and recruit additional factors to evict the nucleosome, thereby making 
the DNA accessible to other transcription factors (Bell et al., 2011; Struhl and Segal, 2013; 
Zaret and Carroll, 2011). Alternatively, some transcription factors might directly open DNA 
by competing with histone octamer for DNA binding during spontaneous unwrapping and 
rebinding of the nucleosome such as RNA polymerase II (Li et al., 2005). Either way, DNA 
accessibility assay captures these open chromatin regions, and therefore provides a robust 
way to detect regulatory elements independently of any given transcription factor.  
DNA accessibility assay such as DNaseI-seq and ATAC-seq also enabled a genome-wide 
approach to identify DNA footprints (Buenrostro et al., 2013; Neph et al., 2012a, 2012b). 
This phenomenon occurs because binding of a protein to DNA often protects that DNA from 
enzymatic cleavage. A DNA footprint can be observed as a small depletion — typically only a 
few base pairs long — within a DNA accessible region. This information can be used to predict 
which DNA-sequence-specific transcription factors bind to a given open chromatin region as 
it produces a specific footprint, hence providing the evidence for the interactions between 
DNA and transcription factors of interests.  
Histone modification
Many researchers are fascinated by histone modifications because of their diversity, 
reversibility and heritability. A histone modification is a covalent post-translational 
modification (PTM) to histone proteins which includes methylation, phosphorylation, 
acetylation, ubiquitylation, and sumoylation. Some of the known histone modifications have 
been suggested to act in diverse biological processes such as gene regulation, DNA repair 
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and chromosomal condensation (Bannister and Kouzarides, 2011). Most well-studied histone 
modifications are involved in gene regulation and primarily found on unstructured tails of 
histone proteins, such as methylation and acetylation. 
Histone methylation is defined as the addition of methyl groups to the amino acid residues 
of histone proteins by histone methyltransferases (HMTs) (Bartke et al., 2010). Many studies 
concentrated on the histone methylation at histone H3 lysine 4 (H3K4), H3K9, H3K27, H3K36, 
H3K79 and H4K20 because of their high correlation with gene activities (Black et al., 2012; 
Martin and Zhang, 2005). Lysines can be monomethylated (me1), dimethylated (me2) or 
trimethylated (me3). The SET-domain-containing proteins and DOT1-like proteins have been 
shown to act as “writers” that methylate lysines. Histone methylation, like many other histone 
modifications, is reversible (Bannister and Kouzarides, 2005; Wu and Zhang, 2014). Two main 
families of histone demethylases have been identified as “erasers” that demethylate methyl 
lysines, including flavin adenine dinucleotide (FAD)-dependent amine oxidase, and Fe(II) and 
α-ketoglutarate-dependent dioxygenase. Mono, di and tri-methyl lysine can be recognized 
and distinguished by “reader” proteins containing chromo, PHD or some other domains, and 
potentially confer different biological meanings (Black et al., 2012; Martin and Zhang, 2005). 
Histone acetylation occurs through the addition of an acetyl group from acetyl coenzyme A 
to a lysine residue (Fukuda et al., 2006). Histone acetylation and deacetylation are catalyzed 
by “histone acetyltransferases” (HATs) or “histone deacetylases” (HDACs), respectively 
(Marmorstein and Zhou, 2014; Seto and Yoshida, 2014). Histone acetylation removes the 
positive charge of the histone octamer, thereby decreasing the interaction between the 
histone proteins and the negatively charged phosphate groups in DNA. This results in a more 
relaxed chromatin structure that assists the access of diverse DNA-binding proteins to the 
DNA (Grunstein, 1997; Tessarz and Kouzarides, 2014). 
Accumulating genome-wide mapping of histone modifications revealed highly stereotypical 
patterns with distinct combinations enriched at different classes of regulatory elements 
(Calo and Wysocka, 2013; Ernst et al., 2011; Zhou et al., 2011). The patterns of methylation 
and acetylation on lysines are used to annotate chromatin states and to identify enhancers 
and promoters in a given cell type. Promoters are typically marked by high H3K4me3 and 
low H3K4me1 whereas for enhancers this is the other way around. Both promoters and 
enhancers usually are additionally marked by H3K27ac upon activation. By contrast, repressed 
promoters and enhancers are often occupied by nucleosomes that contain H3K27me3, which 
has been linked to chromatin repression by polycomb-group proteins. In addition, H3K36me3 
particularly marks areas of transcription elongation, whereas H3K9me3 typically marks 
transcriptionally silenced heterochromatin regions. 
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Histone variants
A number of variants are also found for the core histones H3, H2A and H2B, as well as for 
the linker histone H1 (Bartke et al., 2010; Weber and Henikoff, 2014). These variants differ 
from the canonical histones by the alteration of one or a few amino acids or by the addition 
of larger domains. Some variants do not introduce any considerable structural alteration to 
the nucleosomes such as H3.3, whereas variant like H2A.Z influences the stability of H2A.Z-
containing nucleosomes (Bartke et al., 2010). Generally, histone variants have a specific 
abundant pattern, genomic localization and species distribution, and confer novel functional 
properties on the nucleosome affecting chromatin remodeling and histone modifications. 
Enhancer
Enhancers can be analogous to adjectives or adverbs in human languages. Enhances were 
initially described as short DNA fragments which have the ability to “modify” the expression of 
target genes (Banerji et al., 1981). The hallmark of enhancers is their functional independence 
of genomic distance and orientation relative to the promoters of target genes (Banerji et al., 
1981; Blackwood and Kadonaga, 1998; Plank and Dean, 2014). Further studies demonstrated 
that enhancers locate in regions containing short DNA motifs that act as binding sites for 
DNA-sequence-specific transcription factors (TFs) (Mitchell and Tjian, 1989). These TFs can 
recruit co-activators or co-repressors that then jointly determine the activity of an enhancer. 
As a result, enhancer regions usually coincide with open chromatin regions which can be 
identified by DNA accessibility assay (Consortium, 2012; Plank and Dean, 2014; Roadmap 
Epigenomics Consortium et al., 2015; Yao et al., 2015). 
Understanding enhancers has become an area of great interest, as increasing evidence has 
continuously strengthened their roles in regulating gene expression not only in differentiation 
and development but also in evolution and disease. Enhancers mediate both spatial 
and temporal control of gene activities and hence display cell-type specific repertoires. 
To identify enhancers, the coactivator P300, which is a histone acetyltransferase often 
binding at enhancer regions, was initially used as an indicator (Calo and Wysocka, 2013). 
Recently, increasing knowledge of histone modifications provides more precise prediction 
for enhancers and has been widely used in many studies. Even though there is no universal 
rule about which histone modifications should be used to identify enhancers, H3K4me1 and 
H3K27ac are well accepted as they are highly correlated with enhancer activity. This is also 
confirmed by advanced computational methods which use machine-learning approaches 
such as Hidden-Markov-Model (HMM) and Random-Forest to combine the signals of dozens 
of histone modifications to predict cis-regulatory elements including enhancers (Ernst and 
Kellis, 2012; Hoffman et al., 2012; Whalen et al., 2016). In addition, other datasets are 
also often integrated into the prediction, such as DNA accessibility, co-factor binding, RNA 
polymerase II binding and enhancer RNAs. 
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One mechanism by which enhancers can control distal genes is through their long-range 
physical interactions with promoters (Ong and Corces, 2011). It was proposed that the 
presence of enzymes at active promoters could also induce an opening of chromatin at 
enhancer regions because of the physical contacts between enhancers and promoters. This is 
supported by the finding of enhancer RNA (eRNA), a class of short non-coding RNA molecules 
that are transcribed from the DNA sequence of enhancer regions. Some potential functional 
roles of eRNA have been reported for regulating specific genes (Ilott et al., 2014; Kaikkonen 
et al., 2013, 2013, 2013; Li et al., 2013; Mousavi et al., 2013; Pnueli et al., 2015; Sigova et al., 
2015). 
Enhancer-promoter interaction networks are highly dependent on the nature of the genes. 
For instance, housekeeping genes seem to have no or few enhancers, whereas tissue-specific 
genes are often regulated by one or a few enhancers. Also, several enhancers can regulate one 
single promoter to fine tune the expression levels of their target gene in different cell types. 
Alternatively, one single enhancer can control several genes, which are usually coregulated 
(Andersson et al., 2014; Heinz et al., 2015; Li et al., 2012; Zhang et al., 2013).
Recently, enhancers with a special status called latent enhancers have been determined 
during stimulation in differentiated cells (Ostuni et al., 2013). These enhancers are not 
labeled by any enhancer-associated histone modifications (that is, H3K4me1 and H3K27ac) 
but acquire these active marks and transcription factor binding upon stimulation of cellular 
signaling pathways. This suggests an epigenetic memory of the exposure to environmental 
agents in cis-regulatory repertoire. 
Another interesting form of enhancers is called super-enhancer, which is a region of the 
mammalian genome comprising a cluster of enhancers that is collectively bound by high 
level of transcription factors (Pott and Lieb, 2015; Whalen et al., 2016; Whyte et al., 2013). 
Super-enhancers are frequently identified near genes important for controlling and defining 
cell identity, and can therefore be used to quickly identify key nodes determining cell identity. 
To validate the prediction of enhancers, the DNA sequence of an enhancer can be directly 
tested for its ability to enhance the transcription from a minimal core promoter. This includes 
traditional approaches such as the luciferase assay and genome-wide approaches like Self-
transcribing active regulatory region sequencing (STARR-seq) (Arnold et al., 2013). 
Polycomb-group proteins
Polycomb-group proteins are a family of proteins first discovered in Drosophila as genes 
important for embryonic development (Di Croce and Helin, 2013). Polycomb-group proteins 
are well known for silencing Hox genes through modulation of chromatin configuration. 
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Many Polycomb-group proteins are conserved in eukaryotes and form at least two distinct 
complexes, the Polycomb-repressive complexes 1 and 2, PRC1 and PRC2, respectively. 
PRC1 and PRC2 silence genes either synergistically or independently (van Kruijsbergen et al., 
2015). In the classical model, PRC2 is involved in recruiting PRC1 to the promoters of their 
common target genes (Boyer et al., 2006; Cao et al., 2002; Wang et al., 2004). In mammals, 
EZH2 is an important PRC2 subunit, which is a histone methyltransferase (HMT) that 
deposits H3K27me3 via its SET domain. The histone modification H3K27me3 is a hallmark 
of gene repression and usually found in the promoter regions of developmental genes. This 
modification can be recognized by a family of proteins which contain the chromobox (CBX) 
domain and function as subunits of PRC1, thereby recruit PRC1 to the H3K27me3 regions 
set by PRC2. Subsequently, PRC1 catalyzes the monoubiquitylation of histone H2A at lysine 
119 (H2AK119ub) by the two ring-domain-containing proteins, RING1B and BMI1. Recent 
studies have demonstrated that PRC1 can also be involved in the recruitment of PRC2 by 
its deposition of H2AK119ub (Blackledge et al., 2014; Cooper et al., 2014). Of note, it is also 
shown that PRC1 can still deposit H2AK119ub and repress gene transcription independently 
of PRC2 and H3K27me3 (Tavares et al., 2012). In addition, DNA methylation is also an 
important determinant of PRC2 recruitment (Reddington et al., 2013). 
Polycomb group proteins have long been linked to cell-fate specification (Burton and Torres-
Padilla, 2014; Sparmann and van Lohuizen, 2006). In embryonic stem cells, lineage-specific 
genes, which define the identities of cells during differentiation, are primed for expression 
and kept in a repressed state known as bivalent state by the histone modification H3K4me3 
and H3K27me3 together with PRC1 and PRC2. Dysregulation of Polycomb protein levels 
often results in early embryonic lethality (Sauvageau and Sauvageau, 2010). Polycomb group 
proteins have also been linked to the progression of cancer, as malfunction of these proteins 
can lead to activation of proto-oncogenes and the loss of function of tumor suppressor genes 
(Bracken and Helin, 2009; Sauvageau and Sauvageau, 2010; Sparmann and van Lohuizen, 
2006). 
3D genome — high-level structure of chromosome
Individual regulatory DNA elements and genes are not instructive for operating and directing a 
cell without the communications between them and their interactions with other molecules. 
Hence, it is not surprising that gene regulation relies not only on the local chromatin 
configuration, but also on the three-dimensional (3D) conformation of chromosomes which 
compartmentalizes the nucleus and facilitates the communication between separated 
functional DNA elements especially the CREs and their target genes. The genome together 
with a large variety of small molecules and biological macromolecules are housed in the 
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heart of a eukaryotic cell, the nucleus. However, the diameter of a nucleus is hundreds of 
thousands folds smaller than the total length of the genome. This discrepancy implicates a 
complex hierarchical compaction and organization of the chromosomes that is deployed to 
fit the genome into the nucleus while still ensuring the accessibility of desired sequences. 
Such hierarchical organization can be classified into at least three layers: primary structure, 
comprising DNA sequences, DNA-binding proteins, and nucleosomes that determine 
which regulatory DNA elements are accessible to transcription factors (TFs); secondary 
structure, comprising interactions between nearby nucleosomes that define local chromatin 
architecture; and tertiary structure, comprising long-range chromatin interactions that can 
span even more than a few hundreds of kilo bases and facilitate the communications between 
distal regulatory DNA elements and their target genes. All the above layers make the nucleus 
a crowded environment yet well-organized network that administrates the communication 
between diverse cellular elements. 
Active and repressive chromatin
The genome can be divided into two main compartments which represent the two states of 
its secondary structure, being active and repressive. These two compartments are displayed 
in a cell-type specific manner and can be defined using different approaches such as open 
chromatin assays, ChIP-seq for a combination of histone modifications or profiling of lamina-
associated domains (LADs) and nucleolus-associated domains (NADs) (Pombo and Dillon, 
2015). 
A recent technique called Hi-C provides an additional way to classify the compartments 
based on the long-range physical chromatin interaction patterns in the genome. The two 
main compartments identified by Hi-C study are termed A and B compartments which are 
associated with active and repressive chromatin respectively. Genomic loci from the same 
compartment type preferentially interact with each other rather than to the loci from the 
opposite compartment (Dixon et al., 2015; Lieberman-Aiden et al., 2009). Moreover, A/B 
compartments coincide genome-wide with the active and repressive chromatin identified 
by other independent assays for the same cells such as profiling of histone marks, DNA 
replication timing, LADs and NADs (Dixon et al., 2015; Rao et al., 2014). One further study 
using deep sequenced Hi-C data revealed that at least six subcompartments can be observed 
correlating with distinct patterns of histone modifications (Rao et al., 2014). Such patterns 
indicate relative nuclear positioning of individual regions of subcompartments. 
Topologically associating domains
The building blocks of a genome are not randomly arranged in the nucleus but hierarchically 
organized rendering a similar structure as the chapters and paragraphs of a book. Firstly, in 
eukaryotic nuclei, individual chromosomes are mostly aggregated in their own territories. 
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This is supported by both microscopy-based fluorescence in situ hybridization (FISH) (Bolzer 
et al., 2005; Meaburn and Misteli, 2007; Parada et al., 2004) and sequencing-based whole 
genome derivatives of 3C experiments (Kalhor et al., 2012; Lieberman-Aiden et al., 2009). 
Secondly, the chromosomes are further partitioned into a number of relatively discrete 
regions termed topologically associating domains (TADs) (Dixon et al., 2012; Rao et al., 2014). 
A TAD is a continuous genomic region that constrains the physical interactions to occur mainly 
inside the fragment of relatively isolated chromatin. Depending on the resolution, the size of 
TADs range from a few hundreds of kilo bases to several millions of bases. Regions delimiting 
TADs are called TAD boundaries which usually contain insulator sites and are enriched with 
housekeeping genes (Dixon et al., 2012; Rao et al., 2014; Van Bortle et al., 2014). 
TADs are conserved among different cell types and behave as the basic units of the genome. 
During DNA replication, replication domain boundaries coincide nearly one-to-one with TAD 
boundaries, suggesting TADs are stable regulatory units of replication timing (Dileep et al., 
2015; Kalhor et al., 2012). It has also been shown that the regions displaying switching of 
A/B compartments during stem cell differentiation typically correspond to single or series of 
TADs, indicating that TADs are the units of dynamic alterations in chromosome compartments 
(Dixon et al., 2015). Furthermore, the identities of TADs in replication-timing and nuclear 
compartmentalization are significantly associated with distinctive patterns of epigenetic 
marks (Rao et al., 2014). 
At TAD boundaries, the CCCTC-binding factor (CTCF) has been identified as one of the key 
players which together with cohesin are involved in the formation of a loop between two 
distal genomic loci (Phillips and Corces, 2009). However, many genomic CTCF-binding sites 
are not located at TAD boundaries but within TADs even with a 3D map of the human genome 
at kilobase resolution, indicating that CTCF and cohesin alone are insufficient to separate 
different TADs (Dixon et al., 2012; Rao et al., 2014). This is also supported by the mild effects 
on TAD organization in the cells that are depleted of CTCF or cohesion (Seitan et al., 2013; 
Sofueva et al., 2013; Zuin et al., 2014). How the TADs are created remains unclear. 
Chromatin interactions between DNA regulatory elements
The cells with large genomes have evolved mechanisms to compartmentalize chromosomes 
at all scales, which provide more precise control of interactions mainly between certain 
regulatory DNA elements. Genome-wide maps of the proteins that bind to enhancers, 
promoters, and insulators, together with high resolution maps of the physical chromatin 
contacts, revealed that each chromosome contains thousands of DNA loops which are 
associated with CTCF and its looping partner cohesion (Dixon et al., 2012, 2015; Rao et 
al., 2014; Tang et al., 2015). These architectural loops further compartmentalize TADs into 
smaller insulated domains which ensure the correct wiring of enhancers and promoters. 
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Several lines of evidence suggest that enhancers regulate any gene that is co-localized within 
the same insulated domain (Andersson et al., 2014; Symmons et al., 2014). Although most 
chromatin interactions between regulatory elements are restricted within the same domain, 
many inter-chromosomal interactions were also detected and validated to be functionally 
important (Joshi et al., 2015; Schoenfelder et al., 2015; Spilianakis and Flavell, 2004; Zhang 
et al., 2013). 
OUTLINE OF THE THESIS
Effects of chemical signals on chromatin organization
One fascinating aspect of cells is that they can receive and process signals (mostly chemical 
signals) from outside in order to respond to the changes in their living environment. In 
multicellular organisms, cells use many classes of chemical signals, including hormones and 
cytokines, to regulate physiology and behavior of their surrounding cells or target distal 
organs or tissues. Such regulations are compiled by the binding of signaling molecules to 
specific receptor proteins in the target cells resulting in a change in cell function. It has been 
shown that such functional modulations of cells happens as early as at the transcriptional 
level (Barolo and Posakony, 2002). However, mechanisms of chemical-signal-mediated 
transcriptional response are still poorly understood, especially at the level of chromatin 
topology. 
Accurate regulation of transcription is mediated by interaction networks consisting of 
promoters, enhancers and many proteins including transcription factors. During chemical 
stimulation, receptor proteins recognize the particular structure of the signaling molecules, 
and then trigger the corresponding cellular biological pathway in which transcription factors 
(TFs) are involved to alter the expression of target genes. It is interesting that genome-wide 
studies have revealed many TFs bind not only to promoter regions, but often to genomic 
regions that are distal to promoters (Carroll et al., 2006; Consortium, 2012; John et al., 2011; 
Nielsen et al., 2008; Rao et al., 2011; Welboren et al., 2009). Such observation implicates 
that spatial organization of chromatin is likely associated with chemical-signal-mediated 
transcriptional response. 
To investigate the effects of chemical signals on chromatin reorganization, we set out to study 
the effect of external stimuli by triamcinolone acetonide (TA) and tumor necrosis factor alpha 
(TNFa) on gene expression and chromatin organization. TA, which belongs to a class of steroid 
hormones called glucocorticoids (GCs), can activate glucocorticoid receptor (GR) pathway 
and regulate genes controlling development, metabolism, and immune response (Kadmiel 
and Cidlowski, 2013). TNFa, a proinflammatory cytokine, can activate nuclear factor kappa-b 
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(NF-κB) pathway which regulates genes influencing a broad range of biological processes 
including innate and adaptive immunity, inflammation and stress response (Hoesel and 
Schmid, 2013). Both GR and NF-κB can rapidly act in response to stimuli as they reside in 
the cytoplasm and remain inactive in their corresponding protein complexes, and do not 
require synthesis of new protein in order to become activated. GR is dissociated from the 
complex upon the binding of glucocorticoid and subsequently translocates into the nucleus 
where it binds to chromatin to regulate target genes (Kadmiel and Cidlowski, 2013). Similar to 
GR, NF-κB is released upon stimuli, translocates to the nucleus, and subsequently regulates 
target genes via its binding to chromatin (Hoesel and Schmid, 2013). Activated GR and NFκB 
predominantly bind to genomic regions that are distal to promoters. Only around 25% of 
the binding sites contain DNA motifs for GR and NFκB respectively, indicating other proteins 
facilitate the association of GR and p65 with chromatin. Indeed, P300 is present at almost all 
of these binding sites, which is a co-factor shared by GR and NFκB and generally considered 
as a hallmark of active enhancers (Rao et al., 2011). Co-activated GR and NFκB share a 
large proportion of binding sites and correlate with expression of many genes in a mutual 
antagonistic or synergistic manner. However, it was not entirely clear how GR and NFκB 
regulate their target genes from their distal binding sites. 
Dynamics of chromatin organization between two states of pluripotency
Embryonic stem cells (ESCs) are able to differentiate and generate all cell types in the body. 
This ability is termed pluripotency. The pluripotent and self-renewal properties of ESCs make 
them an invaluable model for fundamental research into the regulatory mechanisms in early 
development. ESCs are derived from the inner cell mass (ICM) of a blastocyst and classically 
cultured in growth media supplemented with fetal calf serum and leukemia Inhibitory Factor 
(LIF). More recently, ESCs are also cultured in serum-free 2i medium that contains LIF plus 
two small-molecule kinase inhibitors PD0325901 and CHIR99021, targeting the mitogen-
activated protein kinase (MEK) pathway and the glycogen synthase kinase-3 (GSK3) pathway, 
respectively (Ying et al., 2008). It is well accepted that 2i ESCs represent a ground-state 
pluripotency, whereas the classical serum-derived ESCs are reminiscent of post-implantation 
pluripotent stem cells (Marks and Stunnenberg, 2014; Marks et al., 2012; Nichols and Smith, 
2009; Plusa and Hadjantonakis, 2014; Ying et al., 2008). 
Both mouse embryonic stem cells (mESCs) grown in serum+LIF (‘‘serum mESCs’’) and 2i+LIF 
media (‘‘2i mESCs’’) are pluripotent; however, they show distinct transcriptomic profiles and 
epigenetic landscapes (Habibi et al., 2013; Marks and Stunnenberg, 2014; Marks et al., 2012). 
2i mESCs have higher expression levels of metabolic genes and diminished expression levels of 
lineage-priming genes compared to serum mESCs. In serum mESCs, the promoters of around 
3,000 genes display a bivalent chromatin state (co-occurrence of Histone marks H3K27me3 
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and H3K4me3) and are said to be poised for activation; these genes predominantly are 
involved in cell-fate determination and development. In 2i mESCs, the number of bivalent 
promoters drastically reduces; however, loss of repressive mark H3K27me3 does not result 
in transcriptional activation. In addition, the genome of 2i mESCs is globally hypo-methylated 
similar to the cells in ICM, whereas serum mESCs are hyper-methylated. Additional data from 
our lab show that only minor changes in H3K4me3 and H3K9me3 were observed between 
serum and 2i mESCs, but enhancer related marks H3K4me1 and H3K4me3 are undergoing 
extensive redistribution. However, it has not been explored whether 3D genomic organization 
play a role in initiation and/or maintenance of the two states of pluripotency by mediating 
the physical communication between regulatory DNA elements. 
Epigenomic reprogramming during monocyte-to-macrophage 
differentiation and ‘Innate immune memory’
The immune system in vertebrates protects organisms from infection and is categorized into 
two layers, innate immunity and adaptive immunity. 
Innate immunity refers to nonspecific defense mechanisms that come into play immediately 
or within hours of infection or injury in the body, and is found in all classes of plants and 
animals. Upon infection, innate immune system initiates a process called inflammation 
to promote healing of damaged tissue following the clearance of pathogens. Various cell 
types involved in such processes including resident macrophages, dendritic cells, or blood 
circulating monocytes and neutrophils. These cells detect infection or injury using pattern 
recognition receptors (PRRs) on the surface or within the cell. PRRs recognize two classes 
of molecules. One class refers to pathogen-associated molecular patterns (PAMPs) which 
are broadly shared by pathogens but distinguishable from host molecules, including viral 
nucleic acids, fungal beta-glucan, and lipopolysaccharide (LPS) from Gram-negative bacteria. 
The other class refers to damage-associated molecular patterns (DAMPs) that are released 
from injured cells. Dysregulation of inflammation might lead the body to a state like sepsis or 
autoimmunity. 
Immunological memory is a phenomenon that after an initial response to a specific pathogen, 
the immune system responds with the same pathogen more strongly to subsequent 
encounters, which is the basis of vaccination. The consensus was that immunological memory 
is an exclusive characteristic of adaptive immunity in vertebrates as innate immune system 
mounts only nonspecific responses. The discovery of PRRs challenged this dogma. Moreover, 
recent studies have shown a similar phenomenon in the absence of adaptive immune system 
in plants, invertebrates and also vertebrates, yet the second exposures were different from 
the first one. These studies suggest a trained immunity of innate immune system which can 
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be primed by a first stimulus and display enhanced responses upon later infection that can 
be maintained for up to a few months. Currently, the molecular bases of trained immunity 
are partially defined, but evidence supports the convergence of multiple regulatory layers, 
including changes in chromatin organization and the persistence of microRNAs (miRNAs) 
induced by the primary stimulus. 
Monocytes and macrophages play an important role in the pathophysiology of sepsis and 
inflammation, along with other innate and adaptive immune cells (Biswas and Lopez-Collazo, 
2009). Stimulating monocytes or macrophages with LPS inhibits their functions in immune 
response and causes so called LPS-induced tolerance in which these cells fail to properly 
response to re-stimulation. Transcriptome analysis of tolerant monocytes from sepsis patients 
(Shalova et al., 2015) and a mouse sepsis model (Foster et al., 2007) reveal that the tolerized 
phenotype cannot be explained purely through failure of specific signaling pathways induced 
by PRRs to activate downstream genes. This implicates a role for local chromatin architecture 
and specific transcriptional regulators in controlling the expression of tolerized genes 
(Glass and Natoli, 2016). Studies in human cancers have revealed commonalities between 
inflammation and cancer associated tolerance, including the role for IDO1 in both (Bessede 
et al., 2014). Accordingly, several anti-cancer drugs, such as bromodomain and extraterminal 
domain family (BET) inhibitors (Nicodeme et al., 2010) and a topoisomerase inhibitor (Rialdi 
et al., 2016) have proven efficacious in blocking inflammation-associated death in mice. The 
specific epigenetic and transcriptional remodeling induced by the initial LPS exposure, and 
the extent to which it specifies tolerance to future LPS exposure, is an important question. 
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IN THIS THESIS
In this chapter, Chapter 1, I briefly introduced the basic concepts related to our studies, 
including essential knowledge of epigenetic mechanisms and current understandings of 3D 
genomic organization. 
In Chapter 2, we investigated the impact of signal-dependent transcription factors on gene 
regulation and chromatin reorganization. We determined epigenetic dynamics and TF binding 
patterns in the cells of which glucocorticoid receptor and nuclear factor kappa-b pathways are 
activated by glucocorticoid (GC) and tumor necrosis factor alpha (TNFa) respectively. We then 
investigated how those TF binding sites influenced gene expression via chromatin interactions 
using circular chromosome conformation capture coupled with next generation sequencing 
(4C-seq) and high-resolution chromatin interaction analysis by paired-end tag sequencing 
(ChIA-PET) of P300. This study suggests an active role of signal-dependent transcription 
factors in chromatin and long-range interaction remodeling. In this study, I analyzed the data 
of ChIA-PET, 4C-seq, and ChIP-seq, and helped drafting the manuscript. 
In Chapter 3, we investigated the dynamics of 3D genomic organization during the transition 
between two states of pluripotency. We established Capture Hi-C with target-sequence 
enrichment of DNase I hypersensitive sites. We observed a group of extremely long-range 
intra- and inter-chromosomal interactions (ELRIs) between a small subset of H3K27me3 
marked bivalent promoters involving the Hox clusters in serum-grown but not in 2i-grown 
mESCs. We then investigated the role of PRC2 in establishing these interactions using Capture 
Hi-C on Eed-/- serum mESCs. Our study together with a parallel study suggest that PRC2 likely 
acts as an initiator of ELRIs by deposition of H3K27me3 and subsequent recruitment of 
canonical PRC1, which may act as the physical mediator of ELRIs. In this study, I analyzed the 
data of Capture HiC, 4C-seq, DNase I-seq, ChIP-seq, and RNA-seq, and helped drafting the 
manuscript.
In Chapter 4, we integrated time-resolved epigenomes and transcriptomes to characterize 
the molecular events involved in LPS-induced tolerance. We investigated epigenetic and 
transcriptional changes during LPS stimulated, beta-glucan stimulated and normal monocyte-
to-macrophage differentiation. We further investigated epigenetic and transcriptional 
changes in tolerized macrophages under secondary LPS exposure. In addition, we assessed 
the ability of beta-glucan exposure to tolerance reversal both in vitro and in vivo. Our findings 
show that the innate immune ‘‘training stimulus’’ beta-glucan can reverse macrophage 
tolerance ex vivo and move forward in understanding how the tolerized phenotype can be 
reversed in sepsis patients. In this study, I helped in the analysis of RNA-seq and ChIP-seq data 
and drafting the manuscript.
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In Chapter 5, we performed Capture Hi-C to investigate the dynamics of 3D genomic 
organization during monocyte-to-macrophage differentiation and immunological training. 
We investigated the associations between the changes at epigenetic, transcriptional and 
3D genomic organization levels. We demonstrate that despite the absence of cell division, 
the monocyte-to-macrophage differentiation is associated with higher-order chromatin 
reorganization, including changes in A/B compartments, strengthening of TADs and their 
boundaries and a global gain of short-range interactions. While differentiation is associated 
with profound changes, immunological training does not cause spatial chromatin dynamics, 
suggesting that differentiation is the main driver of chromatin remodeling. In this study, I 
analyzed the data of Capture Hi-C, ChIP-seq, and RNA-seq, and helped drafting the manuscript.
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Abstract
Background: The impact of signal-dependent transcription factors, such as glucocorticoid receptor and nuclear
factor kappa-b, on the three-dimensional organization of chromatin remains a topic of discussion. The possible
scenarios range from remodeling of higher order chromatin architecture by activated transcription factors to
recruitment of activated transcription factors to pre-established long-range interactions.
Results: Using circular chromosome conformation capture coupled with next generation sequencing and
high-resolution chromatin interaction analysis by paired-end tag sequencing of P300, we observed agonist-induced
changes in long-range chromatin interactions, and uncovered interconnected enhancer–enhancer hubs spanning up
to one megabase. The vast majority of activated glucocorticoid receptor and nuclear factor kappa-b appeared to join
pre-existing P300 enhancer hubs without affecting the chromatin conformation. In contrast, binding of the activated
transcription factors to loci with their consensus response elements led to the increased formation of an active
epigenetic state of enhancers and a significant increase in long-range interactions within pre-existing enhancer
networks. De novo enhancers or ligand-responsive enhancer hubs preferentially interacted with ligand-induced genes.
Conclusions: We demonstrate that, at a subset of genomic loci, ligand-mediated induction leads to active enhancer
formation and an increase in long-range interactions, facilitating efficient regulation of target genes. Therefore, our data
suggest an active role of signal-dependent transcription factors in chromatin and long-range interaction remodeling.
Keywords: ChIA-PET, Chromosome conformation capture, Enhancer, GR, Long-range interaction, NFκB, P300,
Transcription regulation
Background
Mechanisms of transcriptional response mediated by
signal-dependent transcription factors (inducible TFs)
are not well understood at the level of chromatin top-
ology. Recent genome-wide studies have revealed that
the majority of TF binding sites (up to 90 %) are distal
to promoters and located in intragenic and intergenic re-
gions [1–9]. These studies collectively revealed cell-type-
specific constellations of distal regulatory regions that
change during differentiation and development in a
highly ordered fashion, whereby some distal regulatory
regions are being set up de novo and others are decom-
missioned. This implies that at least some lineage-
specific and/or signal-dependent TFs effectively open
the chromatin structure and prepare the chromatin for
subsequent binding of other TFs. A simplistic model of
how such plasticity can be achieved is that long-range
interactions among and between enhancers and pro-
moters are dynamically established or disrupted. Many
recent studies have purported an active or “instructive”
role of inducible TFs in mediating long-range chromatin
contacts for efficient regulation of target genes [10–14].
The orchestrated long-range interaction changes have
also been reported in embryonic stem cells (ESC) and
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ESC-derived lineages [15] on a topological domain
(TAD) level. In contrast, other studies suggest a static or
“permissive” model in which inducible TFs passively join
pre-existing interaction networks of regulatory elements
without affecting the organization of long-range interac-
tions [14, 16, 17]. The HoxD locus serves as an example
of pre-formed long-range interactions [18]. Interestingly,
in another report focusing on the HoxD locus, the
authors directly compared the interaction profiles ob-
tained by chromosome conformation capture (3C)-based
methods and fluorescent in situ hybridization. The au-
thors conclude that interactions identified by 3C-based
methods at such high resolution do not always represent
true proximal ligations, but may be a consequence of in-
direct cross-linking [19]. Discrepancies between studies
on inducible TF-mediated long-range chromatin con-
tacts may be due to differences in resolution and meth-
odology or to the use of asynchronous cells.
Glucocorticoid receptor (GR) is a ligand inducible TF
that belongs to the nuclear receptor superfamily [20].
Hormone binding dissociates the GR-containing cyto-
plasmic complex; GR then translocates to the nucleus
where it binds to chromatin to regulate target gene ac-
tivity. Nuclear factor kappa-b (NFκB) is a heterodimeric
TF that regulates various biological processes such as
cell growth, development, and the inflammatory re-
sponse. In response to inflammatory stimuli such as the
pro-inflammatory cytokine tumor necrosis factor alpha
(TNFα), NFκB dissociates from an inhibitory cytoplas-
mic complex, translocates to the nucleus, and subse-
quently regulates its target genes [21–25]. Co-activated
GR and NFκB share a large proportion of genomic regu-
latory elements and co-regulate many genes in a mutual
antagonistic or synergistic manner [7, 26–29]. The ma-
jority of GR and p65 (a major NFκB subunit) binding
events occur at genomic loci that exhibit pre-existing
enhancer signatures. In this scenario, TFs other than GR
and NFκB have established and maintain an open chro-
matin conformation, facilitating binding or recruitment
of GR and p65 to their binding sites [30–32]. At a mi-
nority of GR and p65 binding sites (~10 %), the activated
TFs establish de novo enhancer-like loci [5, 33, 34].
To gain insight in how GR and NFκB regulate their
target gene repertoire from distal binding sites (DBSs),
we mapped the chromatin interactions before and after
GR and NFκB activation by generating high-resolution
chromatin interaction profiles using the chromatin inter-
action analysis by paired-end tag sequencing (ChIA-
PET) method [35, 36]. We used antibodies against
enhancer-associated P300 and against RNA polymerase
II (POLII). P300 is a co-factor shared by GR and NFκB
and its genomic occupancy in general is considered a
hallmark of active enhancers [37–40]. We scrutinized
the local chromatin interaction networks at genomic loci
that are de novo established and compared them to
those of pre-existing loci. We extended our analysis
using high-resolution circular chromosome conform-
ation capture (4C) technology on a subset of genomic
viewpoints harboring de novo programmed regulatory
elements. Collectively, our comprehensive analyses re-
veal a role of signal-dependent TF-induced dynamic
changes in chromatin regulatory networks and its im-
pact on gene regulation.
Results
P300 is recruited to latent distal binding sites by ligand
activated GR and/or NFκB
To gain insight into the impact of GR activation on the
chromatin state and three-dimensional (3D) organization,
we first performed chromatin immunoprecipitation
followed by deep sequencing (ChIP-seq) for GR, P300,
epigenetic marks (H3K27ac, H3K4me3, and H3K4me1)
and DNase I accessibility analysis. Ligand-activated GR
binds to several thousand genomic loci [5, 7, 8, 41], of
which more than 90 % (7679/8303) were located dis-
tally (>5 kb) from transcription start sites in HeLa
cells (Additional file 1: Figure S1A). The vast majority
(6760/7679) of these DBSs were DNase I accessible,
bound by P300, and marked with H3K27ac and
H3K4me1 prior to hormone stimulation (Fig. 1a–c).
We refer to these as “pre-existing” P300 sites. Import-
antly, a subset of GR DBSs (919/7679) displayed the
hallmarks of poised enhancers prior to ligand treat-
ment, being largely inaccessible to DNase I, lowly
marked with H3K4me1, and not marked with H3K27ac
and P300. Interestingly, P300 was robustly recruited to
these epigenetically dormant loci upon GR induction
(“induced” P300 sites; Fig. 1a–c). At a smaller subset
(529/6760) of GR DBSs, P300 occupancy was moderately
reduced upon hormone treatment (data not shown). Next,
we analyzed the pre-existing and induced P300 DBSs for
TF motifs [7]. As expected, ligand-induced P300 DBS
were highly enriched for glucocorticoid response elements
(GREs), whereas AP1 was the most prevalent motif de-
tected at pre-existing P300 sites (Fig. 1d). Our observa-
tions together with published data [5] suggest that at the
induced P300 DBSs that are pre-marked with H3K4me1,
GR binds directly to consensus GREs and recruits P300 to
set up enhancer-like elements.
P65 was also predominantly bound at distal gen-
omic loci (11,454/12,546) (Additional file 2: Figure S2A),
of which the majority (10,453/11,454) were occupied by
P300 prior to TNFα stimulation (pre-existing P300 sites).
At a subset of p65 DBSs (1001/11,454), P300 was de-
tectable only upon TNFα stimulation (Additional file 2:
Figure S2B,C). TNFα-induced P300 DBSs were enriched
for the NFκB response element (NFκB-RE) (Additional
file 2: Figure S2D). Furthermore, induced P300 DBSs
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that were barely or not marked by H3K27ac were in-
accessible to DNase I, yet displayed readily detectable
levels of H3K4me1 prior to TNFα induction and p65
binding (Additional file 2: Figure S2E). In line with a
recent study in mouse macrophages [34], we presume
that TNFα induction activates poised or latent en-
hancers. We also observed pre-existing P300 binding at
many sites (~25,000) that were not significantly co-
occupied by GR or p65 (Additional file 3: Figure S3A,B).
These sites likely have a regulatory role in association with
other TFs.
Because GR and p65 share a large number of regula-
tory elements (~30 %) and co-regulate many genes, we
performed a similar analysis upon co-activation of GR
and p65. We detected all the induced P300 DBSs that
were uncovered upon single activation of GR or p65. An
additional subset of inducible P300 sites (~700) was un-
veiled only upon co-stimulation, displaying significantly
increased DNase I accessibility and H3K27ac, and a mar-
ginal increase in H3K4me1 (Additional file 4: Figure S4,
Additional file 5: Figure S5, Additional file 6).
Taken together, GR and p65 mostly join pre-existing
enhancer-like P300 DBSs that are set up by other TFs
such as AP1. At a subset of latent genomic locations
marked with low levels of H3K4me1, GR and/or NFκB
binding induces DNA accessibility, recruitment of P300,
and H3K27ac deposition. Because the induced P300 sites
are highly enriched for their respective consensus re-
sponse elements, it appears that recruitment of GR and
NFκB to their respective cis-acting elements can initiate
the formation of an active enhancer configuration, in
line with recent studies [5, 33, 34].
ChIA-PET reveals P300 enhancer interaction networks
Next we focused on long-range chromatin contacts
associated with P300 DBSs. We performed chromatin
interaction analyses on co-stimulated cells to uncover
the largest number of induced P300 DBSs (2881), and
contrasted them to vehicle treatment. We performed
ChIA-PET, an antibody-based method, to map the
genome-wide chromatin interactions at high resolution
[35, 36, 42]. We mapped the chromatin interactions
using P300 and POLII antibodies. Sequencing of the
P300 ChIA-PET libraries yielded 36.7 and 18.2 million
uniquely mapped paired-end tags (PETs) for vehicle and
co-stimulated samples, respectively. Among these, 1.4
and 1.2 million reads were self-ligation PETs (defined as
ligation endpoints or anchors less than 5 kb apart) ac-
counting for 15,148 and 16,366 putative P300 binding
sites in vehicle and co-treated libraries, respectively
(Additional file 7: Table S1). The vast majority (>90 %)
of these self-ligation PETs co-localized with the P300
binding sites identified by ChIP-seq (Additional file 8:
Figure S6A). ChIP-seq binding sites with low signal
strength were not detected as binding sites in ChIA-PET
data sets (Additional file 8: Figure S6B). Therefore, we
used ChIP-seq binding sites (identified from ~20 million
unique reads) as anchors to identify high confidence
chromatin contacts. Ligation PETs that had their an-
chors between 5 and 1000 kb from each other and co-
localized with high confidence P300 ChIP-seq binding
sites were defined as long-range interactions. We identi-
fied 2363 and 5429 intra-chromosomal interactions
using the P300 antibody in vehicle and co-stimulated
cells, respectively. Using a similar approach, a large
number of intra-chromosomal interactions were de-
tected in a ChIA-PET analysis using a POLII antibody
(Additional file 9: Table S2). P300 and POLII ChIP-seq
binding sites that were involved in chromatin interac-
tions were of higher signal strength compared to those
not detected in chromatin interactions (Additional file 8:
Figure S6C).
The majority of P300-associated long-range interac-
tions occurred between distal regulatory elements
(DBSs, ~60 %), whereas about 20 % occurred between
promoters and DBSs (Fig. 2a). In contrast to the
P300 interactome, POLII-associated interactions were
found predominantly between promoters (64 %) and
only 19 % involved DBS-promoter interactions (Fig. 2b).
Visual inspection suggested that identified chromatin in-
teractions occurred frequently between a multitude of
P300 DBSs that aggregate into interaction subdomains
(Additional file 8: Figure S6D) similar to replication or
TADs [43, 44]. Indeed, more than 95 % of all P300 and
POLII long-range interactions were confined to such do-
mains as defined by DNA replication timing in HeLaS3
cells [44, 45] (Additional file 8: Figure S6E). Whereas the
average TAD length is ~1.7 Mb, the average widths of
P300 and POLII subdomains were 118 kb and 96 kb, re-
spectively. Direct comparison of individual P300 and
POLII interaction domains revealed that two fifths
(39.6 %) overlapped, whereas the remainder appeared
to involve only P300 or POLII (Fig. 2c, upper panel).
The degree of P300 and POLII anchor overlap in
(See figure on previous page.)
Fig. 1 Activated glucocorticoid receptor (GR) recruits P300 to epigenomically latent genomic regions. a Color profile depicting the GR and P300
signal at all GR-bound regions with either constitutive or ligand (triamcinolone acetonide [TA]) -induced P300 occupancy. b Example screenshot
depicting the TA-induced P300 distal binding site (DBS; dotted box) and constitutive P300 DBS. c Basal (untreated cells) H3K27ac, DNase I hyper-
sensitive site, and H3K4me1 signal at all GR-induced and constitutive P300 DBSs. d Motif occurrence at all GR-bound DBSs presented as a function
of TA-dependent P300 recruitment (x-axis). DMSO dimethyl sulfoxide, RE response elements
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Fig. 2 P300 ChIA-PET interaction profile shows an enhancer-centered interaction pattern in contrast to promoter-centered RNA polymerase II
(POLII) interactome. a Proportion of distal binding site (DBS)-promoter, promoter-promoter, and DBS-DBS interactions identified by P300 ChIA-PET
in cells treated by vehicle (dimethyl sulfoxide [DMSO]) (upper panel) or triamcinolone acetonide (TA) + tumor necrosis factor alpha (TNFα) (lower
panel). b Proportion of DBS-promoter, promoter–promoter, and DBS–DBS interactions identified by POLII ChIA-PET in cells treated with vehicle
(upper panel) or TA + TNFα (lower panel). c Venn diagram depicting the extent of overlap between P300 interaction subdomains and POLII interaction
subdomains (upper panel). Histogram depicting the percentage of P300 and POLII shared anchors in P300 & POLII interaction subdomains (lower panel).
d Example screenshots of P300-rich (left panel), P300 & POLII-rich (middle panel), and POLII-rich (right panel) interaction subdomains depicting the
ChIP-seq and ChIA-PET interaction data. e Distribution of glucocorticoid receptor (GR) (left panel) and p65 (right panel) binding sites in P300 rich, P300
& POLII-rich, and POLII-rich interaction subdomains
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P300 and POLII shared interaction domains varied,
with most of the subdomains sharing less than 50 %
of anchors (Fig. 2c, lower panel). Representative ex-
amples of P300-rich, P300 and POLII, and POLII-rich
interaction subdomains are shown in Fig. 2d.
Because GR and p65 preponderantly bind to putative
enhancers that are marked with P300, it would be ex-
pected for GR and p65 binding sites to be enriched
within the P300 ChIA-PET interaction network. Indeed,
about 60 % of GR and 50 % of p65 binding sites were lo-
cated within P300 centric interaction subdomains (P300
rich, P300 & POLII). POLII-rich promoter–promoter
networks were largely devoid of GR and p65 binding
events (Fig. 2d,e).
Ligand treatment enhances long-range interactions at
induced P300 distal binding sites
Next we set out to investigate whether pre-existing and
induced P300 sites participate equally in long-range
chromatin interactions. Upon ligand activation we ob-
served a significant gain of DNaseI accessibility and ac-
tive chromatin marks at induced P300 DBSs. We reason
that these sites might have an increased interaction upon
ligand activation.
To validate the P300-mediated long-range interactions
and to gain insight into their frequency, we selected 4C
viewpoints in eight different P300 interaction subdo-
mains that encompassed 58 different genomic loci (an-
chors) in our ChIA-PET analysis. 4C-seq libraries from
at least two independent biological replicas per view-
point were sequenced to obtain more than 2 million
high-quality, uniquely aligned reads (Fig. 3, Additional
file 10: Figure S7, Additional file 11: Figure S8, Additional
file 12: Figure S9). This sequencing depth is regarded
adequate to map all ligation events within the view-
point [46].
In the ZBTB16/NNMT locus (Fig. 3a), transcription of
the NNMT gene was induced by co-stimulation. This
locus contained one ligand-induced P300 binding site
that also gained H3K27ac and DNase I accessibility (see
also Fig. 1b) and three pre-existing P300 sites. Using one
of the pre-existing P300 sites as the viewpoint in 4C
experiments, we detected its interaction with other pre-
existing P300 sites. Upon ligand activation, we observed
the formation of novel interactions involving the ligand-
induced P300 DBS as well as a general increase in the
interaction signal at pre-existing sites. In ChIA-PET, we
detected interactions between all the enhancers only
upon ligand induction.
The KLF6 locus encompassed multiple constitutive
and four induced P300 binding sites (Fig. 3b). Upon
stimulation, transcription of the KLF6 gene was highly
induced and multiple enhancers gained P300, H3K27ac,
and DNase I accessibility. A GR-induced DBS was used
as the viewpoint for 4C. In vehicle-treated cells, we
detected weak 4C signals between the bait and sur-
rounding pre-existing and induced P300 DBSs. These
contacts were robustly increased upon co-stimulation.
An additional six genomic viewpoints showed a simi-
lar increase in interaction frequencies and inclusion
of induced P300 binding sites in the interaction net-
work upon ligand induction (Additional file 11: Figure S8,
Additional file 12: Figure S9).
To assess the interaction frequency at P300 DBSs, we
divided the P300 DBSs that were detected in our 4C
analysis (eight viewpoints) into induced and pre-existing.
For each group we plotted the average of P300 ChIP-seq
and 4C signal (reads per kilobase per million mapped
reads [RPKM]) in control and stimulated cells. The con-
stitutive P300 binding sites displayed a similar ChIP-seq
and 4C signal pattern in vehicle-treated and ligand-
treated cells (Fig. 3c). Importantly, induced P300 binding
sites showed a significantly higher (p < 0.001, t-test) 4C
signal in ligand-treated cells than the control cells
(Fig. 3d).
GR and NFκB activation enhances long-range chromatin
contacts
The 4C assays support the presence of long-range inter-
action networks among P300 DBSs. Furthermore, they
uncovered a significant increase in contact frequency at
induced but not at pre-existing P300 DBSs (Fig. 3c,d).
To further investigate this difference, we divided the
ChIA-PET interaction subdomains into two groups: sub-
domains containing only pre-existing P300 DBSs, and
subdomains containing at least one induced P300 DBS.
We then compared their interactome in the ChIA-PET
profiles. However, to directly compare the two condi-
tions, the immunoprecipitation-introduced bias inherent
to ChIA-PET had to be taken into account. The ChIP
step results in a restricted representation of the interac-
tome. A possible confounding factor in ChIA-PET is
that chromatin regions with a higher number of binding
sites with high occupancy (RPKM) – that is higher local
concentration of P300 – may be ChIPed with higher effi-
ciency than regions with fewer binding sites and lower
P300 occupancy.
In order to accurately compare the pre-existing and
induced subdomains in untreated and co-stimulated
ChIA-PET libraries, we first estimated the local P300
concentrations (average P300 signal) by summing up the
RPKM values of P300 DBSs in ChIA-PET interaction
subdomains harboring at least five P300 DBSs with a
different degree of P300 induction (Fig. 4a). With few
exceptions, the co-stimulation marginally affected the
local concentration of P300 as compared to vehicle-
treated cells (<2-fold) (Fig. 4b). Next, we selected subdo-
mains that upon co-stimulation responded with no more
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than a 25 % change in total P300 concentration (subdo-
mains within the shaded area in Fig. 4b). We computed
the chromatin interaction frequencies (ChIA-PET inter-
actions/subdomain) in subdomains that had at least one
or no induced P300 DBSs. In order to take into account
the coverage difference of the two P300 ChIA-PET librar-
ies, we used the one-sided Mann–Whitney–Wilcoxon test.
Interestingly, P300 hubs bearing induced P300 DBSs dis-
played a significant increase in chromatin contacts upon
co-stimulation versus vehicle-treated cells (Fig. 4c, upper
panel). Such preference is not evident in subdomains har-
boring only pre-existing P300 DBSs (Fig. 4c, lower panel).
Thus, preferential involvement of ligand-induced P300
DBSs in chromatin interactions implies that GR and/or
A
C D
B
Fig. 3 Glucocorticoid receptor (GR)-dependent and p65 activation-dependent changes in chromatin interactions. a, b Direct comparison of
chromatin contacts revealed by P300 ChIA-PET and 4C-seq analyses at the ZBTB16 (a) and KLF6 loci (b). 4C-seq bait loci are marked on each
screenshot (blue arrow). Genomic regions that show a marked change in 4C signal upon triamcinolone acetonide (TA) + tumor necrosis factor
alpha (TNFα) treatment are marked red below the Δ4C track. c Direct comparison of changes in average ChIP-seq signal (left panel) and 4C signal
(right panel) at all the constitutive P300 distal binding sites (DBSs) within the ten 4C-seq genomic view points upon TA + TNFα treatment. d Direct
comparison of changes in average ChIP-seq signal (left panel) and 4C signal (right panel) at all the induced P300 DBSs within the ten 4C-seq
genomic view points upon TA + TNFα treatment. DMSO dimethyl sulfoxide
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NFκB binding to DNA via their cognate cis-acting ele-
ments opens up the closed chromatin by recruiting
chromatin-remodeling complexes. Such open chromatin
regions preferentially contact other P300 DBSs with a
similar regulatory factor composition and chromatin
state, resulting in an interaction network that is synchro-
nized upon ligand-dependent GR and/or NFκB recruit-
ment, resulting in increased contact frequency. We
preferentially detected the networks that were highly af-
fected by ligand stimulation. These networks are already
established prior to stimulation (as detected by 4C-seq).
However, the increase of the contact frequency at in-
duced P300 DBSs upon ligand activation indicates the
synchronization of such networks.
We therefore consider that the (over) representation
of induced interactions in our data sets may imply that a
considerably larger proportion of cells in the population
have the P300 protein network at these loci because the
queried loci were synchronized by ligand treatment.
GR and NFκB networks are enriched with their target
genes
Finally, we assessed the impact of agonist-induced regu-
latory elements and their special re-organization on
transcriptional regulation using gene-body POLII density
as a direct read-out [6]. We quantified all the DBS-
promoter contacts that were identified in both P300 and
POLII interaction data sets. Importantly, 70 % of P300
and 50 % of POLII bound DBS were not contacting the
nearest (first) active transcription start site (TSS) but a
more distal TSS (Fig. 4d). Next, we computed the gene-
body POLII density of genes that were connected to (in-
duced and pre-existing) P300 DBSs. We observed a con-
sistent positive correlation between ligand-dependent
gene induction and P300 induction at the DBS (Fig. 4e).
Genes linked to induced P300 DBSs respond avidly to
ligand induction as compared to genes that are interact-
ing with pre-existing P300 DBSs. Similarly, expression of
all genes in the agonist-induced interaction subdomains
was significantly increased upon co-stimulation whereas
genes in the constitutive subdomains were unresponsive
to agonists (Fig. 4f ). Gene ontology (GO) analysis of
genes in the induced P300 hubs instigated by activation
of NFκB (TNFα or co-stimulated) are enriched for GO
terms associated with inflammatory response whereas
genes linked to activated GR-induced P300 hubs are
enriched for various biological processes, including
macromolecule metabolic processes. Genes connected to
constitutive P300 hubs are enriched for GO terms asso-
ciated with general cellular processes (Additional file 13:
Table S3). Taken together, our data strongly suggests
that GRE-containing or NFκB RE-containing latent en-
hancers that are activated upon ligand stimulation pref-
erentially engage the GR and NFκB target genes and
subsequently modulate their expression.
Discussion
In this study, we have analyzed the impact of agonist-
activated GR and p65 (NFκB) on chromatin state, 3D
organization, and transcriptional regulation. Activated
GR and p65 are mainly recruited to pre-existing regula-
tory elements that are pre-bound by P300, and display
the epigenetic signature of active enhancers prior to TF
activation, that is, they fall into the “permissive” model
category. Our findings are in line with recent findings
suggesting that signal-dependent TFs largely access the
enhancer landscape that is set up by other lineage-
specific TFs such as PU.1, C/EBPα, and AP1 [4, 5, 30, 34].
However, in ChIP-seq, we also observed de novo re-
cruitment of P300 by activated GR and/or p65 to
thousands of regions that subsequently acquired
enhancer-like epigenetic features, in line with recent
studies [5, 33, 34]. ChIA-PET and 4C analysis indicate
that these sites are involved in interaction that would
fall into the “instructive” category. The chromatin
signature and epigenetic changes in response to ligand
activation at these induced DBSs are reminiscent of
“latent enhancers” [34, 47].
(See figure on previous page.)
Fig. 4 Ligand-induced enhancement of chromatin contacts within P300 interaction subdomains. a Bar plot depicting the percentage of induced
P300 peaks in the P300 hubs with at least five P300 peaks. b P300 local concentration at all P300 interaction subdomains that are ordered based
on average P300 density (x-axis) and ligand-induced change in P300 concentration (y-axis). Sub-domains harboring at least five P300 distal bind-
ing sites (DBS) are presented. c Total number of chromatin interactions detected at each interaction subdomain upon vehicle dimethyl sulfoxide
(DMSO, blue dots) and triamcinolone acetonide (TA) + tumor necrosis factor alpha (TNFα, red dots) treatment is presented. Sub-domains that show
no more than 25 % change in total P300 concentration (reads per kilobase per million mapped reads) that either harbor at least one induced
P300 DBS (upper panel) and only constitutive P300 DBS (lower panel) are used. p-values (Mann–Whitney) were generated by comparing interaction
ratios (TA + TNFα/DMSO) between the induced and constitutive subdomains that are within each bin (shaded area). d Proportion of DBSs to
nearest first gene promoters or DBSs to distal gene promoter interactions identified by P300 and RNA polymerase II (POLII) ChIA-PET analysis. TSS
transcription start site. e Co-activation-dependent changes in expression of genes that are directly looped to P300 DBSs. P300 DBSs were initially
ordered according to agonist-induced P300 recruitment (low to high) and subsequently divided into 10 equal bins. The average transcriptional
change of genes in each bin is presented. Expression of genes that are in bins harboring significantly repressed (gray), induced (red), and
constitutive (blue) P300 DBSs upon co-stimulation. f Co-activation-induced changes in expression of genes that are within interaction
subdomains harboring either induced or only constitutive P300 DBSs
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An important question is how the agonist-induced en-
hancers and their target genes are spatially organized.
We have compared the P300-mediated chromatin inter-
actomes before and after GR and NFκB co-activation.
Using ChIA-PET against P300, we observed the forma-
tion of P300-mediated long-range interactions at subdo-
mains bearing induced P300 DBSs in response to ligand
activation. With the current depth of ChIA-PET librar-
ies, these interactions appeared to be either formed de
novo (from latent enhancers) or stabilized upon ligand
induction. In 4C analysis we reproducibly detected in-
creased interactions at induced P300 DBSs; the induc-
tion in the 4C approach is, however, less pronounced as
compared to ChIA-PET. This difference is likely due to
intrinsic differences between the two assays: 4C detects
long-range interactions irrespective of the presence or
absence of P300 and hence is able to detect lower
strength or lower frequency interactions and those that
are P300 independent. In ChIA-PET, the immunoprecip-
itation step enriches for interactions mediated by P300
and does not pick up P300 independent interactions,
providing an all or nothing picture. Collectively and in
agreement with each other, our ChIA-PET and 4C re-
sults show that activation of GR and/or NFκB facilitates
an induced interaction signal at a subset of DBSs. We
interpret this increased signal as an increase in either
the interaction frequency (stabilization of a network) or
in the proportion of cells that engage in such interaction
(synchronization of a network).
Recent 3C-based studies of individual loci reported on
the role of GR and NFκB in long-range gene regulation
[10, 13, 48]. For example, the Lcn2 gene locus is engaged
in multiple long-range contacts with GR DBS. In agree-
ment with our findings, it was shown that activated GR
increases local chromatin interactions without dramatic
change in 3D organization. In another report exploiting
the 4C approach, activated GR was shown to bind a
downstream enhancer of the Tsc22d3 gene, causing a
2-fold increase in long-range enhancer–promoter inter-
action and activation of transcription [13]. Similarly, TNFα
induces chromatin interactions between distal NFκB-
bound enhancers and the promoter proximal regulatory
sites of CCL2 [10]. In contrast, a recent study based on
genome wide Hi-C analysis revealed that the vast majority
of TNFα responsive enhancers, as determined by p65
binding, show little change in DNA looping after TNFα
treatment [16]. The authors note that only ~15 % of p65
DBSs display an activated enhancer signature (increase in
H3K27ac signal and enhancer RNA production) upon
TNFα treatment. The apparent discrepancy with our
study is likely due to the differences in resolution of ap-
plied techniques. In agreement with Jin et al., we found
that the majority of long-range interactions are pre-
established and not dynamic; however, by applying
ChIA-PET and high-resolution 4C, we found a signifi-
cant increase in long-range interactions at induced
but not constitutive P300 DBSs. These changes in a
subset of interactions are conceivably difficult to pick up
using a relatively low-resolution Hi-C-only approach.
One of the questions debated in the field of chromatin
topology is the extent to which long-range interactions
are dynamic and correlate with gene expression, such as
in response to extracellular stimuli or during differenti-
ation. The instructive model suggests de novo formation
of long-range interactions, where lineage-specific and/or
signal-induced TFs establish a new interaction landscape
and affect the expression of their target genes [10–14, 49].
Our data provides support for this model: at ligand-
induced DBSs, ChIA-PET and 4C data show an increased
interaction signal at loci that were largely closed with low
or no active epigenetic marking (H3K27ac) but with low
levels of H3K4me1, reminiscent of latent enhancers [34].
Our data also provide support for the permissive model,
showing that the long-range interaction landscape is
pre-formed in the absence of ligand induction.
Ligand-activated TFs appear to join a pre-set network
of enhancers and trigger transcription by lineage-
specific and/or signal-induced TFs [16–18].
Conclusions
We conclude that the ligand-activated GR and p65
induce chromatin accessibility, P300 recruitment, and
alterations of 3D chromatin structure at a subset of gen-
omic loci. At subdomains with induced P300 binding,
activated GR and p65 facilitate close spatial proximity of
the induced P300 DBS with a pre-existing interaction
network and enhancement of 3D chromatin contacts. Our
data suggest that ligand induction causes synchronization
or stabilization of active chromatin states and higher order
structure in a large proportion of cells to facilitate efficient
regulation of their target genes. We speculate that this
spatial clustering of regulatory elements can cause an in-
crease in the local concentration of regulatory proteins,
which ultimately can enhance the transcriptional activity
of associated genes. Further experiments are needed to
validate and expand on these findings, to elucidate the role
of inducible TFs in long-range regulation, and to firmly es-
tablish that increased physical looping interaction indeed
leads to increased transcription.
Methods
Cell culture
HeLa B2 cells were maintained as described [7]. Cells
were cultured in Dulbecco’s Modified Eagle Medium
supplemented with 10 % charcoal stripped fetal calf
serum for 72–96 h before subsequent treatment and/or
harvesting. Cells were treated with either DMSO or 1 μM
of TA (T6501, Sigma-Aldrich, St. Louis, Missouri, United
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States) for 4 h with or without an additional treatment with
10 ng/mLTNFα (T0157, Sigma-Aldrich) for the last hour.
ChIP-seq
ChIP was performed according to standard protocol [50]
with minor modifications. Paraformaldehyde (1 %)
cross-linking was carried out for 10 min followed by the
chromatin preparation as described earlier [7]. Nuclei
were re-suspended in ChIP-incubation buffer at a con-
centration of 20 × 106 cells/mL and sheared (seven cycles
with each cycle containing 10 s power on and 10 s
interval) using Bioruptor®Plus (B01020001, Diagenode,
Liege, Belgium). Sonicated chromatin equivalent of 4 ×
106 cells was incubated with relevant antibody overnight
at 4 °C. Antibodies against P300 (sc-585x, Santa Cruz
Biotechnology, Inc., Dallas, Texas, United States), POLII
(MMS-126R-500, Covance, Inc., Princeton, New Jersey,
United States), H3K27ac (C15410196, Diagenode),
H3K4me1 (C15410194, Diagenode), and H3K4me3
(C15410003, Diagenode) were used. ChIP-seq sample
preparation and sequencing was performed according to
manufacturer’s instructions (Illumina, San Diego, Cali-
fornia, United States) and essentially as described [6, 9,
51] (http://www.blueprint-epigenome.eu).
ChIP-seq data analysis
The image files generated by HiSeq2000 (Illumina) were
processed to extract sequence data and the 36/42 bp
tags were unambiguously mapped to the human genome
(NCBI, hg19) using the bwa aligner, allowing at most
one nucleotide mismatch. Reads were further direction-
ally extended to 200 bp, corresponding to the original
length of the DNA fragments used for sequencing. For
each base pair in the genome, the number of overlapping
sequence reads was determined, averaged over a 10 bp
window, and visualized in the University of California
Santa Cruz genome browser (http://genome-euro.ucsc.edu).
ChIP-seq data sets were normalized as described [6, 7] in
order to eliminate the differences caused by sequencing
depth/mapping efficiency.
Detection of putative P300 and POLII binding sites was
performed using MACS (version 1.4.2) [52] with the
p-value <10−9. Peaks identified by using each antibody in
DMSO, TA, TNFα, and TA +TNFα were combined in a
common pool and sequence tags were counted under each
peak location (for each data set separately). Then we calcu-
lated the intensity (log2 RPKM) of peaks in each treatment.
Binding sites that showed a significant change (median ±
2 ×median absolute deviation; p < 0.05) in signal for P300
or POLII in a treatment compared to that in the vehicle-
treated sample were regarded as dynamic binding sites.
Published GR, p65, and POLII ChIP-seq data that were
generated in an identical experimental setup in HeLa B2
cells [GEO: GSE24518] were used in this study.
DNase I-seq
DNase I libraries were prepared from DMSO-treated
and TA + TNFα-treated Hela B2 cells as described
(http://www.uwencode.org/protocols). In brief, 5 × 106
nuclei were isolated using Buffer A (15 mM NaCl; 60
mM KCl; 1 mM EDTA, pH 8.0; 0.5 mM EGTA, pH 8.0;
15 mM Tris–HCl, pH 8.0; 0.5 mM spermidine) supple-
mented with 0.06 % IGEPAL CA-630 detergent. DNase I
treatment (60 units) was performed for 3 min and the
reaction stopped with stop buffer (50 mM Tris–HCl, pH
8; 100 mM NaCl; 0.10 % SDS; 100 mM EDTA, pH 8.0; 1
mM spermidine; 0.3 mM spermine). The sample was
further fractionated on 9 % sucrose gradient for 24 h at
25,000 rpm at 16 °C. Fractions containing DNA frag-
ments smaller than 1 kb were purified and processed for
sequencing according to the Illumina library preparation
protocol. Normalized (read number equalized) DNase I
data sets were used for the downstream analysis and
visualization.
ChIA-PET library preparation
ChIA-PET libraries were prepared using the standard
protocol [35, 36]. Chromatin preparation and ChIP en-
richment using P300 and POLII antibodies were per-
formed as described above. Briefly, chromatin captured
on magnetic beads was trimmed (blunt end), phosphory-
lated on 5′ ends, then underwent biotinylated half-linker
ligation. Chromatin complexes were then divided into
two equal halves and two independent half-linker
ligation reactions were performed using half-linkers A
and B containing specific barcodes (linker-A TAAG;
linker-B ATGT). Subsequently, chromatin complexes
were eluted from the beads and two linker ligation ali-
quots were combined together for proximity ligation
under diluted conditions. Subsequently, reverse cross-
linked and purified circular DNA was digested using
MmeI enzyme (the restriction site is encoded on the
linker). Next, biotinylated DNA fragments were immobi-
lized on M-280 streptavidin Dynabeads (Invitro-
gen, Carlsbad, California, United States) followed by
adaptor ligation. The efficiency of the library preparation
was evaluated by polymerase chain reaction (PCR) and
subsequent gel electrophoresis. Next, each library char-
acterized by adaptor-ligated DNA fragments carrying 20
bp of genomic DNA flanking the 36-bp linker sequence
on either side was sequenced on a HISeq200 (Illumina).
A typical sequencing run yielding 200 million single-end
reads of 100-bp length was generated for each library.
ChIA-PET data analysis
The first 72 bp of each sequenced read carrying the
complete ChIA-PET ligation product (linker plus gen-
omic DNA) was taken for the further analysis after trim-
ming the ends of each read. Subsequently, single-end
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sequenced reads were split at the linker ligation junction
(linkerA/B-|-linkerA/B) and flipped to make the data
compatible (similar to paired-end sequencing reads) for
the ChIA-PET data analysis pipeline [42]. The average
distance between binding sites (P300 and POLII), identi-
fied based on the ChIA-PET self-ligation PETs and the
binding sites identified by ChIP-seq, were examined to
ascertain the reproducibility of binding sites by these
methods. The binding sites identified by both methods
were highly comparable, but a larger number of total
binding sites were identified by ChIP-seq owing to the
higher sequencing depth. Therefore, we used ChIP-seq
binding sites as anchors to identify the intra-chromosomal
and inter-chromosomal interaction PETs. True long-range
interaction signals were distinguished from the non-
specific technical interaction noise by using the method
described earlier [42]. Briefly, interaction PETs having a
PET count equal to two or more for P300 libraries and
three or more for POLII libraries at a false discovery rate
<0.05 were considered as high confidence interaction clus-
ters. We used a 5 kb and 1 Mb genomic span as the lower
and upper cutoff limits, respectively, to define the high
confidence interaction PET data. Each interaction PET
contained a pair of interacting anchors. Direct overlap
(book end or 1 bp) of anchors of each cluster with that of
other clusters was performed to identify interaction com-
plexes or interaction subdomains. Hence, the interaction
clusters were further collapsed in to interaction com-
plexes/subdomains based on the interconnectivity of the
PET clusters.
Identification of dynamic interactions using ChIA-PET
data sets
To minimize the bias induced by local P300 concentra-
tion on the chromatin interactions detected by ChIA-
PET, we analyzed the changes of interaction frequencies
per each P300 ChIA-PET defined subdomain as follows.
For each subdomain, we counted the number of P300
peaks and calculated the P300 concentration (average
log2 RPKM) in DMSO-treated and TA + TNFα-treated
samples. All the subdomains are ranked by the average
P300 concentration of DMSO and TA + TNFα treat-
ments. We discarded the subdomains with less than five
P300 peaks, and separated subdomains with at least one
induced P300 peak (261 subdomains) and the ones with
only constitutive P300 peaks (283 subdomains). We plot-
ted the number of interaction clusters identified in DMSO
and TA +TNFα data sets separately for individual subdo-
mains. The subdomains were further filtered by the fold
change of P300 concentration (>−0.3 and <0.3) and this
resulted in 131 and 206 subdomains, respectively. The
Mann–Whitney test was adopted to investigate the
agonist-induced change in average chromatin interaction
frequencies in comparable groups of subdomains that
harbor only constitutive P300 DBSs against those having
at least one agonist-induced P300 DBS.
4C-seq library preparations
4C assays were performed as described previously [46]
with minor modifications. Briefly, 107 cells were cross-
linked for 10 min with 2 % paraformaldehyde, quenched
with glycine, and lysed in 50 mL lysis buffer (50 mM
Tris, pH 7.5; 150 mM NaCl; 5 mM EDTA; 0.5 % NP-40;
1 % TX-100; 1X protease inhibitors) for 30 min. Nuclei
were then digested by DpnII enzyme followed by inacti-
vation of the restriction enzyme by incubating at 65 °C
for 20 min. The digested chromatin was subsequently
ligated (circularized) overnight at 16 °C with 50 U T4
ligase. Ligated chromatin was then reverse cross-linked
by incubating with proteinase K at 65 °C and the RNA
was removed by additional incubation at 37 °C with RNase
A. The purified DNA was further digested with a second
restriction enzyme of choice (BfaI, MseI, or NlaIII)
followed by circularization of the DNA. The 4C product
was subsequently amplified with bait-specific inverse
primers (Additional file 14: Table S4). From each 4C
library, about 3200 or 800 ng DNA was amplified in
multiple parallel PCR reactions containing 200 ng of DNA
each, which were subsequently pooled and purified.
Amplified bait-containing DNA fragments were li-
gated to NextFlex DNA barcoded adaptors (Bioo Scien-
tific, Austin, Texas, United States). Adaptor-ligated DNA
was purified by Agencourt AMPure XP purification system
(Beckman Coulter, Brea, California, United States), PCR
amplified (eight cycles), and sequenced single-end on the
Illumina HiSeq2000 to obtain 50-bp-long reads.
4C-seq data analysis
To improve the mappability of the sequence reads, we
generated a reduced genome by extracting the sequences
flanking the DpnII sites (30 bp on each strand from the
DpnII sites to downstream) based on build version hg19
of the human genome. Then we estimated the mappabil-
ity of the extracted sequences (each strand separately)
and only uniquely mappable DpnII sites were considered
for downstream analysis.
All the reads from each library were parsed based on
the bait-specific primer sequence and mapped to the re-
duced genome using bwa (version 0.6.2) with the default
parameters. The mapping data of the individual libraries
are summarized (Additional file 15: Table S5). We ini-
tially mapped each replicate library separately and
merged the replicate libraries based on their quality. The
4C signal was calculated using a sliding window of 10 kb
(±5 kb of a given DpnII site) and normalized to the total
number uniquely mapped reads. Δ4C is the difference of
4C signal in each genomic bin (10 kb) between the nor-
malized DMSO and TA + TNFα data sets.
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Gene ontology analysis
GO analysis was performed using the DAVID web tool
[53, 54]. Gene sets were analyzed for enriched GO terms
(biological processes) compared to the human genome
database as background. Fisher’s exact test was used to
identify significantly enriched GO terms.
Data availability
All the ChIP-seq, ChIA-PET, and 4C raw data files have
been submitted to GEO database [GEO: GSE61911].
Previously published GR, p65, and POLII ChIP-seq data
can be accessed via [GEO: GSE24518].
Ethical approval
No approvals were required for the study, which com-
plied with all relevant regulations.
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SUMMARY
Serum-to-2i interconversion of mouse embryonic
stem cells (mESCs) is a valuable in vitro model for
early embryonic development. To assess whether
3D chromatin organization changes during this tran-
sition, we established Capture Hi-C with target-
sequenceenrichment ofDNase I hypersensitive sites.
We detected extremely long-range intra- and inter-
chromosomal interactions between a small subset
of H3K27me3 marked bivalent promoters involving
theHox clusters in serum-grown cells. Notably, these
promoter-mediated interactions are not present in 2i
ground-state pluripotent mESCs but appear upon
their further development into primed-like serum
mESCs. Reverting serum mESCs to ground-state 2i
mESCs removes these promoter-promoter interac-
tions in a spatiotemporal manner. H3K27me3, which
is largely absent at bivalent promoters in ground-
state 2i mESCs, is necessary, but not sufficient, to
establish these interactions, as confirmedbyCapture
Hi-C on Eed/ serum mESCs. Our results implicate
H3K27me3 and PRC2 as critical players in chromatin
alteration during priming of ESCs for differentiation.
INTRODUCTION
The pluripotent properties of mouse embryonic stem cells
(mESCs) make them an invaluable model for fundamental
research into the regulatory mechanisms in early development.
mESCs are classically cultured in growth media supplemented
with fetal calf serum and leukemia Inhibitory Factor (LIF) or,
more recently, in serum-free 2i medium that contains LIF plus
two small-molecule kinase inhibitors: PD0325901, targeting
the mitogen-activated protein kinase (MEK) pathway, and
CHIR99021, targeting the glycogen synthase kinase-3 (GSK3)
pathway (Ying et al., 2008). It is well accepted that 2i mESCs
represent a ground-state pluripotency, whereas the classical
serum-derived mESCs are reminiscent of post-implantation
pluripotent stem cells (Marks and Stunnenberg, 2014; Marks
et al., 2012; Nichols and Smith, 2009; Odsworth et al., 2015;
Plusa and Hadjantonakis, 2014; Ying et al., 2008).
mESCs grown in both serum+LIF (‘‘serummESCs’’) and 2i+LIF
media (‘‘2i mESCs’’) are pluripotent; however, they show distinct
epigenetic landscapes and transcriptomic profiles (Habibi et al.,
2013;Marks et al., 2012). 2imESCshave higher expression levels
of metabolic genes and diminished expression levels of lineage-
priming genes compared to serummESCs (Marks et al., 2012). In
serum mESCs, around 3,000 genes have a bivalent chromatin
state (co-occurrence of H3K27me3 and H3K4me3 marks) and
are said to be poised for activation and predominantly coincide
with promoters of genes involved in cell-fate determination and
development (Azuara et al., 2006; Bernstein et al., 2006; Ku
et al., 2008). In 2i mESCs, the number of bivalent genes reduces
drastically; however, loss of repressive H3K27me3 does not
result in transcriptional activation (Marks et al., 2012; Pasini
et al., 2007). 2i mESCs have a hypo-methylated DNA similar to
pre-implantation embryos, whereas serum mESCs are hyper-
methylated, reminiscent of post-implantation embryos (Habibi
et al., 2013; Leitch et al., 2013; Seisenberger et al., 2012; Smith
et al., 2012). Together, these findings suggest that serummESCs
are epigenetically more restricted and developmentally primed
as compared to ground-state 2i mESCs.
The 3D organization of chromatin may well play a role in initi-
ation and/or maintenance of the distinct epigenetic landscapes
and gene expression in the two states of pluripotency. The plas-
ticity of the 3D conformation and its instructive role has been a
subject of debate in recent years. The prevailing view is that in
closely related cell types global interaction dynamics are limited,
while fine-tuning of local interactions is potentially more frequent
and linked to the transcriptional state (Bickmore, 2013; Dixon
et al., 2015; Gibcus and Dekker, 2013; de Wit et al., 2013).
Most of the promoter-promoter and promoter-enhancer
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interactions take place within Topologically Associated Domains
(TADs), which are on average 880 kb in size (Dixon et al., 2012).
On the other hand, long-range interactions that span across
TADs as well as chromosomes are rare when compared to the
frequency of intra-TAD interactions (Gibcus and Dekker, 2013;
Schwartz et al., 2012; Seitan et al., 2013; Sofueva et al., 2013).
In this study we assessed the dynamic reorganization of the
3D chromatin architecture in two closely related states of plurip-
otency using a Capture Hi-C (CHi-C) approach.
RESULTS
CHi-C
To study dynamics in chromatin architecture and to characterize
long-range interactions, we performed Hi-C using DpnII as
the restriction enzyme, potentially reaching a genome-wide
coverage at a resolution of less than 1 kb. We subsequently per-
formed enrichment of interactions by a target-capture (called
CHi-C), similar to the exome sequencing approach. We enriched
ligation products (interactions) using probes designed to capture
targeted regions (Table S1). Probeswere designed to capture loci
targeting the union of all DNase I hyper-sensitive sites (DHSs)
from the chromatin of serum and 2i mESCs (Figures S1A and
S1B, Table S1). This elaborate representation of the genome of
100k loci allows probing of promoter-promoter, promoter-
enhancer, and enhancer-enhancer contacts (Figure 1A). After
paired-end sequencingwas performed,we removed unanchored
reads and duplicates, yielding a total of 784 million reads (Table
S1) with 2 million significant long-range contacts. The fold
enrichment for the probe-targeted open chromatin regions was
20-foldwith a capturing efficiency of 58.4%on average (at least
one-end overlap with targeted regions). To validate the robust-
ness of the CHi-C approach, all experiments were conducted in
two biological replicates and resulted in high reproducibility (Fig-
ures S1C–S1H). The distributions of promoter-promoter, pro-
moter-enhancer, and enhancer-enhancer interactions between
2i and serum mESCs were found to be very similar (Figure 1A).
Extremely Long-Range Interactions
We computed a score for each interaction that is a function of
distance and frequency of contact between two genomic frag-
ments, using a pipeline specifically developed to analyze
CHi-C data, called ‘‘CHiCAGO’’ (Cairns et al., 2015). We used
five di-tag reads within five adjacent DpnII fragments as a cut-
off. Visual inspection showed high-ranking interactions involving
Hox and other genomic loci in serummESCs that were absent or
very low in 2i CHi-C (Table S2). Next, we performed virtual-4C
analyses to identify long-range interactions excluding intra-
TAD interactions. We filtered for differential long-range interac-
tions between serum and 2i mESCs (>3-fold change). The Circos
plots revealed prominent interactions that are intra- as well as in-
ter-chromosomal (Figure 1B, red lines), henceforth defined as
Extremely Long-Range Interactions (ELRIs). Including Hox
genes, 108 protein coding genes and 93 non-coding genes
were identified to be directly overlapping with ELRI loci (Table
S2). Most of the previously reported Hox interactions in serum
mESCs (Vieux-Rochas et al., 2015) were independently identi-
fied by our CHi-C approach. ELRIs nearly exclusively occur in
serum mESCs and are absent or strongly reduced in ground-
state 2i mESCs. Local intra-TAD contacts appear largely unaf-
fected (Figure 1B, blue lines, and Figure S1I). Examples of dy-
namic interactions between the HoxD locus and Lmx1b or Wt1
loci on chromosome 2, as well as the reverse from Lmx1b to
HoxD locus, Lhx2, and Dlx1/Dlx2, are illustrated (Figures 1C–
1E). To validate the results obtained from CHi-C, we performed
4C on selected ELRI loci and found high consistency, showing
the robustness of the CHi-C approach (Figure S2). FISH experi-
ments proved to be challenging because of the refractory prop-
erties of 2i mESCs and did not yield confident results.
Characteristics of ELRI Loci
We next investigated the epigenetic makeup of ELRI loci by
profiling histone marks: H3K4me3, H3K36me3, H3K4me1,
H3K27ac, H3K9me3, and H3K27me3. In addition, we also pro-
filed other DNA-binding proteins: RNA Polymerase II, Ring1B,
Suz12, and CTCF (Figure 1F). The analysis reveals H3K27me3
as the prominent feature of ELRI loci. The presence of
H3K27me3 with low levels of H3K4me3 is the hallmark of biva-
lent loci. Like H3K27me3, Ring1B and Suz12 are also prominent
factors localized at ELRI loci (Figure 1F). The presence of
H3K27me3 is not an exclusive feature of ELRI loci as the vast
majority of bivalent loci, even those with very high H3K27me3
marking, do not participate in ELRIs (Figure 1G). A virtual-4C
plot from the HoxD viewpoint underscores the selective nature
of ELRIs (Figure 1D). Thus, the presence of H3K27me3 is a prom-
inent, but not selective, feature of ELRIs.
It is well established that bivalent loci coincide with promoters
of genes involved in cell-fate determination and development
(Azuara et al., 2006; Bernstein et al., 2006). Accordingly, ELRI
loci also largely overlap with promoters of transcription factors
involved in cell-fate determination (78/108) and possess a ho-
meobox DNA-binding domain (63/108) (Figure 1H, Table S2).
Plotting the distributions of ELRI CHi-C and H3K27me3 tags re-
veals their spatial co-localization and confinement to a region
(with an average size of 36 kb) centered on the transcription start
sites (Figure 1I). The intimate connection between ELRI contacts
and H3K27me3 can also be appreciated from Lmx1b and Wt1
ELRI promoters (Figures 1C and 1D).
After establishing the connection between ELRI loci and co-
localization with promoters, we compared the strength of ELRIs
with other classes of promoter-promoter interactions. We com-
puted the average normalized di-tags for promoter-promoter in-
teractions representing intra-TAD interactions (300 kb to 1 mb),
inter-TAD interactions (>1 mb), and ELRI contacts identified by
the CHiCAGO pipeline (Figure 1J). Notwithstanding the extreme
long distance, ELRI contacts were similar in strength to pro-
moter-promoter intra-TAD contacts and were stronger than
non-ELRI promoter-promoter inter-TAD interactions (Figure 1J).
Loss of ELRIs in Eed–/– Serum mESCs
Epigenetic profiling of ELRI promoters points to a role of
H3K27me3 in the interactions. To investigate the putative role of
PRC2 and H3K27me3 deposition in ELRIs, we performed CHi-C
on Eed/ mESCs cultured in serum media. Eed is one of the
core components of the PRC2 complex and the absence of Eed
results in destabilization of the PRC2 complex and a complete
loss of H3K27me3 (Boyer et al., 2006; Wang et al., 2002). We
observed that in Eed/ mESCs, ELRIs are lost or strongly
Cell Stem Cell 17, 748–757, December 3, 2015 ª2015 Elsevier Inc. 749
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reduced, similar to the situation in 2i mESCs (Figures 2A and 2B).
To quantify the loss of ELRI strength, we compared average
normalized di-tags on ELRI promoters of Eed/ mESCs with
WT serummESCs and 2i mESCs (Figure 2C). The strength of EL-
RIs inEed/mESCswascomparable to the strength observed in
2i mESCs. In contrast, the intra-TAD interactions (Figure 2A, blue
Figure 1. ELRIs in Serum mESCs are Lost in 2i mESCs
(A) The bar plots show the abundance of different classes of all CHi-C interactions in serum and 2i mESCs.
(B) A graphical representation of ELRIs using a Circos plot for the chromosomes involved (outermost ring). The plots show the interactions for all H3K27me3
marked loci (blue outer ring) in serum mESCs (left) and 2i (right). Inter- and intra-chromosomal ELRI contacts (red lines) and interactions between other bivalent
genes (blue lines) are represented in the inner plots. The four Hox gene clusters are marked in red.
(C) Schematic representation of chromosome 2 and positions of genes, indicated by dashed squares. Density plots of CHi-C signals are plotted along with the
chromosome. Two ELRI contacts (Lmx1b andWt1) interacting with HoxD are highlighted in red, while non-ELRI genes (Dll4 and Gad2) are highlighted in black.
(D) Zoom-in snapshots of browser views for Lmx1b,Wt1, Dll4, and Gad2 from the HoxD locus as viewpoints. Snapshots for Lmx1b andWt1 depict differential
ELRI contacts with the HoxD locus, in serum mESCs (orange track) and 2i mESCs (dark blue track). Single DpnII fragment resolution of CHi-C shows ELRI
contacts focalized on promoters that overlap with H3K27me3 peaks in serum mESCs and are absent in 2i mESCs. H3K27me3 tracks for serum mESCs and 2i
mESCs are colored red and light blue, respectively.
(E) Zoom-in snapshots as in (D) from Lmx1b as the viewpoint, showing interaction patterns with the HoxD locus, Lhx2, and Dlx1/Dlx2.
(F) A heat map showing topography of histone marks and DNA-binding factors on ELRI loci compared to other bivalent and active genes. Color scheme indicates
highest to lowest enrichment.
(G) A box plot showing comparable H3K27me3 intensity (log2RPKM) on ELRI and other bivalent loci.
(H) Diagrams of the gene-functional classes of ELRIs.
(I) Average profiles of CHi-C and H3K27me3 signals from serummESCs on the transcription start sites (TSSs) of ELRI genes. CHi-C signal (orange line) shows the
focal nature of ELRI contacts around the TSSs of ELRI genes and its correlation with the H3K27me3 mark (blue line).
(J) Comparison between strengths of ELRIs and all other promoter-promoter contacts. Promoter-promoter contacts are illustrated in three distance intervals: 300
kb to 500 kb, 500 kb to 1 mb, and >1 mb. The strengths of other significant promoter-promoter interactions, ELRI contacts, and random promoter-promoter
contacts are represented in blue, red, and gray, respectively. The definition of strength can be accessed in the Supplemental Information.
Also see Figure S1.
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Also see Figure S2.
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line)weregenerallynot affectedby the lossof theH3K27me3mark
in Eed/mESCs as in 2i mESCs (Figure 2A). This implicates that
unlike ELRIs, these intra-TAD interactions are not dependent on
H3K27me3 and PRC2. We validated the Eed/ CHi-C experi-
ments by 4C onHoxA and HoxD as well as on selected ELRI pro-
moters (Figures S2A and S2B). We also compared Eed/ CHi-C
data with existing 4C data, showing good overlap (Figure S2C,
Denholtz et al., 2013). Thus,PRC2andH3K27me3play indispens-
able roles in the formation of ELRIs.
Time-Dependent Loss of ELRIs during Transition from
Serum-to-2i mESCs
To study the dynamics of ELRIs during transition from serum-to-
2i, we performed CHi-C on Day1 and Day3 after medium ex-
change (Figure 3A). The interaction patterns of ELRIs show a
gradual loss starting as early as Day1. Most ELRI contacts are
drastically reduced or were not detected anymore at Day3,
such as the interaction between Bmi1 and the HoxD locus (Fig-
ure 3A). Other ELRI contacts such as Meis2 and Pax6 are still
observable at Day3, although at severely reduced strengths (Fig-
ure 3A). This dynamic loss of ELRI strength was validated using
the 4C approach on Day1 and Day3 mESCs, as exemplified by
HoxA and Vax2 (Figures 3B and S3A) as well as other ELRI con-
tacts (Figure S3B). To quantify the loss of ELRI strength we
compared average normalized di-tags on ELRI promoters during
the transition of serum-to-2imESCs (Figure 3C).Compared to the
strengthof ELRIs inWTserummESCs,weobservedonaveragea
67% reduction on Day1 and an 85% reduction on Day3.
The loss of ELRIs in Eed/ and in WT 2i mESCs shows that
H3K27me3 deposited by the PRC2 complex is necessary for EL-
RIs. However, H3K27me3 deposition is not sufficient for ELRIs,
because most bivalent loci that are equally marked with
H3K27me3 are not involved in ELRIs. Given the interplay be-
tween PRC2 and PRC1 in epigenetic shaping of repressive chro-
matin, we investigated the role of PRC1 in ELRIs as PRC1 has
been shown to be recruited to H3K27me3 to reinforce the func-
tion of PRC2 (Ku et al., 2008). We performed ChIP-seq experi-
ments on Suz12 and Ring1B during the serum-to-2i transition.
The occupancy of the PRC2 component Suz12 on ELRI loci
was unaltered in serum mESCs even up to Day3 (Figure 3D,
mid-panel), whereas H3K27me3 and ELRI contacts were largely
lost (Figure 3D, left panel). In contrast, Ring1B, a central compo-
nent of PRC1, shows a gradual reduction starting as early as
Day1, and the loss of occupancy becomes pronounced or
completed at Day3 in excellent synchrony with the loss of ELRIs
(Figure 3D, right panel). The reduced occupancy observed is not
due to reduced expression of Ring1B or other detected PRC
components as determined by quantitative Mass Spectrometry
(Figure S3C).
This temporal concordance between loss of ELRIs and PRC1
indicates a role of PRC1 as a reader of H3K27me3 and possibly
in mediating ELRIs. We observed that bivalent genes that do not
display ELRIs also have occupancy of PRC1 (Ring1B) similar to
that of ELRI loci. During the serum-to-2i transition, bivalent loci in
general show the same kinetics as ELRI loci with respect to loss
of Ring1B (Figure 3D). It seems likely that ELRIs require a specific
composition of the modular PRC1, specific transcription factor
co-binding, epigenetic context, or some combination thereof
that acts only on ELRI loci.
ELRI-Related Local Chromatin Dynamics and Gene
Transcription
We next investigated the effect of ELRIs on gene expression. We
previously showed that in 2i, two-thirdsof thebivalent genes (total
3,000) are not yet marked with the H3K27me3, but only 10%
show significant transcriptional activity (Marks et al., 2012). Simi-
larly, 18% of ELRI genes are significantly expressed in 2i, and
they become repressed in serum having gained H3K27me3 and
ELRIs (Figures 4A–4B, Table S3). Strikingly, these genes encode
subunits of PRC1: Cbx4, Cbx8, and Bmi1 (Morey et al., 2012).
This suggests a potential change in the composition of PRC1 in
the transition from ground-state 2i to primed serum mESCs.
Another ELRI gene that is significantly more highly expressed in
2i mESCs is Tbx3, which has been shown to be important for
self-renewal of mESCs (Ivanova et al., 2006).
Next, we looked at the temporal changes in local chromatin ar-
chitecture of the ELRI genes during the transition from the
serum-to-2i mESCs state. Loss of ELRIs coincides with diverse
spatiotemporal changes in local intra-TAD interaction patterns
and gene expression. The diverse changes in the local 3D chro-
matin structure and their effects on gene expression are illus-
trated by the following four examples.
ELRI loci such as those encoding Bmi1 gradually lost the
H3K27me3 mark, and their interactions with Hox and with local
inter-TAD H3K27me3 marked regions were also lost. These
changes were accompanied by gain of H3K27ac at the
Bmi1 promoter, i.e., a change in chromatin state (Figure 4C, or-
ange shaded region), and they resulted in increased transcrip-
tional activity. The Lbx1 locus also gradually lost ‘‘negative’’
H3K27me3-mediated interactions, while some of the interacting
regions in serum mESCs, which had been decorated with the
repressive H3K27me3, gained ‘‘positive’’ histone modifications
H3K27ac and H3K4me1 in 2i mESCs (Figure 4F, green shaded
region). In contrast to Bmi1, the transcriptional activity of Lbx1
Figure 3. Dynamics of ELRIs and PRC Subunit Occupancy during the Serum-to-2i Transition
(A) Differential ELRI contacts during the serum-to-2i transition. Using the HoxD locus (blue shaded regions) as the viewpoint, CHi-C signals on chromosome 2
(sum of normalized di-tags in a sliding window of 10 DpnII fragments) are plotted for serum, Day1, and Day3 of serum-to-2i transition and 2i. Dynamics of ELRIs
are highlighted as red shaded regions. On top, ELRI contacts are indicated by red arches.
(B) A browser view of interaction between the viewpoint HoxA locus (shaded blue) and Vax2 (shaded red) during the serum-to-2i transition and in Eed/mESCs
(sliding window of 25 HindIII fragments). Red dashed arch indicates ELRI contact. A zoom-in view on the right shows the loss of ELRI onVax2 during the serum-to-
2i transition and in Eed/ mESCs.
(C) Bar plots of relative strength of ELRI contacts in serum, Day1, and Day3 of serum-to-2i transition and 2i. Standard error of the mean (SEM) of the enrichment is
calculated using the two biological replicates.
(D) Box plots for intensities of H3K27me3, Suz12, and Ring1B on ELRI loci and other bivalent genes in serum, Day1, and Day3 of serum-to-2i transition and 2i
mESCs.
Also see Figure S3.
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was not significantly increased (Figure 4F). In the case of Tbx3,
interactions with H3K27me3 loci were lost (Figure 4E, orange
shaded regions), and contacts with enhancer-like loci (marked
with H3K27ac and H3K4me1) were strengthened (Figure 4E,
green shaded region). However, unlike Lbx1, the transcriptional
activity was increased in response to local chromatin changes.
Finally, at the Meis2 locus, the loss of ELRI and H3K27me3 re-
sulted in the formation of novel contacts between the promoter
and potential enhancers (H3K27ac and H3K4me1 marked loci)
and enhanced transcription of Meis2 (Figure 4D, green shaded
regions).
ELRI genes move from a relatively active chromatin state (in 2i
mESCs) to a repressed chromatin state (in serum mESCs) when
these changes are considered in a developmental context (2i-to-
serum state pluripotency). The changes in the chromatin state
are illustrated in a heat map (Figure S4A). The gradual gain of
H3K27me3 is evident on all ELRI loci during the transition from
ground-state to primed mESCs. However, only a subset of
30 genes lose H3K27ac during the transition from the 2i-to-
serum state and are transcriptionally repressed.
DISCUSSION
In this study, we show that ELRIs involving Hox and other
genomic loci are present in serum mESCs but not yet estab-
lished in the ground-state 2i condition. Our analysis provides
evidence for spatiotemporal changes in 3D chromatin structure
involving establishment of ELRIs during the 2i-to-serum transi-
tion. The overall organization of ELRI contacts established dur-
ing this transition suggests a coordinated program that encom-
passes extensive reshaping of the transcriptome, epigenome,
and 3D interactome during early stem cell differentiation. The
absence of ELRIs in 2i ground-state seems to indicate that these
interactions are not essential for the maintenance of pluripo-
tency. Based on the idea that 2i mESCs represent an earlier
developmental state (i.e. the inner cell mass [ICM]) and serum,
a later developmental state (Boroviak et al., 2014; Habibi et al.,
2013; Hackett and Surani, 2014; Huang et al., 2014; Marks and
Stunnenberg, 2014; Nichols and Smith, 2009; Odsworth et al.,
2015; Plusa and Hadjantonakis, 2014; Ying et al., 2008), we hy-
pothesize that ELRIs are absent in embryos prior to implantation
and that these interactions are acquired at later stages, probably
to restrict or poise controlled genes for transcriptional activity.
This proposal would be in line with the previous findings that
H3K27me3 and PRC2 are not essential for pre-implantation em-
bryos, but are essential for differentiation and formation of pri-
mary cell layers (Pasini et al., 2007; Wang et al., 2002).
The severe reduction in levels of H3K27me3 at ELRI loci in 2i
mESCs, compared to serum mESCs, hints at a role of PRCs in
ELRIs. CHi-C on Eed/ showed that PRC2 activity is necessary.
The occupancy of ELRI loci by Suz12 remains unaltered up to
Day3, at which point 85% of ELRI strength is lost, showing that
the enzymatic activity of PRC2 is a critical factor, rather than
its binding at ELRI loci.
The synchrony between loss of ELRIs and loss of the PRC1
componentRing1B issuggestiveof its role inELRIs.The traditional
view is that PRC2 acts as the initiator in the formation of a PRC2/
PRC1 chromatin state by depositing H3K27me3 that recruits
PRC1 through the Cbx reader protein family (Boyer et al., 2006;
Simon and Kingston, 2009). In serum mESCs, PRC2 has been
shown to recruit PRC1 components to Hox loci (Boyer et al.,
2006). Hence, it is possible that PRC2 acts only as the recruiter
of PRC1, which then mediates ELRIs. In line with this model,
knocking out Eed precludes H3K27me3 deposition and conse-
quently recruitment of a PRC1 complex (Boyer et al., 2006;
Wanget al., 2002). In fully converted 2imESCs (Day15–18), similar
toEed/mESCs, theH3K27me3mark is strongly diminished, re-
sulting in poor recruitment of PRC1 (Habibi et al., 2013).Wepostu-
late that, in 2i mESCs, the loss of enzymatic activity of Ezh2
results in poor or lack ofH3K27me3deposition; consequently, ca-
nonical PRC1cannot bind andELRIs cannot be established. In the
past, Denholtz et al. (2013) have also suggested a role of PRC2 in
chromatin compaction in serum mESCs, although the HindIII-
based 4C did not have sufficient resolution to reveal the pro-
moter-promoter nature of ELRI contacts described in this study.
The subunit composition of the PRC1 complex involved in EL-
RIs remains to be established. Our data show that Ring1B occu-
pancy is not only reduced at ELRI loci but is also reduced at other
bivalent loci and displays the same kinetics during the transition.
Thus, the mere presence of Ring1B (PRC1) is insufficient to
generate selectivity in ELRIs. A role of Ring1B in canonical
PRC1 has been reported in local compaction at Hox loci (Eske-
land et al., 2011). Furthermore, Eskeland and coworkers using
the Eed/ mESCs, showed that PRC2 is not sufficient for local
compaction of chromatin in mESCs, providing a striking parallel
to our study.Given thehighlymodular composition of PRC1com-
plexes (Chen and Dent, 2014; Creppe et al., 2014; Senthilkumar
and Mishra, 2009), we hypothesize that a specific PRC1 subunit
composition is required for ELRI formation, and this specific
PRC1 complex distinguishes ELRI loci from other bivalent loci.
While our manuscript was in revision, Schoenfelder and co-
workers identified extremely long-range interactions in serum
mESCs using a promoter CHi-C approach. Based on Ring1A-
Ring1B-dKO mESCs, they pointed to a role of PRC1, in line
with our speculation (Schoenfelder et al., 2015). Their promoter
and our DHS capture approaches identify ELRIs that largely
overlap (80% of coding genes in Schoenfelder et al., 2015 are
independently identified in our study as ELRIs; Figure S4B).
While we firmly established a role of PRC2 using CHi-C on the
Eed/ mESCs, they revealed the critical role of PRC1 in the
Figure 4. Transcriptional and Chromatin State Changes at ELRI Loci
(A and B) Left panels: a histogram for probabilities of differential expression for 108 ELRI genes (top) and 2,985 other bivalent genes (bottom); genes with a
probability value of greater than 0.2 were considered as differentially expressed (represented as green). Right panel: of the 108 ELRI genes, 89 genes remained
unchanged in transcriptional activity and 19 genes were upregulated in 2i mESCs compared to the serum condition.
(C–F) Snapshots of ELRI loci of Bmi1, Meis2, Tbx3, and Lbx1 genes, respectively. ELRI genes (blue shaded) interact with local H3K27me3 regions (orange
shaded). While resolving H3K27me3-marked ‘‘negative’’ interactions, new ‘‘positive’’ interactions between the promoters and H3K27ac-marked regions (green
shaded) are established. On top of the black boxes for the exemplified loci, intra- and inter-chromosomal interactions between Hox loci and other ELRI loci are
represented as density plots. The red dashed arches represent repressive interactions, whereas the green dashed arches represent positive interactions.
Also see Figure S4.
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process. In the Ring1A-Ring1B-dKO mESCs, ELRIs cannot be
established because these dKO mESCs have an active PRC2
complex but a defunct PRC1 complex. Taking both studies
together, it is prudent to postulate that PRC2 acts as an initiator
of ELRIs by deposition of H3K27me3 and subsequent recruit-
ment of canonical PRC1, whichmay act as the physical mediator
of ELRIs.
EXPERIMENTAL PROCEDURES
Cell Culture
E14 Tg2a (also called E14) is a male mESC line of 129/Ola background. Serum
(E14) mESCs were grown in DMEM containing 10% fetal calf serum in the
presence of LIF, referred to as serum medium. 2i (E14) mESCs were grown
in serum-free NDiff 227 supplemented with MEK inhibitor PD0325901 (1mM)
and GSK3 inhibitor CHIR99021 (3mM) in the presence of LIF, referred to as
2i medium (Ying et al., 2008). All cell cultures were conducted in feeder-free
conditions. The serum-to-2i transition was carried out by washing the mESCs
in serum medium twice with PBS and then switching to 2i medium. Eed/
mESCs were provided to us by Luciano di Croce and Anton Wutz, and are
described in Morey et al. (2012) and Schoeftner et al. (2006). Eed/ mESCs
were also grown in identical conditions to those of WT E14 serum mESCs.
CHi-C
The CHi-C experiment was divided into two parts: in-nucleus Hi-C and ssDNA
probe capture enrichment. In-nucleus Hi-Cwas carried out as described in Na-
gano et al. (2015). DpnII was used as the restriction enzyme. On beads DNA
amplification PCRwas carried out with seven to nine cycles to generate around
1 mg of Hi-C library DNA. The ssDNA probe capture step was carried out using
the protocol providedbyRocheNimbleGen Inc. (http://sequencing.roche.com/
products/nimblegen-seqcap-target-enrichment/seqcap-ez-system/seqcap-ez-
developer.html) optimized for the probe capture library. Libraries were indexed
using NEXTflex adapters (Bioo Scientific Corporation) and 75 bp or 43 bp
paired-end sequencing was performed on Illumina instruments using TruSeq
reagents (Illumina), according to the manufacturer’s instructions.
DNase I-Seq, ChIP-Seq, 4C, and RNA-Seq
A detailed description of sample preparation and data analysis is available in
the Supplemental Experimental Procedures.
Public Datasets Used in This Study
4C primers and 4C data for Eed/ mESCs and serum mESCs are from Den-
holtz et al. (2013). The CHi-CHox loci interactors list is from Schoenfelder et al.
(2015). H3K4me3, H3K9me3, and H3K36me3 ChIP-seq data are from Marks
et al. (2012).
ACCESSION NUMBERS
The accession number for all the raw data generated using high-throughput
sequencing reported in this paper has been deposited in the GEO database
(GEO: GSE72164).
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SUPPLEMENTAL FIGURE LEGENDS 
 
Figure S1, related to Figure 1. Characteristics of the DHSs for probe design and reproducibility between CHi-C 
biological duplicates. (A) Venn diagram for DHSs in serum and 2i mESCs. CHi-C probes were designed against the 
union. (B) Genomic distribution of DHSs based on gene annotation and ChIP-seq of histone marks (C) 
SmoothScatter plots show the numbers of di-tags captured by each probe between experiments with high 
reproducibility. (D) SmoothScatter plots show the number of tags for each fragment pairs (fragments of 20kb binned 
genome) between biological replicates. (E) SmoothScatter plots show the number of tags for each called interaction 
between biological replicates, signifying high reproducibility. (F) Both top and bottom figures show high robustness 
between the normalized tag approach and Hit% approach. Top and bottom figures were generated using a sliding 
window of 30 DpnII and 100 DpnII fragments, respectively. Top and bottom figures together show high robustness 
when using different sizes of sliding window. (G) Virtual-4C plots showing ELRIs observed on chromosome 2 with 
high reproducibility between biological duplicates. The rate of the loss of ELRIs in the second experiment (rep2) for 
serum-to-2i transition was observed to be higher. (H) Heat-map of correlations for ELRI contacts between all CHi-C 
samples. (I) Non-ELRI contacts between H3K27me3 marked regions largely unchanged in serum and 2i mESCs.  
Figure S2, related to Figure 2. Comparison between CHi-C, in-lab generated 4C and 4C from public data sets. (A) 
4C validation of differential ELRI contact from HoxA locus to Vax2 and reverse, using 2 different baits for serum, 2i 
and Eed-/- mESCs. (B) 4C validation of differential ELRI contacts from HoxA locus to other ELRI genes highlighted 
using blue shaded area. (C) High correlation visualized between ELRIs detected by CHi-C and publically available 
4C data (Denholtz et al., 2013) for serum mESCs and Eed-/- mESCs. ELRIs detected from HoxD to other loci on 
chromosome 2 are highlighted by red bands. All ELRI contacts are represented as red arches.  
Figure S3, related to Figure 3. In-lab generated 4C validation for ELRIs detected by CHi-C on the complete serum-
to-2i transition and Eed-/- mESCs. (A) Loss of the interaction between HoxA and Vax2 revealed by CHi-C validated 
using 4C experiments on serum-to-2i transition and Eed-/- mESCs. (B) Loss of the interaction between HoxD and 
other ELRI loci revealed by CHi-C validated using 4C experiments on serum-to-2i transition and Eed-/- mESCs. All 
ELRI contacts are represented as red arches. (C) Bar plot showing the changes of whole cell protein levels of PRC 
components detected using quantitative Mass Spectroscopy for serum-to-2i transition. Y-axis represents Log2 fold 
change compared to serum mESCs. X-axis represents the time points during serum-to-2i transition (4hrs, 8hrs, 
16hrs, 24hrs, 32hrs and 18Days/2i mESCs after medium switch).  
Figure S4, related to Figure 4. Switching of chromatin state of ELRI promoters from serum to 2i pluripotent state. 
(A) Heat-map shows a gradual loss of H3K27me3 mark on Day1 and Day3 of serum-to-2i transition on all ELRI 
promoters. A subset of genes (black dash-lined boxes) show a gradual gain in H3K27ac during the transition. All 
ELRI genes with increased transcriptional activity in 2i form a part of the subset and are labeled in red. (B) Venn 
diagram showing high overlap between ELRI loci detected by our DHS-based CHi-C and promoter-based CHi-C in 
a parallel study (Schoenfelder et al., 2015).  
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SUPPLEMENTAL TABLE LEGENDS 
 
Table S1, related to Figure 1. Experimental information of Capture Hi-C and 4C. The union of DHSs in serum and 
2i mESCs; all DpnII fragments targeted by CHi-C Probes; list of all virtual baits used; sequencing statistics of CHi-
C; list of all primers used for 4C. 
Table S2, related to Figure 1. Identification of ELRIs and annotation of ELRI genes. List of ELRI regions from 
CHiCAGO pipeline and virtual 4C analysis; list of all ELRI genes; all homeobox containing ELRI genes; all ELRI 
transcription factors;  
Table S3, related to Figure 4. ELRI genes that up-regulated in 2i. List of all ELRI genes with significantly increased 
transcriptional activity in 2i.  
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EXTENDED EXPERIMENTAL PROCEDURES 
DNase I-seq 
DNase I libraries were prepared as described in (Shen et al., 2002). Nuclei were isolated using Buffer A (15 mM 
NaCl, 60 mM KCl, 1 mM EDTA, pH 8.0, 0.5 mM EGTA, pH 8.0, 15 mM Tris-HCl, pH 8.0, 0.5 mM Spermidine) 
supplemented with 0.015 % IGEPAL CA-630 detergent. DNase I treatment was done for 3 minutes and the reaction 
was stopped with stop buffer (50 mM Tris-HCl, pH 8, 100 mM NaCl, 0.10 % SDS, 100 mM EDTA, pH 8.0, 1 mM 
Spermidine, 0.3 mM Spermine). The sample was further fractionated on 9% Sucrose gradient for 24 hours at 25000 
rpm at 16 °C. Fractions containing fragments smaller than 1kb were purified and processed according to the 
Illumina library preparation protocol. 
ss-DNA probe design for CHi-C 
ss-DNA probes were designed by Roche NimbleGen Inc. as a custom design. Probes were generated for the union of 
DNase I hotspots (~100,000) for serum and 2i mESCs (~250,000 tiled individual probes), hence providing coverage 
for all of the open chromatin (Table S1). The length of each probe was on an average 75 nucleotides. The probes 
were biotinylated for easy capture with streptavidin beads. Total size of the capture probe library was 41.9Mb. 
ChIP-seq 
ChIP experiments were carried out according to the protocol described (Marks et al., 2012). For Ring-1B and Suz12 
ChIPs, 6 million cells per ChIP were used; for H3K27me3, H3K4me1 and H3K27ac ChIPs, 1 million cells per ChIP 
were used. The antibodies used are as follows: Anti-Ring1B (D22F2) antibody from Cell Signaling and 5µl was 
used per ChIP; Anti-Suz12 (ab1207) antibody from Abcam and 3µl was used per ChIP; Anti-H3K27me3 (07-449) 
antibody from Upstate (Millipore) and 3µl was used per ChIP; Anti-H3K27ac (C15410196-10) and Anti-H3K4me1 
(CS-037-100) antibodies from Diagenode and 3µl was used per ChIP. 
RNA-seq 
Total RNA was extracted using RNeasy mini kit (QIAGEN) following the manufacturer’s instructions. 5ug of 
extracted RNA was depleted from ribosomal RNA using Ribo-Zero Gold Kit (Epicentre Madison, Winsconsin, 
USA). Then, rRNA-depleted RNA was used for library preparation using the TruSeq RNA Sample Prep Kit 
(Illumina) following the manufacturer’s instructions. Libraries were indexed using NEXTflex adapters (Bioo-
Scientific Corporation, Austin, TX, USA) and 43bp paired-end sequencing was performed on Illumina instruments 
using TruSeq reagents (Illumina, San Diego, CA, USA), according to manufacturer’s instructions. 
4C-Seq 
4C assays were performed as described previously (Splinter et al., 2012) with minor modifications. Briefly, 10 
million cells were cross-linked for 10 minutes with 2% paraformaldehyde, quenched with glycine and lysed in 50 ml 
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lysis buffer (10mM Tris pH 7.5, 10mM NaCl, 2% NP-40, 1X protease inhibitors) for 30 minutes. Nuclei were then 
digested with 800U HindIII enzyme followed by 4 hours ‘in nuclei’ ligation at 16˚ C with 2000U T4 ligase (NEB) 
(Nagano et al., 2015). Reverse crosslinked and purified DNA was further digested with 50U DpnII enzyme, 
followed by circularization. 3200ng of 4C library was amplified with bait-specific inverse primers (Table S1), 
pooled and purified. Amplified library was adaptor ligated, PCR amplified (8 cycles) and paired-end sequenced on 
the Illumina NextSeq 500 to obtain 50bp x2 long reads.  
Quantitative Mass Spectrometry 
Total proteins for each sample were isolated and tryptic digested following a published label-free proteomics 
protocol (Liu et al., 2012). Three measurements were made for each sample. At least two biological replicates were 
carried out for each time point. Protein identification and quantification were performed using MaxQuant software 
(version 1.3.5.7) with standard settings (Cox and Mann, 2008) and searched against the UniProtKB/Swiss-Prot 
mouse database (generated from version 06-2012).  
DNase I-seq and ChIP-seq data analysis 
Reads were mapped to the reference mouse genome (mm9) using BWA (Li, 2014) with default parameters and only 
uniquely mapped reads were kept. PCR duplicates were removed. MACS2 (Zhang et al., 2008) was used to call 
peaks with parameters “--nomodel --broad”. Peaks were filtered based on peak score. Overlap peaks were merged if 
they are from ChIP-seq samples of the same antibody or DNase I-seq samples.  
RNA-seq data analysis 
MMSEQ package (Turro et al., 2011) was used to infer gene expression levels. Reads were mapped to mouse gene 
annotation (Ensemble release 67). MMDIFF (Turro et al., 2014) was used to calculate probability of differential 
expression with default settings. Genes were considered to be up regulated in 2i, if RPKM > 1 in each 2i biological 
replicate and probability > 0.2.  
4C-Seq Data analysis 
To improve the mappability of the sequencing reads, we generated a reduced genome by extracting the sequences 
flanking the HindIII cutting sites (30bp on each strand from the HindIII cutting sites to downstream) based on the 
reference mouse genome (mm9). Then we evaluated the mappability of the extracted sequences (each strand 
separately) and only uniquely mappable HindIII cutting sites were considered for downstream analysis.  
All the reads from each library were parsed based on the bait-specific primer sequence and mapped to the reduced 
genome using BWA with the default parameters. 4C signals and 4C hits were calculated using a sliding window of a 
fixed number of HindIII fragments and normalized to the total number of uniquely mapped reads.  
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compared to when HindIII is used as the restriction enzyme. To achieve a 3D map at single DpnII resolution, 
innumerous reads will be needed. Therefore, to lower the need of sequencing depth, we created “virtual targeted 
fragments” by merging adjacent targeted DpnII fragments and “virtual non-targeted fragments” using tiles of 5 
DpnII fragments. Besides the default threshold of 5 for the CHiCAGO score, we also called for at least 5 reads to 
support an interaction.  
Identification of ELRIs 
We defined Hox related extremely long-range interactions as ELRIs. Hence, we used the loci of the four Hox gene 
clusters as the viewpoints separately and did comprehensive identification of ELRI genes with a 4C-like analysis 
approach (Van De Werken et al., 2012). Firstly, we extracted the reads that one-end is from a given point of view 
(one of the four Hox gene clusters). Secondly, CHi-C signal was calculated using the numbers of di-tags in a sliding 
window of a 20 DpnII fragments and normalized to sequencing depth; we also calculated the percentage of hits in 
the sliding window. ELRIs are extremely long-range interactions, hence the intrinsic background from CHi-C is 
virtually non-existent at these interacting loci. Considering the noise, a stringent cutoff for both CHi-C signal (at 
least 5) and percentage of hits (at least 15%) were used to identify the candidates of ELRI loci. We filtered for 
differential long-range interactions between serum and 2i mESCs by calling for the sum of normalized di-tags in a 
sliding window of 20 DpnII fragments with at least three fold changes. All the above parameters were used for the 
identification of ELRIs.  
Calculation of the strength of chromatin contact 
We defined the chromatin contact strength as the number of di-tags for the contact between two genomic fragments 
normalized to sequencing depth (100M informative reads), the length of the first fragment and the length of the 
second fragment. To avoid zero, 0.01 was added to the strength before performing log2.  
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SUMMARY
Innate immune memory is the phenomenon whereby
innate immune cells such as monocytes or macro-
phages undergo functional reprogramming after
exposure to microbial components such as lipopoly-
saccharide (LPS). We apply an integrated epige-
nomic approach to characterize the molecular events
involved in LPS-induced tolerance in a time-depen-
dent manner. Mechanistically, LPS-treated mono-
cytes fail to accumulate active histone marks at
promoter and enhancers of genes in the lipid meta-
bolism and phagocytic pathways. Transcriptional
inactivity in response to a second LPS exposure in to-
lerizedmacrophages is accompanied by failure to de-
posit active histone marks at promoters of tolerized
genes. In contrast, b-glucan partially reverses the
LPS-induced tolerance in vitro. Importantly, ex vivo
b-glucan treatment of monocytes from volunteers
with experimental endotoxemia re-instates their ca-
pacity for cytokine production. Tolerance is reversed
at the level of distal element histone modification
and transcriptional reactivation of otherwise unre-
sponsive genes.
INTRODUCTION
Accumulating evidence suggests thatmonocytes can be reprog-
rammed by exposure to microbe-associated molecular patterns
(MAMPs) during their time in the circulation (Quintin et al., 2014).
In this model, immune tolerance in myeloid cells, be they mono-
cytes in the circulation or macrophages in the tissues (lipopoly-
saccharide macrophages [LPS-Mfs]), represents one extreme
in the spectrum of innate immune memory and can be induced
by high bacterial burden in vivo or lipopolysaccharide (LPS)
exposure in vitro (Netea et al., 2016). On the other hand, trained
immunity can be induced by exposure to certain vaccines,
microbial components, or metabolites, and is a state character-
ized by increased pro-inflammatory response to secondary un-
related infections (Netea et al., 2016). We recently showed that
tolerance (induced by LPS) and trained immunity (induced by
Candida albicans b-glucan [BG]) are both associated with spe-
cific epigenomic states (Cheng et al., 2014; Saeed et al., 2014).
Most notably, the identity of these macrophage subtypes was
specified by differences in primed and active distal element rep-
ertoires (Saeed et al., 2014).
Monocytes and macrophages play an important role in the
pathophysiology of sepsis and inflammation, along with other
innate and adaptive immune cells (Biswas and Lopez-Collazo,
2009). Transcriptome analysis of tolerant monocytes from
sepsis patients (Shalova et al., 2015) and a mouse sepsis model
(Foster et al., 2007) reveals that the tolerized phenotype cannot
be explained purely through failure of specific signaling path-
ways induced by pattern recognition receptors to activate
downstream genes. This implicates a role for local chromatin
architecture and specific transcriptional regulators in control-
ling the expression of tolerized genes (Glass and Natoli,
2016). Further, studies in human cancers have revealed com-
monalities between inflammation and cancer associated toler-
ance, including the role for IDO1 in both (Bessede et al.,
2014). Accordingly, several anti-cancer drugs, such as bromo-
domain and extraterminal domain family (BET) inhibitors and a
topoisomerase inhibitor, have proven efficacious in blocking
inflammation-associated death in mice (Nicodeme et al.,
2010; Rialdi et al., 2016). The specific epigenetic and transcrip-
tional remodeling induced by the initial LPS exposure and the
extent to which it specifies tolerance to future LPS exposure
are unknown.
1354 Cell 167, 1354–1368, November 17, 2016 ª 2016 Elsevier Inc.
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Figure 1. Epigenomic and Transcriptomic Remodeling of Monocytes Induced by Exposure to LPS or BG
(A) Experimental setup for epigenomic interrogation of monocyte-to-macrophage differentiation and induction of tolerance (with LPS) or trained immunity (with BG).
(B) PCA plots of H3K27ac and H3K4me1 dynamic enhancers (monocytes, red circle; naive, circle; LPS, triangle; BG, square; 1 hr, blue; 4 hr, black; day 1, green;
and day 6, brown). Dynamic H3K27ac patterns show a clear deviation from the differentiation pathway (PC1) in LPS-treated cells. On the other hand, BG-treated
cells at day 1 are well on their way toward a full macrophage epigenetic profile.
(legend continued on next page)
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Here, as part of the BLUEPRINT epigenome consortium (http://
www.blueprint-epigenome.eu), we report the time-resolved,
comprehensive epigenomes of human monocyte-to-macro-
phage differentiation and induction of tolerance with LPS and
training with BG. Our epigenomic analysis revealed that tolerance
and trained immunity involve opposing regulation of common
pathways during early exposure to MAMPs, leading to distinct
epigenomic states in the two macrophage subtypes. We there-
fore hypothesized that BG may be capable of reversing LPS-
induced tolerance. We show that ex vivo BG exposure can rein-
state a responsive phenotype in both monocytes tolerized by
ex vivo LPS exposure and monocytes tolerized by in vivo exper-
imental endotoxemia in healthy volunteers. This reversal of toler-
ance involves epigenomic reprogramming of macrophages.
RESULTS
Distinct Temporal Epigenetic Remodeling in Response
to Microbial Components
Two innate immune memory states can be induced in culture
through an initial exposure of primary humanmonocytes to either
LPS or BG for 24 hr, followed by removal of stimulus and differ-
entiation to macrophages for an additional 5 days (Figures 1A
and S1; Quintin et al., 2012; Saeed et al., 2014). The three sub-
types of macrophages generated in this study were untreated
naive macrophages (naive-Mfs), LPS-exposed tolerized macro-
phages (LPS-Mfs), and BG-exposed trained macrophages (BG-
Mfs). To gain insight into the mechanisms and order of events
that ultimately lead to these three subtypes, we generated epi-
genomic data at several time points during this process (two do-
nors; summarized in Table S1 and Figure S1; GEO: GSE85246).
Depending on the modification, 2%–31% of marked regions
showed dynamics during differentiation or LPS or BG exposure,
with H3K27ac at promoters and enhancers being the most dy-
namic mark in number and range (Figure S1; Table S1). Interest-
ingly, epigenetic changes were observable as early as 1 hr in
response to LPS and 4 hr to BG (Figure 1B). The overall
H3K27ac pattern at dynamic promoters and enhancers indicates
that the most pronounced changes are associated with differen-
tiation (principal component 1 [PC1]), with BG- and RPMI-
treated monocytes partially establishing macrophage-specific
active regions already by day 1 (Figure 1B). Conversely, LPS
treatment results in establishment of pro-inflammatory associ-
ated active elements (PC2) and stunted differentiation, followed
by partial ‘‘catch up’’ establishment of differentiation marks
following removal of stimulus (Figures 1B and S1). Contrary to
this catch up of H3K27ac marked enhancers, the H3K4me1
marked enhancer repertoire of LPS-Mfs is significantly different
from those of naive-Mfs and BG-Mfs (Figure 1B). Repressive
marks, H3K9me3 and H3K27me3, showed no dynamics during
the first 24 hr, indicating little role in the early, priming phase of
innate immune memory (Figure S1C; Table S1).
In total, 17,500 enhancers with dynamic H3K27ac were identi-
fied (Figure S1B). The two largest clusters showgain (n = 4,028) or
loss (n = 6,462) of H3K27ac during differentiation in all three
macrophage subtypes (Figure 1C and S1B). The closest genes
associatedwith differentiation gain or loss clusters are associated
with leukocyte differentiation, activation, metabolism, and phago-
cytosis (Table S2). Uponmonocyte exposure to LPS, H3K27ac in-
duction precedes a temporally delayed H3K4me1 (Figures 1C
and S1B). The closest genes associated with these enhancers
are involved in cytokine response and nuclear factor kB (NF-kB)
signaling, among other well-known LPS-response pathways (Ta-
ble S2). The ‘‘BG up/LPS down’’ enhancer cluster shows acceler-
ated H3K27ac deposition in BG-exposed monocytes and little to
no H3K27ac accumulation in LPS-exposedmonocytes relative to
naive-Mfs (Figure 1C). This cluster is composed of >3,200 en-
hancers and shows concordant increase in H3K4me1 to day 6
(Figure S1B). Chromatin segmentation analysis using EpicSeq
(Mammana and Chung, 2015) revealed that these regions gain
H3K4me1 at the expense of repressive H3K27me3 markings in
naive-Mfs and BG-Mfs (Figure S1D). Conversely, LPS-Mfs main-
tain a chromatin state more similar to monocytes, primarily low
H3K4me1 with the presence of H3K27me3 (Figure S1D). The
closest genes to these enhancers are involved in lipid biosyn-
thesis and lysosome and leukocyte differentiation (Table S2), indi-
cating that BG exposure leads to the accumulation of membrane
components necessary for phagocytosis and cytokine release,
whereas LPS exposure prevents their activation (Figure 1C).
Transcriptome Changes Modulated by LPS and
b-Glucan
RNA sequencing (RNA-seq) was performed on the same time
points as epigenetic marks (n = 2 donors; Figure 1A). General ki-
netics similar to those unveiled for epigenetic remodeling was
observable, with monocytes clustering after a short exposure
to BG and LPS (Figure 1D). Over the time course, the major
changes in gene expression patterns were associated with dif-
ferentiation (PC1, 55.8% of the variance) and LPS exposure
(PC2, 10.8% of the variance), which is most pronounced at
4 hr and day 1 (Figure 1D). Over 5,700 protein-coding genes
showed dynamic expression (fold change [FC] > 2, adjusted p
value [padj] < 0.05) in our model between either treatments or
time points (Table S3; Figures 1E and S2A). LPS-induced genes
(C) A total of 17,500 H3K27ac dynamic gene-distal regions were identified and can be clearly separated into four clusters: BG up/LPS down, LPS up, differ-
entiation gain, and differentiation loss. Solid lines aremedian log-FC relative to day 0, and shaded areas represent the 25th and 75th quartile. Naive cells are shown
as a green line, LPS as a red line, and BG as a purple line. H3K4me1 at these regions can be seen in Figure S1B; LPS induces early H3K27ac accumulation,
followed by long-term H3K4me1 marking, while BG induces concurrent accumulation of H3K27ac and H3K4me1.
(D) PCA plots showing the relationships among all samples based on dynamic gene expression. PC1 explains most of the variation and is associated with
differentiation. PC2 is LPS related, with LPS 4 hr and LPS day 1 samples separating from the corresponding naive and BG samples.
(E) Heatmap of differentiation associated genes, as well as those induced by LPS or BG exposure. The general trend in expression is that BG exposed cells start to
express differentiation associated genes faster (at day 1) than naive cells, while LPS exposed cells lag behind.
(F) Top pathways associated with differentiation and showing opposing directions in response to BG and LPS.
See also Figures S1, S2, and S3 and Tables S1, S2, S3, and S4.
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Figure 2. Motif Enrichment at Epigenetically Dynamic Promoters and Enhancers and Associated Transcription Factor Networks
Motif enrichment analysis was performed on ATAC-sequencing (nucleosome-free) peaks that overlap H3K27ac dynamic enhancers and H3K27ac promoters.
(A) Random forest (RF) and a partial least-squares (PLS) classifiers were trained using the TF motifs found by GIMME to determine features (TF motifs) based on
their ability to separate the 4 H3K27ac clusters shown in Figure 1C. Both classifiers produce a feature importance score (between 0 and 100), which is a measure
of how ‘‘characteristic’’ the presence or absence of the TF motif is for the considered cluster. Green dots represent positive features (motif over-represented in
cluster), and red dots represent negative features (motif under-represented in cluster). The EGR2motif was the strongest positive feature for the BG up/LPS down
(legend continued on next page)
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were involved in immune response, whereas LPS-delayed genes
were generally differentiation associated (Figure 1E; Table S4).
The major ontologies of BG-induced genes (662 genes at day
1) were lipid biosynthesis, metabolism, and the lysosome
pathway (Figure 1E; Table S4). Intersection between exposure-
dependent gene expression and promoter acetylation patterns
showed a strong overlap between H3K27ac and gene expres-
sion temporal profiles (Figures S2B and S2C).
LPS-Specific DNA (De)methylation Signatures
Recent studies have revealed extensive DNA methylation re-
modeling during B cell (Kulis et al., 2015) and osteoclast differen-
tiation (de la Rica et al., 2013; Nishikawa et al., 2015). Con-
sidering that our ex vivo differentiation model occurs in the
absence of cell division, we were interested to see the extent
to which (de)methylation plays a role during monocyte-to-
macrophage differentiation and innate immune memory. Unlike
the comprehensive histone modification remodeling, consistent
DNA methylation change (at least 30% change and four or
more significant differentially methylated CpGs per differentially
methylated region [DMR]) was limited to a few hundred genomic
regions (Figure S3). The vast majority of DMRs showed loss of
methylation during monocyte-to-macrophage differentiation
irrespective of MAMP exposure (Figure S3B), consistent with
recent findings in macrophages and dendritic cells (Vento-
Tormo et al., 2016). We did not observe a role for DNA methyl-
ation in ‘‘training’’ the macrophages for future transcriptional
response to infection. More than 90%of DMRs occurred at distal
elements marked by H3K4me1, and only 6% occurred at pro-
moters (Figure S3C). Cumulatively, our data indicate that LPS-
specific DNA methylation changes occur and, due to the more
stable nature of this mark, may represent a useful biomarker
for LPS-induced macrophage tolerance (Figures S3D and S3E).
LPS- and b-Glucan-Specific Transcriptional Networks
Motif analysis was used to gain insight into which pathways
and transcription factors (TFs) regulate the epigenetic changes
associated with differentiation and LPS or BG exposure. Four
clusters of enhancers and promoters were designated based
on H3K27ac dynamics over time: BG up/LPS down, ‘‘LPS up,’’
‘‘differentiation gain,’’ and ‘‘differentiation loss’’ (Figures 1C
and S1B). Two classifiers (random forest [RF] and a partial
least-squares [PLS]) were trained, using the TF motifs found by
GIMME (van Heeringen and Veenstra, 2011). Both score features
(TF motifs) were based on their ability to separate the clusters—
the so-called feature importance score (between 0 and 100)—
which is a measure of how characteristic the presence or
absence of the TF motif is for the considered cluster. Both
classifiers were trained with the caret R-package using 10-fold
cross-validation, repeated five times. We define positive (green
dots) and negative predictors (red dots) as TF motifs that are
more or less abundant of the considered cluster compared to
the other clusters, respectively.
Enhancers that show differentiation gain in H3K27ac were en-
riched for the SPI1 (PU.1) motif, while LPS-induced active en-
hancers were enriched for NF-kBmotif (Figures 2A and 2B).
The top positive predictor motif for the BG up/LPS down cluster
was EGR2, with a score of 100, followed by ARNT (Figure 2A).
EGR2 is downstream of dectin-1 (Goodridge et al., 2007) and
shows prominent, transient induction in BG-exposedmonocytes
(Figure S4A). Enhancers with EGR2motifs are mainly associated
with genes involved in lipid metabolism and biosynthesis and
lysosome function (Figures 1E and 1F). The early activation of
these pathways in BG may account for the higher expression
of LAMP1, the major component of the mature lysosome, in
BG-Mfs (Figure S4A).
Interestingly, LPS-exposed monocytes do not transiently acti-
vate EGR2 (Figure S4A). The discordant effect of BG and LPS on
EGR2 expression, the differential H3K27ac deposition at associ-
ated enhancers, and expression of downstream lipidmetabolism
genes suggests that this pathway plays a role in inducing trained
immunity as opposed to tolerance. In order to further confirm the
relationship between EGR2 and downstream lipid pathways, the
DNA-binding motif of EGR2 was scanned at the promoters of
known transcription factors, as well as lipid metabolism and
lysosome genes that are induced in BG-Mfs compared to mono-
cytes (Figure S4B). The EGR2motif was found at the promoter of
several highly expressed TFs, including MITF, which is a positive
identifier for the differentiation gain promoter cluster (Figure 2A),
and is also not activated in LPS-exposed monocytes (Fig-
ure S4A). Cumulatively, EGR2, MITF, and downstream TF motifs
were found at the promoters of 79% of induced lipid metabolism
and lysosome genes (Figure 2B). This analysis suggests that BG/
dectin-1-induced EGR2 activation leads to higher expression of
downstreamTFs (e.g., MITF) and the establishment of promoters
and enhancers that drive the expression of lysosomal and lipid
metabolism genes (Figure 2C). Given the importance of lipid
pathways in macrophage function, the opposing effect of LPS
and BG on these genes suggests that this pathway may play a
critical role in the low cytokine release in LPS-Mfs and elevated
release in BG-Mfs.
Transcriptional Response of Tolerized Macrophages to
LPS Re-exposure
Previous analysis in an ex vivomousemodel showed that tolerant
LPS-Mfs are impaired in their ability to produce pro-inflammatory
enhancer cluster, NF-kB for the LPS up cluster, SPI1 (PU.1) for the differentiation gain cluster, and JUNB for the differentiation loss cluster. At the promoter
regions NF-kB was a positive feature for LPS up cluster, MITF for the differentiation gain cluster, and CREB1 and JUNB for the differentiation loss cluster.
(B) Motif enrichment is plotted as absolute difference in abundance compared to background (yellow, higher abundance than background; blue, lower
abundance than background) for the top enriched motifs. Consistently identified transcription factor motifs include SPI1 at differentiation associated enhancers,
NF-kB at LPS enhancers, and EGR2 and MITF at BG enhancers. Abundance increase over background supports the level of importance score.
(C) A diagram of the transcription factor network based on EGR2 andMITFmotif occurrence at BG-induced lysosome and lipid metabolism genes. Purple arrows
indicate the direction of expression induced by BG exposure, and red arrows indicate the direction of expression induced by for LPS exposure. BG exposure
induces transient expression of the genes, while LPS exposure inhibits activation. The full network based on promoter abundance is shown in Figure S4B.
See also Figure S4.
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cytokines, but maintain their ability to express other genes, such
as those required for tissue repair (Foster et al., 2007). Given the
wide-ranging epigenetic alterations in LPS-Mfs (Figure 1C; Table
S1), we sought to investigate the epigenetic basis for endotoxin
tolerance by exposing differentiated naive-Mfs, LPS-Mfs, and
BG-Mfs to LPS for 4 hr (LPS re-exposure) (Figure 3A). The overall
transcriptional and histonemodification changes induced inmac-
rophages by LPS re-exposure are shown in Figure 3B, and few
differences were observed between naive-Mfs and BG-Mfs.
LPS-Mfs show an avid response to LPS re-exposure both tran-
scriptionally andwithH3K27ac deposition at promoters and distal
enhancers (observable as large shift in PC2; Figure 3B). This indi-
cates that tolerized macrophages can and do respond to LPS at
the epigenetic and transcriptional level. However, from H3K27ac
and H3K4me1 principal-component analysis (PCA), it is clear that
the epigenetic profile of LPS-Mfs ismarkedly different from that of
naive-Mfs and BG-Mfs (observable as an LPS-Mfs lag on PC1;
Figure 3B).
Polytomous modeling was used to separate genes based on
their transcriptional response to LPS re-exposure (4 hr) in mac-
rophages at day 6. In total, 780 genes showed higher expression
(FC > 2, posterior probability > 0.3) in naive-Mfs following 4-hr
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Figure 3. Macrophage Endotoxin Tolerance Defined at the Transcriptional Level following LPS Re-exposure
(A) The innate immune memory model, including data collection at LPS re-exposure at day 6.
(B) PCA plots of dynamic RNA-seq, H3K27ac at promoters and enhancers, and H3K4me1 peaks, including LPS re-exposure samples. After re-exposure to LPS,
significant enhancer H3K27ac changes occur in LPS-Mfs, indicating that they are capable of activating their enhancers. However, the level of their response is
lower compared to monocytes, naive-Mfs, and BG-Mfs, which can be seen on the second principal component. Unlike RNA and H3K27ac, H3K4me1 does not
show significant changes following LPS re-exposure in any of the three macrophage subtypes.
(C) The total macrophage transcriptional response (750 genes) to LPS was separated into three groups based on the induction of genes in LPS-Mfs, relative to
naive-Mfs and BG-Mfs, revealing a gradient in LPS-Mf response to LPS re-exposure. The groups are (G1) tolerized genes, (G2) partially tolerized genes, and (G3)
responsive genes.
See also Figure S5.
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Figure 4. Histone Modification Dynamics and Open Chromatin Analysis at Tolerized Gene Promoters
(A) Heatmap showing average expression of 777 LPS-responsive genes in naive-Mfs. Genes are ranked based on their induction in LPS-Mfs, first by tolerance
group (G1, G2, and G3) and then by relative induction compared to naive-Mfs within each group. Response to LPS re-exposure is a gradient in LPS-Mfs, with the
most tolerized genes on the left and the most responsive genes on the right.
(B) Heatmap showing abundance of significant motifs in the promoter regions of the three macrophage LPS-responsive gene groups. The tolerized gene pro-
moters are enriched for several transcriptional repressors, such as EGR2 and TP53, while the partially tolerized gene promoters are enriched for IRF and STAT
motifs.
(C) Random forest (RF) and a partial least-squares (PLS) classifiers importance score (between 0 and 100) for each tolerized gene cluster (G1, tolerized; G2,
partially tolerized; and G3, responsive). Green dots represent over-represented motifs, and red dots under-represented motifs. The top features of G1 gene
(legend continued on next page)
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LPS exposure (Figure 3C; Table S5). Transcriptional responsive-
ness to LPS re-exposure in LPS-Mfs is a gradient, with genes
showing complete tolerance (unresponsiveness) (cluster G1), a
partial response (G2), or a full response comparable to naive-
Mfs (G3) (Figures 3C and S5A). Cytokine genes were the most
enriched group and were spread across the LPS re-exposure
response gradient, withCXCL9 (G1) and TNF (G2) showing com-
plete or partial tolerance and IL6 and IL8 showing comparable
responsiveness to naive-Mfs (G3) (Figures S5B and S5C). The
normal induction of interleukin 6 (IL-6) mRNA expression and
the absence of response in ELISA assays therefore suggests
that tolerance is a complex phenotype that involves both damp-
ened transcriptional responses to LPS re-exposure and an
inability to release some cytokines (Figure S5C). The top toler-
ance-specific biological process was ‘‘cytokine production,’’
while the top pathway was ‘‘RIG-I-like signaling’’ and ‘‘p53
signaling’’ (Figure S5D).
Epigenetic Profile of Tolerized Genes
To understand the molecular mechanisms involved in the altered
gene induction by LPS re-exposure in LPS-Mfs, we investigated
promoter motif enrichment at overlapping assay for transposase
accessible chromatin (ATAC) peaks. Because transcriptional
responsiveness to LPS re-exposure in tolerized macrophages
occurs on a gradient (Figure 4A), motif enrichment at promoters
was scanned in a sliding window of 100 promoters throughout
the response gradient from most tolerized (G1) to responsive
(G3) genes (Figure 4B). This analysis identified discrete motif sig-
natures in theG1andG2 tolerizedgroups. TheG1genepromoters
were enriched for several TF motifs, including EGR2, HIF1A, and
p53. The latter TF was also identified as a top tolerized pathway
(Figure S5D). The partially tolerized genes are enriched for IRF
and STAT motifs (Figure 4B). Random Forest analysis also indi-
cated that EGR2 was the top identifier for the G1 group, while
IRF and STATmotifs are top identifiers for the G2 group. Interest-
ingly, theG3groupdoesnotcontainpositive identifiers (Figure4C).
IRF and STAT genes show a tolerized pattern (Figure S6A), indi-
cating that their unresponsiveness to LPS effects downstream
partially tolerized genes. On the other hand, NFKB1 and RELA
showed normal induction in LPS-Mfs (Figure S6B).
Dynamic H3K27ac change during differentiation and LPS or
BG exposure was plotted over the promoter regions of G1, G2,
and G3 genes (Figure 4D). Dynamic promoter H3K27ac was
observed for roughly half of all genes, with the rest showing
consistent high acetylation during all time-points, including
LPS re-exposure (not shown). Tolerized genes (G1) and partially
tolerized genes (G2) showed no or impaired accumulation of
H3K27ac, respectively, after LPS re-exposure in LPS-Mfs
compared to naive-Mfs and BG-Mfs (Figure 4D), while respon-
sive genes (G3) were equally acetylated after LPS re-exposure
in all subtypes (Figure 4D). H3K4me3 patterns at these pro-
moters closely matched those of H3K27ac (Figure S5B). This
finding suggests that LPS-Mfs fail to accumulate H3K27ac at to-
lerized genes either through absence of pro-inflammatory acti-
vators, such as IRF and STATs in the case of G2 genes, or
through presence of tolerance inducing TFs, such as HIF1A in
the case of G1 genes.
b-Glucan Exposure Can Reverse Tolerance in Both
In Vitro and In Vivo LPS-Exposed Monocytes
As indicated before, BG and LPS have an opposing effect on
EGR2 and MITF expression (Figure S4A), accumulation of
H3K27ac at target enhancers and promoters (Figure 1C), and
expression of genes involved in macrophage function, such as
lipid metabolism and lysosome and cytokine production (Fig-
ure 1E). These findings point to a potential for reversal of LPS-
induced tolerance by using BG to stimulate the dectin-1
pathway. To test this hypothesis, monocytes were exposed to
LPS for 24 hr and then to BG for 24 hr, followed by a rest period
before LPS re-exposure (Figure 5A). We refer to these macro-
phages as ‘‘rescue-Mfs’’. Additionally, we used the clinically
relevant small molecular histone mimic bromodomain and extra-
terminal domain family (BET) inhibitor (IBET)151 in a co-treat-
ment with LPS (‘‘preventative’’) or following LPS exposure
(‘‘reversal’’) setting (Figure 5A). ELISAs showed that BG expo-
sure was able to reverse LPS-induced tolerance and reinstate
normal levels of cytokine release in rescue-Mfs (Figure 5B). On
the other hand, IBET151 was only effective in preventing toler-
ance when used to block the LPS-induced response, but it did
not reverse tolerance when administered after LPS (Figure 5C).
This is in line with the finding that IBET151 is effective in blocking
inflammation-associated death in mice (Nicodeme et al., 2010)
but suggests that IBET151 is not an effective treatment in
monocytes that have already experienced an inflammatory
response. Therefore, BG represents a possible treatment option
for restoring proper macrophage cytokine release during the
post-inflammation tolerance phase.
The suitability of the in vitro tolerance model to mimic the
in vivo situation is a major question. Chiefly, does LPS exposure
in vivo induce the same transcriptional responses in monocytes,
and can in vivo LPS-induced tolerance be reversed by BG? To
answer these questions, we used an in vivo experimental human
endotoxemia model (Draisma et al., 2009) (Figure 5D). In this
model, healthy volunteers are injected with 2 ng/kg US Standard
Reference Endotoxin Escherichia coli O:113 LPS (Pharmaceu-
tical Development Section of the National Institute of Health, Be-
thesda, MD, USA), which leads to a sepsis-like state (reviewed in
Bahador and Cross, 2007). Study protocols were approved by
the local ethics committee of the Radboud University Nijmegen
Medical Centre. The volunteers experience transient fever and
cold chills as well as pro- and anti-inflammatory cytokine signa-
tures. The in vivo LPS-exposed monocytes show elevated
promoters are E2F3, EGR2, and ZBTB7B motifs. The top features for G2 gene promoters are IRF and STAT, while G3 promoters do not have over-represented
features but are depleted of EGR2, E2F3, and ZNF350.
(D) Median H3K27ac at dynamic promoters of G1, G2, and G3 group genes, shaded areas represent the 25th and 75th quartile. This shows that LPS-Mfs do not
accumulate H3K27ac at tolerized genes but do so at the promoters of responsive genes. See also Figure S6 for H3K4me3.
See also Figure S6.
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Figure 5. BG Can Reverse Both In Vitro and In Vivo LPS-Induced Tolerance and Reinstate Proper Cytokine Production in Macrophages
(A) The in vitro monocyte tolerance reversal model, with BG added therapeutically after 24 hr of LPS exposure (rescue-Mfs). The histone-mimic and inflammation
blocker IBET was used in a preventative (co-culture with LPS for 24 hr LPS-co-IBET-Mfs) and a therapeutic (added after 24 hr of LPS exposure [LPS + IBET-Mfs])
manner. Following several days of rest, macrophages were re-exposed to LPS and cytokine release measured after 24 hr.
(B) BG re-instates IL-6 release in tolerized macrophages. Data from six donors are shown for naive-Mfs, LPS-Mfs, and rescue-Mfs.
(legend continued on next page)
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mRNA expression of key cytokines at 4 hr (not shown) and fail to
release cytokines in response to a second ex vivo LPS exposure.
In this regard, they behave much like in vitro LPS-tolerized
monocytes. Monocytes were isolated from peripheral blood
taken before and after LPS administration, and then exposed
ex vivo to either culture medium alone, or with BG. Cytokine
release wasmeasured following LPS re-exposure in culture (Fig-
ure 5D). Ex vivo BG exposure increased the release of tumor ne-
crosis factor (TNF) and IL-6 in tolerized monocytes at LPS re-
exposure (Figures 5B and 5C). This finding indicates that BG
can restore cytokine production of in-vivo-tolerized monocytes.
Cumulatively, this confirms that the mechanisms involved in the
establishment of tolerance by LPS in vivo and in vitro are similar,
validating the use of the in vitro model to study reversal of toler-
ance by BG. More importantly, it suggests that the BG effect on
monocyte tolerance may be transferred to the clinic in the future.
b-Glucan Recovers the Transcriptional Response to LPS
at Tolerized Genes
Next, we assessed whether BG reverses tolerance at the tran-
scriptional level. In this experimental setup, monocytes were
exposed to LPS followed by BG and then left to rest 24 hr or
4 days before LPS re-exposure for 4 hr (Figure 6A). Additionally,
monocytes were treated with a combination of LPS and IBET151
(preventative) and LPS followed by IBET151 (reversal). BG was
able to recover the induction of 60% of tolerized genes at day
6 (Figure 6A), including several pro-inflammatory TFs (Figure 6B).
Similar effects were observed when IBET151 was used in a pre-
ventative model, indicating that BG reversal of LPS-induced
tolerance leads to an outcome similar to that produced by block-
ing LPS-induced tolerance altogether. Overall BG reversal led to
a higher median expression of tolerized genes compared to both
preventative and reversal use of IBET151 (Figure 6A).
Epigenomic Analysis of b-Glucan Recovery of Tolerized
Macrophages
BG exposure following LPS exposure recovers the expression of
genes involved in lipid biosynthesis, phagocytosis, and cytokine
transport (Figures S7A and S7B). Recovery of expression was
observedasearly asday3 andmaintainedat ahigher level inmac-
rophages at day 6 (Figure S7B). Interestingly, addition of BG to
naive and tolerized monocytes at day 1, elicited the expression
of EGR2 and MITF within 4 hr, with a lower induction in tolerized
monocytes (Figure S7C). These findings indicate that BG-induced
receptorpathways remain at least partially inducible after theLPS-
induced cytokine response and that these pathways can partially
recover the naivemacrophage epigenetic and transcriptional pro-
grams. Analysis of dynamic H3K27ac promoters and enhancers
in naive-Mfs, LPS-Mfs, rescue-Mfs, and LPS-co-IBET151-Mfs
revealed that BG exposure restores H3K27ac deposition at re-
gions where H3K27ac increase was not obtained following LPS
exposure (Figure 7). Interestingly, while IBET151 blocks 75%
of the transcriptional response to LPS in monocytes at 4 hr (data
not shown), LPS-co-IBET151-Mfs look more like LPS-Mfs at day
6, indicating noeffect of IBET151on the overall epigenomic profile
of LPS-Mfs (Figure 7A, blue square). The effect of BGexposure on
H3K27ac deposition in LPS-Mfs was observable at both pro-
moters and distal enhancers of genes involved in metabolism
and lipid biosynthesis (Figures 7C and 7D).
DISCUSSION
Perturbation of normal monocyte-to-macrophage differentiation
by exogenous signals, such as high bacterial burden in sepsis,
can lead to a changed chromatin state and an associated devi-
ation from steady-state function (Amit et al., 2016). This phenom-
enon is known as innate immune memory, with the best-charac-
terized outcomes being endotoxin tolerance or trained innate
immunity (Netea et al., 2016). Trained immunity can have bene-
ficial effects through priming of macrophages for stronger re-
sponses to subsequent infection and can be induced by a variety
of MAMPs, such as C. albicans (Quintin et al., 2012), Bacille
Calmette-Gue´rin (BCG) vaccine (Kleinnijenhuis et al., 2012),
and BG (Saeed et al., 2014). Conversely, exposure to high levels
of LPS can induce a tolerizedmacrophage phenotype, which is a
major cause of sepsis-associated mortality (SepsisReport,
2012). Previously, we showed that tolerized macrophages
(LPS-Mfs) and trained macrophages (BG-Mfs) have distinct
epigenetic (Saeed et al., 2014), and metabolic states (Cheng
et al., 2014). Mouse studies have shown that such distal element
markings are important for appropriate responses to infection
(Ghisletti et al., 2010; Ostuni et al., 2013) and identity of tissue-
resident macrophages (Amit et al., 2016; Lavin et al., 2014).
Nevertheless, until now, the epigenetic basis for endotoxin toler-
ance in humans has not been explored.
In the current study, our aim was to unveil the early epigenetic
and transcriptional events following monocyte exposure to LPS
or BG and how the resulting epigenetic landscapes determine
the function of tolerized and trained macrophages. LPS- and
BG-induced active histone dynamics were observed as early
as 1 hr and 4 hr after exposure, respectively (Figures 1B and
1C). Generally, H3K27ac accumulation was accompanied by
H3K4me1 accumulation, most obviously at BG-induced en-
hancers (Figure S1B). Contrary to this general pattern, LPS-
induced active enhancers, associated with an inflammation
response, showed discordance in time with accumulation of
H3K4me1 (Figure S1B), which remained at higher levels in
LPS-Mfs compared to naive-Mfs and BG-Mfs. This persistence
of H3K4me1 in LPS-Mfs contributes to the overall epigenetic
signature of this macrophage subtype and may account for
some of the tolerized phenotype (Figure 1B). More pointedly,
we discovered a set of more than 3,000 de novo macrophage
(C) Preventative use of IBET blocks the first LPS response in monocytes, resulting in differentiation of macrophages that can release cytokines at the second LPS
exposure. Therapeutic use of IBET does not re-instate cytokine release in macrophages.
(D) Experimental human endotoxemia model, with ex vivo BG administration. Monocytes were isolated from 12 healthy volunteers before (naive) and 4 hr after
LPS injection (tolerized). Naive or tolerized monocytes were exposed to BG for 24 hr, followed by culture media, or culture media alone. After 3 days ex vivo,
monocytes were re-exposed to LPS, and cytokines were measured 24 hr later.
(E and F) BG recovered IL-6 release in 9 out of 12 tolerized monocytes (E) and TNF release in 8 out of 12 monocytes (F). Data are presented as mean ± SD.
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established distal enhancers that were modulated in the oppo-
site direction by BG or LPS exposure (Figure 1D). Deposition of
H3K27ac and H3K4me1 at these regions was accelerated by
BG exposure and delayed or completely blocked by LPS expo-
sure. Accordingly, expression of genes near these elements was
induced by BG, peaking at 24 hr post-exposure, while they re-
mained lowly expressed in LPS-exposedmonocytes (Figure 1F).
These genes were involved in lipid metabolism and biosynthesis,
phagocytosis, and lysosomematuration (Figures 1G and S2) and
have clear TF motif signatures for EGR2, MITF, and ARNT (Fig-
ure 2A). Interestingly, EGR2, a TF downstream of the BG recep-
tor dectin-1, showed clear transient upregulation by BG but re-
mained inactive in LPS-exposed monocytes, suggesting a
possible role in modulating these pathways (Figure S4). TFs
and pathways linking lipid biosynthesis and inflammation have
been described (Spann et al., 2012). Further, macrophage
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Figure 6. Reversal of Tolerance by BG at the Transcriptional Level
(A) Heatmap of the transcriptional response of naive-Mfs, LPS-Mfs, and rescue-Mfs (BG reversed LPS-Mfs) to LPS re-exposure at day 6. The scale represents
relative expression between LPS exposed naive-Mfs (1) and LPS-Mfs (0). Rescue-Mfs exposed to LPS show the most similar profile to naive-Mfs. On the top of
the heatmap is median expression (log2 RPKM) of tolerized genes at day 6 and LPS re-exposure in naive-Mfs (black), LPS-Mfs (red), LPS-co-IBET-Mfs (blue),
LPS + IBET-Mfs (light blue), and rescue-Mfs (purple).
(B) BG reverses the tolerization of key LPS-induced transcription factors, such as STAT2, STAT5A, IRF1, and IRF8. Log2 fold change increase in mRNA
expression is shown.
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response to infection requires a substantial amount of energy,
and shifts in metabolism and energy production are a whole
mark of macrophage polarization to M1 or M2 subtypes (Ghes-
quie`re et al., 2014), as well as for establishment of trained immu-
nity (Cheng et al., 2014).
Reversal of tolerance after the initial inflammation phase has
garnered interest because of the limited success of inflamma-
tion-blocking treatments to reduce overall sepsis mortality
(Angus and van der Poll, 2013) and because the majority of
sepsis deaths occur due to secondary hospital infection during
the tolerized phase (Gilroy and Yona, 2015). Our hypothesis
was that BG can reverse LPS-induced tolerance because it
discordantly regulated pathways that LPS also affected. Specif-
ically, LPS fails to activate key regulators of lipid, lysosome, and
metabolism genes, EGR2 and MITF, while BG induces their
expression (Figures 1 and 2). Recently, IFNG was shown to
partially recover metabolic function in tolerized monocytes
from sepsis patients, indicating that reversal of tolerance using
innate immune ‘‘trainers’’ is a viable therapeutic strategy (Cheng
et al., 2016). We show that BG exposure can indeed reverse the
tolerance in macrophages induced by LPS exposure, with
rescue-Mfs showing higher release of cytokines in response to
a second LPS stimulus (Figures 5A–5C). This was in contrast to
the inflammation blocker IBET151, which only prevented toler-
ance when used to block the initial LPS response but could not
reverse it when given to cells after LPS-induced inflammation
(Figure 5). In order to further relate our findings to the in vivo sit-
uation, we used an experimental human endotoxemia model to
induce tolerance in vivo (Draisma et al., 2009; Kox et al., 2014).
In terms of cytokine production, in-vivo-tolerized monocytes
behave similarly to their in-vitro-tolerized counterparts. The to-
lerized state of in vivo LPS-exposed monocytes is similar to
that of ex-vivo-exposed monocytes and, most importantly, can
also be rescued by ex vivo BG exposure (Figures 5D–5F),
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Figure 7. Reversal of Tolerance by BG at the Chromatin Level
(A) PCA plot of H3K27ac dynamics among monocytes, naive-Mfs, LPS-Mfs, rescue-Mfs, and LPS-co-IBET-Mfs. BG exposure of tolerizedmonocytes results in a
H3K27ac profile more similar to naive macrophages, while co-incubation of monocytes with LPS and IBET does not lead to activation of these regions.
(B) Heatmap showing re-establishment of the naive-Mf H3K27ac signal by BG exposure in tolerized macrophages.
(C) PCA plot of H3K4me1 dynamics among monocytes, naive-Mfs, LPS-Mfs, Rescue Mfs, and LPS-co-IBET-Mfs, the effect is similar to H3K27ac, but to a lesser
extent. (C) H3K27ac tracks at ATP9B (glucose transport) gene enhancer and (D) LPL (lipid metabolism) gene promoter.
See also Figure S7.
Cell 167, 1354–1368, November 17, 2016 1365
102
Chapter 4
indicating that the mechanisms controlling monocyte tolerance
in vivo can also be reverted to a more responsive phenotype.
In order to determine the ability of BG to reverse tolerance at
the molecular level, we first characterized the transcriptional
and epigenetic response to a second LPS exposure in tolerized
macrophages (Figures 3 and 4). Studies in mouse sepsis models
and human sepsis patients have shown that rather than being
inert in response to a second LPS exposure, tolerized macro-
phages show a shift in the specific pathways that they activate
(Foster et al., 2007; Shalova et al., 2015). In line with these
studies, we show that LPS-Mfs remodel both H3K27ac and
gene expression in response to LPS (Figure 3B). However, the
starting point of LPS-Mfs is significantly different from that of
naive and BG-Mfs, most clearly for H3K4me1 marked en-
hancers, suggesting that while activation is occurring, the avail-
able enhancer repertoire of these cells is limited or not suited.
Our analysis identified a gradient in the LPS-Mf response to
LPS, with some genes showing a tolerized pattern (no induction)
and others showing a responsive pattern (Figure 3C). The most
tolerized gene promoters were enriched for EGR2, HIF1A, and
p53 motifs, among many others. A potential role for HIF1A is in
agreement with a recent transcriptional analysis in monocytes
from sepsis patients (Shalova et al., 2015), while the p53
pathway was a top-ranked tolerized identified by Gene Ontology
(GO) analysis (Figure S5D). The strongest enrichment at partially
tolerized genes was for the IRF and STAT TF motifs that show
strong tolerized expression patterns themselves, ie, IRF1,
IRF8, STAT2, and STAT5A (Figure S6A). IRF8 and its down-
stream target, KLF4, both of which are important regulators of
monocyte differentiation (Kurotaki et al., 2013), show a tolerized
profile and enrichment at tolerized gene promoters (Figure 4B).
Other, non-TF regulators of tolerance, such as IRAK3, HIF1A,
SOCS3, and IDO1, are all more highly expressed in LPS-Mfs
compared to naive-Mfs and BG-Mfs and have previously been
associated with endotoxin-induced tolerance (Bessede et al.,
2014; Saeed et al., 2014; Shalova et al., 2015).
Rescue macrophages (BG exposed following LPS exposure)
were able to induce60%of tolerized genes at LPS re-exposure
(Figure 6). This indicates that BG reversal of tolerance at the tran-
scriptional level is not complete (Figure 6A). Fascinatingly, BG
recovered the expression of tolerized genes to a level greater
than that observed in macrophages treated with IBET and LPS
together (Figure 6A). This indicates that BG can reinstate a
responsive state at a higher level than that obtained by actually
blocking the initial LPS transcriptional response. This important
observation suggests that BG-associated pathways remain
intact even after large-scale epigenetic and transcriptional pro-
grams are induced by LPS. At the level of histone modifications,
BG recovers H3K27ac at regions that are silent in LPS-Mfs,
further supporting the notion that the molecular mechanisms
required for BG-induced chromatin remodeling remain after
the initial LPS response (Figures 7 and S7).
In conclusion, the hypothesis-free epigenomic and transcrip-
tomic analysis of monocyte-to-macrophage differentiation and
innate immune memory generated a number of testable hypoth-
eses. Our findings show that the innate immune ‘‘training stim-
ulus’’ b-glucan can reverse macrophage tolerance ex vivo. This
is an important step toward understanding how the tolerized
phenotype can be reversed in sepsis patients and ultimately pro-
vides the framework for future therapeutic developments in
innate immune diseases.
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STAR+METHODS
KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit polyclonal anti-H3K27ac Diagenode pAb-196-050
Rabbit polyclonal anti-H3K4me1 Diagenode pAb-037-050
Rabbit polyclonal anti-H3K4me3 Diagenode pAb-003-050
Rabbit polyclonal anti-H3K27me3 Diagenode pAb-195-050
Rabbit polyclonal anti-H3K9me3 Diagenode pAb-193-050
Chemicals, Peptides, and Recombinant Proteins
IBET-151 GSK Epinova and Cellzome GSK1210151A
Human Serum Sigma-Aldrich H4522-100ML
RPMI 1640 Medium, GlutaMAX Thermo Fisher Scientific 61870036
Gentamycin Thermo Fisher Scientific 15750060
L-glutamine Thermo Fisher Scientific 25030081
Sodium Pyruvate Thermo Fisher Scientific 11360070
Percoll Sigma-Aldrich P1644-1L
Ficoll Paque Plus Sigma-Aldrich GE17-1440-03
Lipopolysaccharides from Escherichia coli
055:B5
Sigma-Aldrich L2880-10MG
b1,3(D)glucan (b-glucan) (Saeed et al., 2014) N/A
2-Mercaptoethanol Thermo Fisher Scientific 21985023
Actinomycin D Thermo Fisher Scientific 11805017
IGEPAL CA-630 Sigma-Aldrich I8896-50ML
Critical Commercial Assays
KAPA library preparation kit Kapa Biosystems KK8400
riboZero gold rRNA removal kit Illumina MRZG12324
Nextera DNA Library Prep Kit Illumina FC-121-1031
TruSeq SBS KIT v3 - HS (50 cycles) Illumina FC-401-3002
NextSeq 500/550 High Output v2 kit (75 cycles) Illumina FC-404-2005
NEBNext High-Fidelity 2 3 PCR Master Mix New England Biolabs M0541
iQ SYBR Green Supermix Bio-Rad 1708880
100 3 SYBR Green I Nucleic Acid Gel Stain Thermo Fisher Scientific S7563
Human IL-6 elisa Sanquin M9316
Human TNFa elisa R&D DY210
SPRIselect reagent kit Beckman Coulter B23218
E-Gel SizeSelect Agarose Gels, 2% Thermo Fisher Scientific G661002
CD3 MicroBeads, human Miltenyi Biotec 130-050-101
CD19 MicroBeads, human Miltenyi Biotec 130-050-301
CD56 MicroBeads, human Miltenyi Biotec 130-050-401
dNTP set 100 mM Life Technologies 10297-018
dUTP 100 mM Promega U119A
Glycogen (20 mg/ml) Life Technologies 10814-010
Random Hexamer primers Sigma-Aldrich 11034731001
Second Strand Buffer Life Technologies 10812-014
Superscript III Reverse Transcriptase Life Technologies 18080-044
DNA polymerase I, E. coli New England Biolabs M0209S
USER enzyme New England Biolabs M5505L
(Continued on next page)
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CONTACT FOR REAGENTS AND RESOURCE SHARING
Further information and requests for reagents may be directed to, and will be fulfilled by the corresponding author Hendrik G. Stun-
nenberg (h.stunnenberg@ncmls.ru.nl).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Monocytes from Healthy Donors
All primary cells were isolated from healthy volunteers who gave written informed consent (Sanquin Blood bank, Nijmegen, the
Netherlands). Volunteers are of Northern European descent. Peripheral blood mononuclear cells were isolated by centrifugation in
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
E.Coli Ligase New England Biolabs M0205L
Rnasin Plus Rnase Inhibitor Promega N2615
Ribonuclease H Life Technologies AM2293
T4 DNA polymerase New England Biolabs M0203L
Sodium Acetate (3M) Life Technologies AM9740
DNase I QIAGEN 79254
Qubit RNA HS assay kit Life Technologies Q32852
Ribozero Gold Kit Illumina MRZG12324
Rneasy Mini Kit QIAGEN 74106
Deposited Data
Raw data files for RNA sequencing This paper GEO: GSE85243
Raw data files for ChIP sequencing This paper GEO: GSE85245
Raw data files for ATAC sequencing This paper GEO: GSE87218
Raw data files for WGBS sequencing This paper EGA: EGAD00001002693
Experimental Models: Organisms/Strains
Human: primary monocytes from healthy
volunteers
Sanquin Blood Bank N/A
Sequence-Based Reagents
NEXTflex DNA Barcodes - 48 Bioo Scientific 514104
Primer EGR2: F 50 TTGACCAGATGAACGGAGTG
30R 50 GTTGAAGCTGGGGAAGTGAC 30
This paper N/A
Primer MITF: F 50 AACTCATGCGTGAGCAGATG
30R 50 TACTTGGTGGGGTTTTCGAG 30
This paper N/A
Primer CSF1: F 50 CAGATGGAGACCTCGTGCC
30R 50 GCATTGGGGGTGTTATCTCTG 30
This paper N/A
Primer LAMP1: F 50 TGAACAAGACAGGCCT
TCCC 30R 50 TGTGCAGCTCCAGAGTCACC 30
This paper N/A
Software and Algorithms
Bedtools (Quinlan and Hall, 2010) http://bedtools.readthedocs.io/en/latest/
Bamtools (Barnett et al., 2011) https://github.com/pezmaster31/bamtools
Samtools (Li and Durbin, 2009) http://samtools.sourceforge.net/
GSNAP (Wu and Nacu, 2010) http://research-pub.gene.com/gmap/
GimmeMotifs (van Heeringen and Veenstra, 2011) https://github.com/simonvh/gimmemotifs
Caret (Kuhn, 2008) http://cran.r-project.org/web/packages/caret/
index.html
HOMER (Heinz et al., 2010) http://homer.salk.edu/homer/motif/
DAVID (Huang da et al., 2009) https://david.ncifcrf.gov/
bwa (Li and Durbin, 2009) http://bio-bwa.sourceforge.net/
bowtie (Langmead et al., 2009) http://bowtie-bio.sourceforge.net/index.shtml
MACS2 (Zhang et al., 2008) https://github.com/taoliu/MACS
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Ficoll-Paque (GE Healthcare), followed by removal of T cells using an additional Percoll gradient. Monocytes were purified from
PBMCs using negative selection in an LD column magnet separator, with beads for CD3+ (T cells), CD19+ (B cells) and CD56+
(NK cells) positive cells (Miltenyi Biotech), yielding > 95% pure monocytes. Successful isolation of monocytes was confirmed with
FACS, as previously described (Saeed et al., 2014).
In Vitro Monocyte-to-Macrophage Differentiation and Induction of Innate Immune Memory
Monocytes were differentiated into resting macrophages by ex vivo culture in RPMI 1640 medium (Sigma Aldrich) with 10% Human
Serum. Media was supplemented with 10 mg/mL gentamycin, 10 mM L-glutamine and 10 mM pyruvate (Life Technologies). Toleriza-
tion was induced by treatment of monocytes with 10-100ng/mL LPS for 24 hr, followed by washout and five days culture in RPMI +
10% human serum, while trained innate immunity was induced by treatment with 5 mg/mL BG for 24 hr, followed by washout and
5 days in culture. Establishment of tolerance or training in the resultingmacrophages at day 6 was determined by TNF and IL6 release
at 24 hr following LPS stimulation using ELISA. For ChIP-seq, 10x106 monocytes were seeded in 10cm dishes, for RNaseq and
ATAC-seq 1.5 3 106 monocytes were seeded in 6 well plates. IBET151 (GSK) was diluted to 50 mM stock using DMSO. Following
dosage titration 5 mM was determined as the appropriate final concentrations to prevent tolerization, without causing cell death.
IBET-151 was added to monocytes at the same time as LPS for 24 hr, followed by washout and five days culture in RPMI + 10%
human serum to macrophage differentiation.
Experimental Human Endotoxemia Model
In vivo endotoxin tolerance was examined in 12 healthy nonsmoking volunteers who participated in an experimental human endo-
toxemia study. The study is registered at Clinicaltrials.gov (NCT02602977) and study protocols were approved by the local ethics
committee of the Radboud University Nijmegen Medical Centre (NL53584.091.15/CMO 2015-1796). Written informed consent
was obtained from all study participants. Subjects were screened before the start of the experiment and had a normal physical ex-
amination, electrocardiography, and routine laboratory values. Throughout the study period, subjects were not allowed to take any
drugs, including acetaminophen, and were asked to refrain from alcohol and caffeine 24 hr and from food 12 hr before the start of the
endotoxemia experiment. All study procedures were conducted in accordance with the declaration of Helsinki including current re-
visions and Good Clinical Practice guidelines. Experimental human endotoxemia was conducted as described previously (Kox et al.,
2014). Briefly, all subjects received an intravenous bolus injection of LPS (lipopolysaccharide derived from Escherichia coli O:113,
Clinical Center Reference Endotoxin, National Institutes of Health (NIH), Bethesda, MD) at a dose of 2 ng/kg. Blood was obtained
before LPS administration and 4 hr afterward, and monocytes were isolated. Monocytes were exposed to culture or BG ex vivo,
and cytokine production in the supernatants was measured following ex vivo LPS (10ng/ml) exposure. Cytokine production was
determined by ELISA following the protocol of the manufactures (IL-6, sanquin and TNFa, R&D systems).
METHOD DETAILS
Cytokine Assays
TNFa and IL-6 were measured using ELISA according to the manufacturer protocol (IL6: Sanquin; and TNFa: R&D). For cytokines
production assays the differences between groups were analyzed using the Wilcoxon signed-rank test. The level of significance
was defined as a p value < 0.05.
RNA Extraction and cDNA Synthesis
Total RNA was extracted from cells using the QIAGEN RNeasy RNA extraction kit (QIAGEN, Netherlands), using on-column DNaseI
treatment. Ribosomal RNA was removed using the riboZero rRNA removal kit (Illumina). RNA was then fragmented into 200bp frag-
ments by incubation for 7.5 min at 95C in fragmentation buffer (200 mM Tris-acetate, 500 mM Potassium Acetate, 150 mM Mag-
nesium Acetate [pH 8.2]). First strand cDNA synthesis was performed using SuperScript III (Life Technologies), followed by synthesis
of the second cDNA strand. Library preparation was performed using the KAPA hyperprep kit (KAPA Biosystems). Quality of cDNA
and the efficiency of ribosomal RNA removal was confirmed using quantitative RT-PCR using the IQ Sybr Supermix, with primers for
GAPDH, 18S and 28S rRNA.
Chromatin Immunoprecipitation
Purified cells were fixed with 1% formaldehyde (Sigma) at a concentration of approximately 10 million cells/ml. Fixed cell prepara-
tions were sonicated using a Diagenode Bioruptor UCD-300 for 3x 10 min (30 s on; 30 s off). 67 ml of chromatin (1 million cells) was
incubated with 229 ml dilution buffer, 3 ml protease inhibitor cocktail and 0.5-1mg of H3K27ac, H3K4me3, H3K4me1, H3K27me3,
H3K9me3 or H3K36me3 antibodies (Diagenode) and incubated overnight at 4C with rotation. Protein A/G magnetic beads were
washed in dilution buffer with 0.15% SDS and 0.1%BSA, added to the chromatin/antibody mix and rotated for 60 min at 4C. Beads
werewashedwith 400ml buffer for 5min at 4Cwith five rounds of washes. After washing chromatin was eluted using elution buffer for
20 min. Supernatant was collected, 8 ml 5M NaCl, 3ml proteinase K were added and samples were incubated for 4 hr at 65C.Finally
samples were purified using QIAGEN; Qiaquick MinElute PCR purification Kit and eluted in 20 ml EB. Detailed protocols can be found
on the Blueprint website (http://www.blueprint-epigenome.eu/UserFiles/file/Protocols/Histone_ChIP_May2013.pdf).
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Library Preparation for Sequencing
Illumina library preparationwas done using the KapaHyper Prep Kit. For end repair and A-tailing double stranded DNAwas incubated
with end repair and A-tailing buffer and enzyme and incubated first for 30 min at 20�C and then for 30 min at 65�C.Subsequently
adapters were ligated by adding 30ml ligation buffer, 10 Kapa l DNA ligase, 5 ml diluted adaptor in a total volume of 110ml and incu-
bated for 15min at 15�C. Post-ligation cleanupwas performed using Agencourt AMPure XP reagent and products were eluted in 20 ml
elution buffer. Libraries were amplified by adding 25 ml 2x KAPA HiFi Hotstart ReadyMix and 5ml 10x Library Amplification Primer Mix
and PCR, 10 cycles. Samples were purified using the QIAquick MinElute PCR purification kit and 300bp fragments selected using
E-gel. Correct size selection was confirmed by BioAnalyzer analysis. Sequencing was performed using Illumina HiSeq 2000
machines and generated 43bp single end reads. Samples for RNA-seqwere treated to the above protocol exactly, except for a single
additional step: After post-ligation cleanup, and before library amplification, samples were incubated with 3 uL USER enzyme for
15 min at 37�C to digest the 2nd cDNA strand.
Assay for Transposase Accessible Chromatin
Monocytes or macrophages (100,000 cells) were scrapped in a well of a 6-well plate with cold PBS and then spun down at 8003 g for
5 min at 4�C. Cells were washed with 50 ml of cold 1x PBS buffer, incubated in 50 ml of cold lysis buffer (10 mM Tris-HCL (pH 7.4),
10 mMNaCl, 3 mMMgCl2 0, 1% IGEPAL) and spun down at 8003 g for 10 min at 4�C. The nuclei were immediately resuspended in
the transposition reaction mix (22.5 ml TD buffer, 2.5 ml Tn5 Transposase, 25 ml NF H2O) and incubated for 30 min at 37�C. Following
transposition, 100 ml AMPure beads were added to the reaction (sample-to-bead ratio of 1:2), mixed thoroughly by pipetting, and
incubated for 15 min at RT. Samples and beads were washed on the magnetic rack with 80% ethanol, dried for 5 min, and resus-
pended in 15 ml EB buffer. DNA was amplified with 10 - 15 PCR cycles using the mix (15 ml transposed DNA, 0.3 ml 100x SYBR Green
I, 25 ml NEBNext High-Fidelity master mix, 2.5 ml Nextera Primer index N7.. (25 mM), 2.5 ml Nextera Primer index S5.. (25 mM), 4.7 ml NF
H2O). In order to reduce GC and size bias in PCR, the PCR reaction is monitored using qPCR to stop amplification prior to saturation.
Following amplification, samples were incubated purified twice using SPRI beads, first using negative selection with a sample-to-
bead ratio of 1-0.65 and then positive selection with a sample-to-bead ratio of 1-1.8. After 80% Ethanol wash and drying, the sample
was eluted in 20 ml EB buffer, and quality checked before sequencing. Detailed protocol can be found on the Blueprint website (http://
www.blueprint-epigenome.eu/UserFiles/file/Protocols/ATAC_Seq_Protocol.pdf).
Whole Genome Bisulfite Sequencing
Genomic DNA (1-2 mg) was spikedwith unmethylated lDNA (5ng of lDNAper mg of genomic DNA) (Promega). The DNAwas sheared
by sonication to 50-500bp using a Covaris E220 and fragments of size 150-300 bpwere selected using AMPure XP beads (Agencourt
Bioscience). Genomic DNA libraries were constructed using the Illumina TruSeq Sample Preparation kit (Illumina) following the
lllumina standard protocol: end repair was performed on the DNA fragments, an adenine was added to the 30 extremities of the frag-
ments and Illumina TruSeq adapters were ligated at each extremity. Adter adaptor ligation, the DNAwas treated with sodium bisulfite
using the EpiTexy Bisulfite kit (QIAGEN) following the manufacturer’s instructions for formalin-fixed and paraffin-embedded (FFPE)
tissue samples. Two rounds of bisulfite conversion were performed to assure a high conversion rate. An enrichment for adaptor-
ligated DNA was carried out through 7 PCR cycles using the PfuTurboCx Hotstart DNA polymerase (Stratagene). Library quality
was monitored using the Agilent 2100 BioAnalyzer (Agilent), and the concentration of viable sequencing fragments (molecules car-
rying adaptors at both extremities) estimated using quantitative PCR with the library quantification kit from KAPA Biosystem. Paired-
endDNA sequencing (2x100 nucleotides) was then performed using the Illumina Hi-Seq 2000.WGBSdata are available upon request
from the BLUEPRINT consortium.
RNA-Seq Data Analysis
For quality control and visualization, RNA-seq reads were aligned to the hg19 reference genome using GSNAP (Wu and Nacu, 2010)
with non-default parameters -m 1 -N 1 -n 1 -Q -s Ensembl_splice_68. Each RNA-seq sample was subjected to a quality control step,
where, based on read distribution over the annotated genome, libraries that are outlierswere identified and discarded from further anal-
ysis. To infer gene expression levels, RNA-seq reads were aligned to the Ensembl v68 human transcriptome using Bowtie. Quantifica-
tion of gene expression was performed using MMSEQ. Differential expression was determined using MMDIFF. A two model compar-
ison was used to identify differentially expressed genes that confer cellular identity Mo/Mf. The null-model is that the mean expression
levels are the same in both cell types, and the alternativemodel is that themean expression levels are allowed to differ between the two
cell types. Genes with a larger posterior probability for the second model, an RPKM value greater than 2 in any of Mo or Mf and mini-
mally a 2-fold expression change were considered as differentially expressed. Expression changes related to differentiation of each
treatment were studied using a 52-model comparison, a.k.a. polytomous comparison, under the null-model that assumes the mean
expression levels are the same across each time-point. Expression differences related to the treatments at each time-point were stud-
ied using a 5-model comparison, under the null-model that assumes the mean expression levels are the same across each treatment.
ChIP-Seq Data Analysis
Sequencing reads were aligned to human genome assembly hg19 (NCBI version 37) using bwa. Duplicate reads were removed after
the alignment with the Picard tools. For peak calling the BAM files were first filtered to remove the reads with mapping quality less
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than 15, followed by fragment size modeling (https://code.google.com/archive/p/phantompeakqualtools/). MACS2 (https://github.
com/taoliu/MACS/) was used to call the peaks. H3K4me1,H3K9me3 and H3K27me3 peaks were called using the broad setting of
MACS2 while H3K27ac and H3K4me3 were called using the default (narrow) setting. For each histone mark dataset, the data
were normalized using the RpackageDESeq2 and then pair-wise comparisonswere performed (fold change 3, adjusted p-adjvalue <
0.05 and RPKMR 2 in at least in any condition) to determine the differentially expressed genes per condition. The results from all
possible pairwise comparisons (within each condition and similar time points across all conditions per mark) were pooled and
merged to define the dynamic set of enriched regions. Promoters were defined as regions between ± 2kb from TSSs for each
ensemble gene and enhancers were determined as enriched H3K27ac/H3K4me1 regions more than ± 2kb away from the TSS.
To find different patterns over dynamic promoters or enhancers, we applied a K-means clustering procedure (with optimal number
of clusters per each dataset) to the dynamic datasets as described above.
ATAC-Seq Data Analysis
The full ATAC-seq protocol is available at the BLUEPRINT website (http://www.blueprint-epigenome.eu/UserFiles/file/Protocols/
ATAC_Seq_Protocol.pdf). ATAC-seq readsweremapped to the hg19 reference genome using BWA (Li andDurbin, 2009) with default
parameters. Non-uniquely mapped reads and PCR duplicates were removed. MACS2 (Zhang et al., 2008) was used to identify re-
gions of open chromatin (peaks) with parameters ‘‘–nomodel -p 1e-9.’’ Overlap peaks from different samples were merged.
DNA-Binding Motif Scanning
All the DNA-binding motifs used in this study are based on the cis-bp database described in (Weirauch et al., 2014). Only motifs with
direct evidence of binding in the species of vertebrate were selected. Within eachmotif family, as annotated by cis-bp, all motifs were
clustered using ‘gimme cluster’ from the GimmeMotifs package (van Heeringen and Veenstra, 2011) with a threshold of 0.9999. The
annotation of motifs is based on the annotation of human in the cis-bp database. Motifs were used for scanning if the assigned TF is
expressed (> 1 RPKM) in at least one time-point during the differentiation. Total ATAC-seq peaks were scanned for the presence of
motifs. We used Gimme motifs for scanning with dynamic motif scoring cut-offs targeting a false discovery rate (FDR) of both 0.01
and 0.05. To look at the motif enrichments in each set of regions (epigenetic cluster or gene cluster), ATAC-seq peaks were assigned
to the epigenomic cluster or the gene promoters by intersection. Motif occurrences were acquired by intersection of the assigned
ATAC-seq peaks with the motif scanning results on total ATAC-seq peaks. Total ATAC-seq peaks were divided into promoter set
and non-promoter set as the background for the calculation of motif enrichment. Enrichment of motifs in each set of regions was
defined by applying a hypergeometric test using the motif frequency in the corresponding background. This results in TFs that pu-
tatively regulate the activities of the regulatory regions. Motifs in each heat map satisfy an arbitrary cutoff of > 5%motif presence and
a fixed minimal presence difference from background in at least one cluster. Hierarchical clustering (Pearson correlation) was per-
formed in each heat map using the motif occurrence frequencies in the clusters. Based on the gene activity and dynamics, only one
TF was selected to represent a motif if multiple genes are assigned to the same motif. Scanning results from FDR of 0.01 and 0.05
were compared and do not affect the result of enrichment analysis.
Gene Ontology Analysis
Gene ontology analysis on dynamic lists of genes was performed using DAVID (Huang da et al., 2009). Gene ontology on dynamic
enhancer clusters was performed using GREAT (McLean et al., 2010). KEGG pathways and Biological Processes were ranked by p
value and the top terms were plotted.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters including the exact value of n, the definition of center, dispersion, and precision measures (mean ± SEM) and
statistical significance are reported in the Figures and the Figure Legends. Data are judged to be statistically significant when p < 0.05
by two-tailed Student’s T-Test or 2-way ANOVA, where appropriate.
DATA AND SOFTWARE AVAILABILITY
Data Resources
Raw data files for the RNA, ATAC, and ChIP sequencing and analysis have been deposited in the NCBI Gene Expression Omnibus
under accession number: GSE85246.
Links to GEO SubSeries linked to GSE85246:
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85243
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85245
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87218
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Figure S1. Summary of DynamicHistoneMarks and PCAPlots of Dynamic Active HistoneModifications at Promoters andRepressiveMarks,
Related to Figure 1
(A) Percentage of histone ChIP-seq peaks designated as dynamic across time-points and between treatments. H3K27ac was the most dynamic modification,
with almost a third of regions showing significant changes.
(B) Heatmap showing histone intensity of H3K27ac and H3K4me1 at dynamic H3K27ac enhancers with 12kb ± from center of the peak.
(C) PCA plots for all time-points for H3K27ac dynamic promoters, H3K4me3 dynamic promoters, dynamic H3K27me3 regions, and dynamic H3K9me3 regions.
H3K27ac and H3K4me3 at promoters behave similarly over time and in response to LPS or BG exposure, and reflect the behavior of H3K27ac at enhancers.
Unlike active marks, repressive marks show little dynamics up to day 1.
(D) Stacked plots showing chromatin state changes over differentiation at ‘‘LPS-Mf up’’ and ‘‘BG up / LPS down’’ H3K4me1 enhancers. These enhancers are
established through H3K27ac dynamics shown in Figure 1C. The genome was segmented into 9 chromatin states based on the 5 histone marks analyzed. This
analysis indicates that H3K4me1 increase is associated with loss of H3K27me3.
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Figure S2. RNA-Seq Dynamics in Response to LPS and BG and Relationship to Histone Marks, Related to Figure 1
(A) Number of genes showing treatment (LPS or BG) specific expression at each time point (1h, 4h, d1, d6). LPS exposure induces the largest number of genes at
each time-point, with a minimum of 110 transcripts at 1h, and a maximum of 650 transcripts at day 1. Up to 100 genes maintain LPS-specific expression at d6.
Comparatively BG induced gene expression patterns peak at d1, a fraction of which is maintained to d6.
(B) Overlap between gene expression group and promoter H3K27ac cluster. LPS-induced H3K27ac accumulation at promoters correlates well with LPS induced
gene expression at all time-points. However, at day 1 and day 6, the ‘LPS-up’ genes are equally explained by a lag in differentiation-associated repression in LPS
treated cells. Conversely, BG exposure leads to faster expression of differentiation associated genes, with higher overlap between ‘BG-up’ genes and ‘differ-
entiation gain’ and BG-associated H3K27ac promoters.
(C) Example tracks of a BG induced/LPS repressed gene and an LPS induced gene, LPL (Lipoprotein Lipase).
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Figure S3. DNA Methylation Dynamics in Monocyte-to-Macrophage Differentiation and Tolerance and Training, Related to Figure 1
(A) Correlation plot of DNA methylation values, showing clear separation of LPS d1 and LPS-d6 from other samples.
(B) Boxplot of 2,700 DMRs, showing that the general trend is loss of methylation during monocyte-to-macrophage differentiation.
(C) Chromatin context of DMRs. The majority (91%) of DMRs occur in distal regions marked by H3K4me1, 69 occur at H3K27ac marked enhancers and open
chromatin regions. Only 6% occur at promoters.
(D) Boxplots showing DNAmethylation over time for macrophage sub-type specific DMRs. Analysis identified DMRs common to all macrophages, and those that
are only established in LPS-Mf or not-established in LPS-Mf.
(E) Heatmap of H3K27ac changes at DMRs. Generally, DNA de-methylation at DMRs was associated with accumulation of H3K27ac.
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Figure S4. Expression of Transcription Factors with Enriched Motifs at BG-Associated Promoters and Enhancers and Pathways Associated
with Downstream Genes, Related to Figure 2
(A) The expression of main genes enriched at ‘BG up / LPS down’ and ‘Differentiation gain’ promoters and enhancers is shown separately for each donor over
time. Naive cells are green, LPS exposed cells are red, and BG exposed cells are purple. EGR2 expression peaks transiently at 4 hr in BG exposed cells, but by
day 6, there is no difference between Naive, LPS-Mf or BG-Mf.CSF1 andMITF expression peaks at day 1 and then is reduced. Downstream TFUSF2 shares one
motif with MITF, and shows high expression in BG macrophages at day 6. LAMP1 is a major component of the lysosome, and together with LAMP2 makes up
50% of all lysosomal proteins. LAMP1 expression peaks late, and is significantly higher in BG-Mf compared to naive and LPS-Mf. qPCR was used to validate
RNA-seq results in monocytes from multiple donors.
(B) Transcription Factor network based on EGR2 and MITF motif occurrence at BG induced lysosome and lipid metabolism genes. The size of the nodes
represents the number of connections. EGR2 motif is present in the MITF promoters (thick connection). EGR2 and/or MITF motifs are present in another 28 TFs,
which themselves have 14 distinct motifs (and are visible as a cluster. Most genes have a combination of EGR2, MITF and a downstream TF motifs (light brown
circle). The set of genes to the right do not have EGR2 or MITF motifs, but have motifs for one of the downstream TFs (light gray circle). Overall this network
explains 79% of BG-induced lipid metabolism and lysosome-associated genes, compared to 58% based on EGR2 and MITF scan alone. BG induces EGR2
expression, through its receptor, Dectin-1, and higher expression of MITF is observed, as well as its activator cytokine factor CSF1 (see also Figure S4).
Conversely, LPS treatment represses EGR2, CSF1 andMITF. Genes are labeled by time at which their expression peaks in BG exposed cells. EGR2 expression
peaks at 4 hr (brown),MITF and KLF9 at day 1 (gold). The rest of the downstream genes peak at day 1 (gold) or peak at day 6 (green). Connections between TFs
and downstream genes is shown as red lines.
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Figure S5. Tolerance at the Transcriptional Level, Related to Figure 3
(A) Pattern of expression of tolerized and responsive genes during the time-course shown as median logFC of two donors (with first and third quartiles shown as
shaded areas). The most tolerized (G1) genes did not show upregulation in response to the initial LPS exposure in monocytes, while responsive genes (G3)
showed high induction in monocytes.
(B) Notable examples of tolerized and responsive genes. Data are shown as mean RPKM and error bars are standard deviations. Data are represented as
mean ± SD.
(legend continued on next page)
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(C) Expression of IL6 and TNF. Release of these proteins frommacrophages in response to LPS is considered the gold-standard for determining tolerance. At the
transcriptional level TNF is partially tolerized, while IL6 is responsive in LPS-Mf. Error bars represent standard deviation. IL6 and TNF protein release after LPS
restimulation is high in BG-Mf and absent in LPS-Mf compared to naive-Mf. The disconnect between transcription and release of IL6 can potentially be explained
by the larger size and higher lysosome content in BG-Mf, induced by early activation of lipid and lysosome pathways in BG exposed cells.
(D) Top 10 KEGG pathways enriched in tolerized and responsive gene groups from DAVID ontology analysis. Area relates to the number of genes within the
pathway, red font signifies that the pathway only shows significant enrichment in the tolerized gene group. Cytokine-cytokine receptor signaling was the top
pathway in both tolerized and responsive groups indicating that cytokine genes are equally spread across the gradient of LPS-Mf response to LPS re-exposure.
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Figure S6. Active Histone Mark Changes at Promoters of Tolerized and Responsive Genes and Overall Chromatin States at the Same
Promoters, Related to Figure 4
(A) Expression at day 6 and at LPS re-exposure for STAT2 and 5A, and IRF1 and 8 (mean RPKM of 4 donors, error bars represent standard deviation). These
pro-inflammatory TFs show a tolerized response in LPS-Mf to LPS re-exposure. The inability of these genes to be activated may play a role in the tolerance of
downstream targets, as suggested from the enrichment of their motifs in the G2 partially tolerized gene promoters (Figure 4B).
(B) expression at day 6 and at LPS re-exposure for NFKB1 and RELA. These TFs are responsive to LPS re-exposure in LPS-Mf, and their motifs are not
significantly enriched in tolerized genes. This suggests that NF-kB signaling is not impaired at the level of transcription. Data are represented as mean ± SD.
(C) LPS-Mf do not accumulate H3K4me3 at tolerized genes, but do so at the promoters of responsive genes. This pattern is similar to that of H3K27ac shown in
Figure 4D.
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Figure S7. Expression of Genes Involved in Lipid Biosynthesis and Metabolism following BG Reversal of LPS-Induced Tolerance, Related to
Figure 7
(A) Experimental set-up, indicating the collection of samples for gene expression analysis. Samples were collected at day 1 +4h, indicating that monocytes were
treated with media (RPMI) or LPS for 24 hr, at which point cells were exposed to BG for 4 hr and collected. Additionally samples were collected at day 3 and day6.
(B) BG exposure, following LPS, recovers the expression of genes involved in lipid biosynthesis and oxidative phosphorylation as early as day 3. LAMP1 is
an example of a lysosome gene that shows high expression in BG-Mf and low expression in LPS-Mf. BG exposure recovers the expression of this gene in
LPS-BG-Mf.
(C) BG addition at day 1 in Naive monocytes induces the expression of EGR2, MITF and CSF1, as it does when added at day 0 (Figure S4C). In tolerized
monocytes, BG induces the expression of EGR2 andMITF, but to a lesser degree. This indicates that BG receptor pathways are not completely disrupted by LPS
exposure, providing a basis for BG reversal of LPS-induced tolerance.
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ABSTRACT
Monocyte-to-macrophage differentiation in vivo occurs in homeostasis and during 
inflammation. This differentiation is associated with changes on epigenetic and transcriptional 
levels. Here we investigate dynamics of higher-order chromatin organization during monocyte-
to-macrophage differentiation and immunological training by Capture Hi-C. We demonstrate 
that despite the absence of cell division, this differentiation is associated with higher-order 
chromatin reorganization, including changes in A/B compartments, strengthening of TADs 
and their boundaries and a global gain of short-range interactions. While differentiation is 
associated with profound changes, immunological training does not cause spatial chromatin 
dynamics, suggesting that differentiation is the main driver of chromatin remodeling. 
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INTRODUCTION
Under homeostatic conditions monocytes can differentiate to macrophages in vitro and in vivo 
(1). In steady state condition the contribution of circulating monocytes to tissue macrophages 
is limited. However, upon inflammation, monocytes are rapidly recruited and give rise to 
tissue macrophages, which can effectively combat an infection. Upon encountering different 
inflammatory stimuli these macrophages display stimulus-specific responses, suggesting 
their functional plasticity(1-3). Furthermore, it has been recently discovered that in response 
to certain stimuli (e.g. Candida Albicans β-glucan) monocytes can develop an enhanced 
immunological response and resistance to secondary infections – a phenomenon described 
as “trained innate immunity” (4,5). 
 Monocyte-to-macrophage differentiation and response to inflammatory stimuli are 
associated with extensive remodeling of the gene expression program(2,5,6). These changes 
are largely driven by combinatorial action of lineage-specific (e.g. PU1, EGR2) and signal-
dependent transcription factors (e.g. NF-kB, IRF) that bind and activate distal regulatory 
elements or enhancers(7,8). Accordingly, the enhancer repertoire is cell-type specific, and 
in macrophages was shown to be shaped by the tissue microenvironment and exposure to 
external stimuli(3,9,10). 
 Regulatory activity of enhancers can be exerted over large linear distances and 
the three-dimensional organization of chromatin controls proper communication between 
regulatory elements. Recently, it has been demonstrated that on the Megabase (Mb) scale 
chromatin is organized into two compartments: the ‘A’ compartment that is generally 
associated with an active chromatin configuration and the ‘B’ compartment containing 
repressive chromatin(11,12). On a finer scale the A and B compartments are further partitioned 
into self-interacting units or topologically associating domains (TADs). The majority of long-
range interactions, including those between regulatory elements, occur within TADs while 
interactions with other TADs are relatively infrequent(13,14).
 Here, we set out to characterize chromatin organization during terminal myeloid 
differentiation and immunological training by focusing on two closely related cell types: 
monocytes and macrophages. We report widespread changes in 3D chromatin organization 
during monocyte-to-macrophage differentiation. With the use of the high-resolution capture 
Hi-C (CHi-C) approach(15,16), we show that monocyte-to-macrophage differentiation is 
accompanied by extensive ‘A/B’ compartment switching, strengthening of TAD boundaries 
and gain of short-range interactions between regulatory elements, while immunological 
training does not involve changes in higher-order 3D chromatin organization. 
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Figure 1.
RESULTS
Capture Hi-C approach
To study how monocyte-to-macrophage differentiation and immunological training affect 
chromatin organization, human primary monocytes were isolated from healthy volunteers 
and differentiated into naïve macrophages by ex-vivo culturing for 6 days (5). Immunological 
training was performed by an initial exposure of the monocytes to β-glucan (BG) during the 
first 24 hours, followed by withdrawal of the stimulus and 5 days of culture (Figure 1A). We 
have previously demonstrated that monocyte-to-macrophage differentiation is associated 
with extensive epigenetic and transcriptional remodeling, with a distinct signature associated 
with different time-points during differentiation (Figure 1B) (Novakovic, et al). In order to 
investigate chromatin organization during differentiation and immunological training we 
performed CHi-C on monocytes (Day0), intermediate population (Day1/D1) and differentiated 
macrophages (Day6/D6), using the four basepairs (bp) cutting restriction enzyme DpnII. 
CHi-C combines genome-wide detection of chromatin interactions with target enrichment 
by hybridization-based capture, allowing for high-resolution detection of interactions at a 
selection of loci (Figure 1C). Target selection was based primarily on H3K27Ac dynamics 
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during monocyte-to-macrophage differentiation, as this mark is associated with active 
regulatory elements. We have targeted 20193 enhancers and 6826 promoters, ~40% and 
~50% of which, respectively, were associated with a dynamic H3K27ac signal. 
 All CHi-C libraries were deep-sequenced to obtain at least 250 million reads per 
library, which resulted in at least 100 million informative reads after filtering (Supplementary 
Table1). The enrichment of the targeted regions was ~52 fold and average capturing efficiency 
was 56%. The uncaptured remainder of paired-end reads (44%) in our CHi-C samples 
represented conventional Hi-C reads. 
 To validate the robustness of the CHi-C approach, libraries for each time-point were 
prepared in two biological replicates, which displayed high reproducibility (data not shown). 
Furthermore, global clustering of interactions revealed high similarity between samples 
belonging to the same time-points (Figure 1D). 
Figure 2.
Global reorganization of 3D chromatin architecture during monocyte- 
to-macrophage differentiation
To investigate the higher-order chromatin structure globally, we analyzed our CHi-C data 
as conventional Hi-C and compared the interaction frequencies on the chromosomal 
level. Interestingly, in monocytes (Figure 2A, left) and Day1 cells (Figure 2A, middle), we 
observed frequent dispersed long-range interactions, resulting in a blurred pattern on the 
2D interaction matrix. In Day6 macrophages, these long-range interactions were largely lost. 
The retained interactions localized to specific regions, resulting in a sparse checkerboard 
pattern (Figure 2A, right). To further investigate the observed contact redistribution we 
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directly compared the differentiation time-points by subtracting Hi-C interaction frequencies 
(Figure 2B). We observed a progressive increase in short-range (diagonal of the interaction 
matrix) and a clear decrease in long-range interactions during differentiation (Figure 2B). 
 To quantify the observed redistribution of chromatin contacts we calculated the 
ratio of short (<2Mb) versus long-range (>2Mb) interactions (SvL)(17). As expected, Day6 
macrophages displayed higher SvL (1.91 fold) than monocytes and Day1 cells (Figure 2C, 
yellow box). Next we were wondering whether the increase in SvL ratio is associated with 
differentiation in general or is specific for monocyte-to-macrophage differentiation. In order 
to address this question we analyzed external Hi-C and CHi-C datasets for several human 
cell types: human embryonic stem cell (hESC) line H1 (12), hematopoietic progenitors 
CD34+(15), monocytes and three subtypes of macrophages (M0, M1 and M2) (Javierre et al., 
Cell in press). Interestingly, comparison of these cell types (H1, CD34, Monocytes) revealed 
a general decrease in SvL ratio during differentiation, in contrast to an increase observed 
during monocyte-to-macrophage differentiation. Furthermore, the high SvL detected in 
naïve macrophages at Day6, is consistent across different macrophage subtypes (M0, M1, 
M2; data from Javierre et al., Cell in press) (Figure 2C). This indicates that a high SvL ratio, as 
compared to monocytes, is a general property of macrophages. 
A/B compartment rearrangement in mature macrophages
On a megabase (Mb) scale the genome can be partitioned into two compartments, A and 
B, which contain relatively active and inactive chromatin, respectively, and preferentially 
interact with regions belonging to the same compartment. Genes residing in the ‘A’ 
compartment tend to be expressed at higher levels than those in the ‘B’ compartment(11). 
‘A/B’ compartment organization is cell-type specific and ~36% of the genome was shown to 
change compartments in at least one lineage during hESC in vitro differentiation(12). 
 To globally assess chromatin organization dynamics during myeloid differentiation 
we performed principal component analysis (PCA). As expected, hESC clustered away from 
CD34 and differentiated myeloid cells, indicating that differentiation is accompanied by 
reorganization of chromatin. Within the differentiated cells we detected two distinct groups, 
separated on both principal components. The first group included monocytes together with 
Day1 cells. The second group contained fully differentiated macrophages. All macrophage 
subtypes displayed tight clustering, irrespective of their subtype, indicating the similarities in 
their chromatin organization (Figure 3A). 
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Figure 3.
Next, we identified ‘A/B’ compartments based on the first principal component (PC1) from the 
PCA; positive PC1 values were assigned to the ‘A’ compartment (orange) and negative values to 
the ‘B’ compartment (blue) (Figure 3B). Visual inspection confirmed cell-type specific changes 
in compartment organization during myeloid differentiation. For example, we observed 
regions changing compartments early, during H1 to CD34 differentiation and remaining in 
the same compartment in differentiated myeloid cells (Figure 3B, yellow box), those changing 
compartment in monocytes and remaining in the same compartment in macrophages (Figure 
3B, red box), or unchanged throughout differentiation (Figure 3B, blue box). 
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Several studies suggest that chromatin organization is constrained during interphase(18,19) 
and mitosis is required for a region to be repositioned(20). Remarkably, while monocyte-
to-macrophage differentiation occurs without cell division(5), we observed multiple regions 
switching compartments (Figure 3B, green box). In total ~3,3% of the genome (108,9 Mb) 
was associated with significant changes in PC1 values during monocyte-to-macrophage 
differentiation, with the majority of the regions (~2,6%, 84,4 Mb) relocating from ‘B’ to ‘A’ or 
showing a strong increase in PC1 values within the ‘A’ compartment; and ~0,7% (24,5 Mb) 
relocating from ‘A’ to ‘B’ compartment or associated with decrease in PC1 value within the 
B compartment (Figure 3C). Interestingly, while monocyte-to-macrophage differentiation is 
associated with prominent ‘A/B’ compartment reorganization, treatment with β-glucan has 
marginal effect (Figure 3A-C). We could identify only two regions specific for β-glucan treated 
macrophages at Day1 and none at Day6 (Supplementary Figure 1).
 As the ‘A/B’ compartments are suggested to be associated with relative activity 
state, we next analyzed the expression of genes located in changing compartments. As 
expected, genes residing in the regions with decreasing PC1 values were associated with 
reduction in gene expression during differentiation (Figure 3D, left), while those associated 
with increased PC1 values showed gradually induced expression levels (Figure 3D, right). For 
example, expression of the ALDH3A2 gene is induced more than 15 fold during differentiation; 
accordingly, we observe this gene relocating from the inactive ‘B’ compartment in monocytes 
to the active ‘A’ compartment in macrophages (Figure 3E, top). On the other hand, expression 
of the ARL4A gene decreases 2 fold during differentiation, and the gene is relocated to the 
inactive B compartment (Figure 3E, bottom). Global gene ontology (GO) analysis of genes 
residing in switching compartments did, however, not reveal any enrichment in function 
for these genes, suggesting that multiple pathways might be affected by compartment 
reorganization. 
 Lastly, we were wondering when the observed changes in higher order chromatin 
organization happen with respect to the epigenetic and transcriptional changes during the 
differentiation process that we previously identified (Figure 1B). For this, we performed PCA 
analysis of SvL ratio and ‘A/B’ compartment organization for monocytes, Day1 and Day6 naïve 
and β-glucan trained macrophages. We observed that while transcriptional and epigenetic 
changes were already prominent at Day1 (Figure 1B), changes in higher-order chromatin 
organization were only detected at Day6 (Figure 3F), suggesting the temporal uncoupling of 
these events. Furthermore, while on the level of gene expression and H3K27ac occupancy 
we detected a clear difference between naïve and β-glucan exposed macrophages at Day1 
(Figure 1B), we did not detect treatment-dependent changes in higher order chromatin 
structure (Figure 3F).  
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Figure 4.
Strengthening of TAD boundaries during monocyte-to-macrophage 
differentiation
On a Kilobase scale the ‘A/B’ compartments are further partitioned into TADs. Multiple studies 
suggest that TAD organization is similar between cell types and stable during differentiation 
(13,14), while others demonstrate that TAD boundaries can be altered (21,22). In order to 
investigate the TAD organization during monocyte-to-macrophage differentiation we first 
performed TAD calling based on the 40 Kb resolution interaction matrix. We detected ~2000 
TADs in monocytes and ~3000 TADs in macrophages. The large difference in the number of 
TADs that we identified in monocytes and macrophages suggests extensive remodeling of 
TAD boundaries. To investigate this, we assessed the boundary strength by computing and 
comparing the directionality index (DI) of monocytes and macrophages (13). 187 boundary 
regions were identified as dynamic based on 4 fold change cut-off of DI. In agreement with 
the increased number of TADs in macrophages, all of the dynamic boundaries were stronger 
at Day6 (Figure 4A-B). Furthermore, increase in boundary strength was detected almost 
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exclusively at Day6 and not at Day1, consistent with the ‘A/B’ compartment reorganization 
(Figure 3C). 
 As TAD boundaries are frequently associated with insulator protein CTCF (13) and 
CTCF is required for their maintenance (23), we hypothesized that strengthening of the TAD 
boundaries during monocyte-to-macrophage differentiation is associated with differential 
CTCF binding. Motif analysis of TAD boundaries confirmed the frequent association of the 
CTCF motif with TAD boundaries in monocytes and macrophages (data not shown). Thus, 
we performed CTCF ChIP-seq in monocytes and macrophages and compared the binding 
profiles. As expected, CTCF binding was enriched at TAD boundaries (Figure 4C), however, 
no significant difference in CTCF occupancy was found at macrophage-specific boundaries 
(Figure 4D). Hence, the increase in boundary strength in macrophages is not caused by 
increased CTCF occupancy in macrophages. Motif enrichment analysis at dynamic boundaries 
did not reveal any additional motif besides CTCF, associated with these boundaries. 
Terminal myeloid differentiation alters intra-TAD chromatin organization
The higher number of called TADs in macrophages might also suggest changes in chromatin 
organization within the TADs. In order to investigate this, we computed the TAD score – a ratio 
of intra-TAD interactions to inter-TAD interactions on the same chromosome (12,24). For most 
of the TADs we observed a gradual increase in TAD score during monocyte-to-macrophage 
differentiation (Figure 4E-F), suggesting that domains become more compartmentalized in 
macrophages. Next, we wanted to assess how the increase in TAD score relates to changes 
in the epigenetic and transcriptional landscape. For this, we have sorted the TADs based on 
the fold change of their score in macrophages compared to monocytes and divided them in 
ten bins. Bin one contained the least and bin ten the most changing TADs. These dynamic 
TADs were not enriched for differentially expressed genes (data not shown), suggesting that 
increased compartmentalization of these TADs is not directly associated with transcriptional 
changes of genes within them. 
 We reasoned that while we could not detect a distinct gene expression pattern 
associated with dynamic TADs, the changes in TAD score might be associated with epigenetic 
changes. For each bin we calculated the enrichment of activating (H3K27Ac, H3K4me1, 
H3K4me3) and repressive (H3K27me3, H3K9me3) histone marks, accessible chromatin 
and insulator protein CTCF (Figure 4G). Interestingly, the least changing TADs appeared to 
be associated with activating marks, open chromatin and switching from active to inactive 
compartment. The most changing TADs on the other hand, were found to be enriched for 
the repressive histone mark H3K27me3 and switching from inactive to active compartment 
(Figure 4G). One possible scenario is that upon relocation from inactive to active compartment, 
these TADs are restricted to prevent the spread of H3K27me3 or long-range repression of 
regulatory elements in neighboring TADs. 
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DISCUSSION
In this study we analyzed changes in chromatin organization during terminal myeloid 
differentiation and induction of trained immunity. Notably, monocyte-to-macrophage 
differentiation occurs in the absence of cell division (5), allowing us to uncouple differentiation-
induced changes in chromatin organization from changes associated with cell division.  
 During differentiation changes in gene expression are accompanied by reorganization 
of chromatin (12,25). As these changes often coincide, it is not clear whether changes in 
gene expression and nuclear repositioning are causally related. Some locus-specific studies 
suggested that changes in gene expression and epigenetic make-up are sufficient to induce 
repositioning of the locus (26,27), while others suggest that changes in gene expression do 
not lead to repositioning (28). During monocyte-to-macrophage differentiation extensive 
epigenetic and transcriptional changes can already be observed at Day1 (Figure 1B). 
Remarkably, no changes in higher-order chromatin organization could be detected at this time-
point (Figure 3F). This temporal uncoupling of chromatin reorganization and transcriptional/
epigenetic changes might suggest their independence and lack of a direct causal relation, 
although further experimental validation is required to confirm this observation.
 Changes in ‘A/B’ compartments during differentiation have been recently reported for 
hESC and several derived lineages (12). The extent of the observed changes varied dependent 
on the assayed lineage, from ~3,8% in mesendoderm to 25% in mesenchymal stem cells 
(MSC)(12). In monocyte-to-macrophage differentiation, despite of the close relation between 
the two assayed cell types, ~3,3% of the genome was associated with compartment changes, 
comparable with the extent of changes between hESC and mesendoderm. Interestingly, 
during hESC differentiation the majority of the detected compartment changes were 
associated with an ‘A’ to ‘B’ transition and expansion of the inactive ‘B’ compartment(12), 
while in monocyte-to-macrophage differentiation the majority of the switching regions 
relocated from the ‘B’ to the ‘A’ compartment. Recent reports suggest that stimulus-specific 
responses during macrophage activation are associated with distinct transcription factor 
networks, which are signal-dependent and operate in a permissive chromatin environment 
(2,27,29). Thus, the general increase in PC1 values and switching to the ‘A’ compartment can 
be associated with the establishment of an open, permissive transcriptional environment in 
macrophages, which might attribute to their functional plasticity (3). In line with this, our 
analysis revealed that macrophage subtypes, while different on transcriptional, epigenetic 
and functional levels (2,29), share a similar chromatin organization (Figure 3A).
 Coinciding with a global gain of short-range interactions and switching to the 
‘A’ compartment, we observed that topological domains in macrophages adopt a more 
pronounced organization (Figure 4A-B,E-F). This reorganization is accompanied by 
strengthening of TAD boundaries, which appears to be CTCF-independent (Figure 4A-D). 
However, other insulator proteins might be responsible for increase in boundary strength. 
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For instance, a component of the cohesin complex, SMC1A, is strongly up-regulated (~3 fold) 
during monocyte-to-macrophage differentiation (data not shown). The cohesin complex is 
required for insulator activity of CTCF(30) and its depletion leads to reduction of intra-TAD 
interactions(31), in agreement with pattern observed in monocytes, where SMC1A is lowly 
expressed. Alternatively, boundary strength might be affected by combinatorial action of 
insulator proteins (32), similar to boundary remodeling in response to temperature stress in 
Drosophila (21). 
 Functionally, the most changing TADs display strong enrichment of the H3K27me3 
chromatin mark (Figure 4G). We speculate that stronger insulation of these TADs might be 
required to prevent the spreading of repressive chromatin or, alternatively, to prevent an 
aberrant activation of inactive genes within the domain, as has been recently reported for the 
HOX locus (23). Future genome editing experiments of dynamic TAD boundaries are required 
to address their functional significance in macrophage biology.
 In summary, we show that monocyte-to-macrophage differentiation is accompanied 
by extensive changes in three-dimensional chromatin organization, including a global 
increase in short-range interactions in macrophages, changes in ‘A/B’ compartments and 
reorganization of TADs. Treatment with β-glucan, on the other hand, does not alter higher-
order chromatin organization, suggesting that differentiation, rather than treatment-specific 
activation is the main driver of changes in the three-dimensional chromatin structure of 
macrophages.
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MATERIALS AND METHODS
Monocytes isolation from healthy donors
All primary cells were isolated from healthy volunteers who gave written informed consent 
(Sanquin Blood bank, Nijmegen, the Netherlands). Peripheral blood mononuclear cells were 
isolated by centrifugation in Ficoll-Paque (GE Healthcare), followed by removal of T cells using 
an additional Percoll gradient. Monocytes were purified from PBMCs using negative selection 
in an LD column magnet separator, with beads for CD3+ (T cells), CD19+ (B cells) and CD56+ 
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(NK cells) positive cells (Miltenyi biotech), yielding >95% pure monocytes. Successful isolation 
of monocytes was confirmed with FACS, as previously described (5).
In vitro Monocyte to macrophage differentiation and induction of trained 
innate imunity
Monocytes were differentiated into resting macrophages by ex vivo culture in RPMI 1640 
medium (Sigma Aldrich) with 10% Human Serum. Trained innate immunity was induced 
by treatment with 5 μg/mL BG for 24 hours, followed by washout and 5 days in culture. 
Establishment of tolerance or training in the resulting macrophages at day 6 was determined 
by TNF and IL6 release at 24 hours following LPS stimulation using ELISA. For ChIP-seq, 10x106 
monocytes were seeded in 10cm dishes, for CHi-C at least 50x106 monocytes were seeded 
in 14cm dishes.
Chromatin immunoprecipitation and sequencing (ChIP-seq)
ChIP was performed according to standard protocol (33) with minor modifications. 
Paraformaldehyde (1%) crosslinking was carried out for 10 minutes followed by the chromatin 
preparation as described earlier (34).  Nuclei were re-suspended in ChIP-incubation buffer 
at a concentration of 20x106 cells/ml and sheared (5 cycles with each cycle containing 10 
sec power on and 10 sec interval) using BioruptorPico (B01060001, Diagenode). Sonicated 
chromatin equivalent of 4x106 cells was incubated with 15 μl CTCF antibody (ab70303, Abcam) 
overnight at 4°C. ChIP-Seq sample preparation and sequencing was performed according to 
manufacturer’s instructions (Illumina). 
Capture Hi-C (CHi-C)
The Capture Hi-C experiment was divided into two parts, in-nucleus Hi-C and ss-DNA probe
capture enrichment. In-nucleus Hi-C was carried out as described in Nagano et al., 2015. DpnII 
was used as the restriction enzyme. On beads DNA amplification PCR was carried out with 
7-9 cycles to generate around 1μg of Hi-C library DNA. ssDNA probe capture step was carried 
out using the protocol provided by Roche NimbleGen Inc. (http://sequencing.roche.com/
products/nimblegen-seqcap-target-enrichment/seqcap-ez-system/seqcap-ez-developer.
html) optimized for the probe capture library. Libraries were indexed using NEXTflex adapters 
(Bioo-Scientific Corporation, Austin, TX, USA) and 75bp or 43bp paired-end sequencing was 
performed on Illumina instruments using TruSeq reagents Illumina, San Diego, CA, USA), 
according to manufacturer’s instructions.
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ChIP-Seq data analysis
Tags were mapped to the reference human genome hg19 using the Burrows-Wheeler 
Alignment Tool2 (BWA). Before down stream use, duplicates reads and reads with a MAPQ<15 
were discarded. For visualization the number of overlapping sequence reads was determined 
per base pair, averaged over a 10 bp window and visualized in the UCSC genome browser 
(http://genome.ucsc.edu). For comparison bam files were normalized to the same number of 
reads. Peakcalling was performed with MACS2((35)) software and peaks for monocytes and 
macrophages were merged. RPKM was calculated for merged peaks.  
Capture Hi-C data analysis
Mapping
The two ends of paired-end reads were mapped to the reference human genome (hg19) 
separately, using BWA MEM with default parameters. Reads were filtered based on mapping 
quality score (both ends MAPQ≥10) and PCR duplicates were removed. Reads were also 
removed if the two ends are from the same DpnII fragment. 
Normalization 
First, all the reads were treated as from conventional Hi-C library. Raw contact matrices were 
generated for individual libraries and merged libraries from the same condition at fixed locus 
sizes of varying resolution including 20kb, 40kb, 100kb, 200kb. For each matrix, the contacts 
on the diagonal bins were considered informative and removed. Normalization of the matrices 
were then performed with iterative correction (36) in Bioconductor R package “HiTC” with 
default settings. After normalization, the rows of the contact matrix approached a constant. 
Differential Hi-C interaction maps were calculated by subtracting the second condition from 
the first one using the normalized contact matrices of 200kb resolution. 
SvL ratio calculation
The short-range versus long-range, or SVL ratio, was calculated as described previously(17). 
In this calculation, we considered only intra-chromosomal interactions within a single 
chromosome using the normalized contact matrices of 40kb resolution. 
A/B compartment identification
A/B compartment calling was performed at 40kb resolution as previously described (12). Briefly, 
the normalized 40kb contact matrices were used to calculate the expected contact frequency 
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between two 40-kb bins given the distance separating them in the genome. A sliding 200kb 
window was then used with a step size of 40kb to generate an observed/expected matrix. 
This matrix was then used to calculate the Pearson correlation matrix and subsequently used 
for principal component analysis. Genomic regions were identified displaying significant 
changes in A/B compartment, if these regions show statistically significant variability in PC1 
values across all conditions using ANOVA and at least 40 difference in the PC1 values in any 
two conditions. 
TAD calling
Topological domains were systemically identified based on the directionality index (DI) score 
using a Hidden Markov Model (HMM) previously described (13)at 40kb resolution. The final 
coordinates of topological domains were manually inspected and calibrated according to all 
the domains obtained above. The intra-domain contact score (TAD score) was calculated as 
described previously (25). 
Capture Hi-C
CHiCAGO CHi-C analysis package (http://regulatorygenomicsgroup.org/chicago) was used to 
call significant contacts. To improve quality, the whole genome was windowed into 3 DpnII 
site tiles. Virtual baits were created using the 3 DpnII site tiles that contain at least one 
targeted DpnII fragment. Interactions were filtered based on interaction score and number 
of reads (score≥5 and at least 2 reads). 
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FIGURE LEGENDS
Figure 1. Three-dimensional chromatin organization profiling during monocyte-to-
macrophage differentiation.  (A) Schematic overview of experimental set-up for studying 
monocyte differentiation and trained immuntity. (B) PCA plots of mRNA, H3K27ac and 
H3K4me1 dynamics during monocyte-to-macrophage differentiation. (C) Schematic 
representation of CHi-C approach. (D) Global clustering of Hi-C interaction profiles. 
Figure 2. Global reorganization of interaction landscape. (A) Normalized Hi-C interaction 
maps for the q-arm of chromosome 9 in monocytes (left), Day 1 (middle), and Day 6 (right). 
The color maps for relative interaction probability are displayed on the same scale for each 
heatmap. The PC1 signal was used to define the A (orange) and B (blue) compartments and is 
displayed below each heatmap. (B) Differential heatmaps for the q arm of chromosome 9 in 
monocytes (left), Day 1 (middle), and Day 6 (right). The color maps are displayed on the same 
scale for each comparison. Red is used to designate enrichment in the first condition, and 
blue depletion. (C) The ratio of short-range (<2 Mb) versus long-range (>2Mb) interactions 
(SvL) calculated for each chromosome arm across the whole genome at 40kb resolution.
Figure 3. A/B compartment switching during differentiation. (A) Comparative PCA analysis 
of chromatin organization during myeloid differentiation. (B) Screenshot exemplifying cell-
type specific A/B compartment organization. Region switching in H1 to CD34+ transition 
(yellow), monocyte-to-macrophage transition (green), CD34+ to monocyte transition (red) 
and non-dynamic (blue). (C) Heatmap of regions significantly changing their PC1 value 
during monocyte-to-macrophage differentiation. “Decrease” corresponds to regions with 
a decrease in PC1 in macrophages compared to monocytes. These regions relocate from 
A to B compartment or display a significant decrease in PC1 within the B compartment. 
“Increase” corresponds to regions with an increase in PC1 in macrophages compared to 
monocytes. These regions relocate from B to A compartment or display a significant increase 
in PC1 within the A compartment. (D) Box plots of average expression of genes residing 
in regions with decreased (left) or increased (right) PC1 value. (E) Example screen shot of 
genes switching compartments during monocyte-to-macrophage differentiation. ALDH3A2 
gene (left) is belongs to B compartment in monocytes and Day1 macrophages, and relocates 
to A compartment in Day6 macrophages. ARL4A gene (right) belongs to A compartment in 
monocytes and Day1 cells and repositions to B compartment in Day6 macrophages. (F) PCA 
analysis of time-dependent changes in higher-order chromatin organization. SvL ratio (left) 
and A/B compatments (right) demonstrate that Monocytes and Day1 macrophages are very 
similar, while Day6 macrophages are different.  
Figure 4. Domain-level changes in chromatin organization. (A) Heatmap displays 
directionality index (DI) values at 40 Kb resolution for the dynamic boundaries. (B) 
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Normalized Hi-C interaction maps are shown for regions with dynamic TAD boundaries in 
monocytes (top), Day 1 (middle), and Day6 macrophages (bottom). (C) Bar plot of CTCF 
binding sites distribution relative to TAD boundary. (D) Box plot of CTCF occupancy ratio in 
Day6 macrophages over monocytes for all TAD boundaries and dynamic TAD boundaries. 
(E) Distribution of TAD score: the ratio of intra-TAD interactions versus all cis interactions 
of a TAD, calculated at 40kb resolution. (F) TAD score in Day6 macrophages (y-axis) plotted 
against TAD score in monocytes (x-axis). All the TADs were sorted by the ratio of their TAD 
score in monocytes and macrophages and binned into 10 groups. (G) Heatmaps showing 
the enrichment of several chromatin features (epigenetic modifications, accessibility, CTCF 
binding, A/B switching) in the TADs in each of the 10 bins. 
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Thanks to the rapid evolution of technologies and the sustained investigations from 
researchers, a large variety of regulatory elements have been discovered in the genome 
and their roles in gene regulation have been continuously deciphered. The activities of 
these elements are found tightly connected with local chromatin configuration. Such local 
chromatin configuration is often called epigenetic memory or epigenetic dynamics. 
In eukaryotic cells, DNA winds around histone proteins forming the basic structural units 
of chromatin called nucleosomes. Both DNA and histone proteins play a role in epigenetic 
memory. The histone proteins are especially important, because they can be decorated 
with various modifications and are deeply associated with the accessibility of the DNA. Such 
diversity of local chromatin configuration makes epigenetic memory important in regulating 
gene expression and defining the properties and behavior of the cells. Genome-wide profiling 
of histone modifications, DNA accessibility and DNA modifications has become a robust and 
efficient approach to identify functional regulatory elements in distinct cell states or cell types. 
We studied three different cell systems that mimic the crosstalk in inflammation (Chapter 
2), the transition between two states of pluripotency (Chapter 3), and the differentiation 
from monocyte to macrophage (Chapter 4 and 5), to investigate the impacts of epigenetic 
memory on gene regulation and to understand the underlying mechanisms that direct the 
cellular changes. 
Impacts of epigenetic memory on gene expression
The epigenetic memory in cells is inheritable, and establishes corresponding stable gene 
expression patterns. Eukaryotic organisms or at least metazoan utilize epigenetic memory to 
respond in particular to environmental signals or stimuli over different time scales (D’Urso and 
Brickner, 2014). Across generations of an organism, such epigenetic memory is also known 
as genomic imprinting by which the epigenetic marks for the imprinted genes are inherited 
from the parents whereas the expression patterns of the imprinted genes are maintained in 
the children (Peters, 2014). Within the same generation of an organism, epigenetic memory 
defines cell identities and potentials for differentiation during development (Cantone and 
Fisher, 2013), and establish the abilities of the cells or the next generations of the same cells 
to respond to the environmental stimuli similar to their previous experiences (Bonasio et al., 
2010). 
Our studies mainly focused on the relatively short timescale, as it can help us to dissect how 
cells respond, survive and adapt during environmental changes. All of the three cell systems 
were manipulated by changing the environment of the cells. In Chapter 2, the patterns 
of epigenetic dynamics together with DNA motif analysis enabled us to further classify 
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the binding sites of signal-dependent nuclear receptors GR and p65 into constitutive and 
induced groups that display distinctive regulatory manners. In Chapter 3, various epigenetic 
features at some bivalent promoters were used to determine the differences between 
the ELRI (Extremely Long-Range Promoter-Promoter Interaction) promoters and non-ELRI 
promoters. In Chapter 4, time-resolved epigenomes and transcriptomes together unveiled 
the early events following monocyte exposure to LPS or BG and how the resulting epigenetic 
landscapes determine the function of tolerized and trained macrophages. In Chapter 5, we 
integrated the time-resolved epigenomes and transcriptomes with the chromatin interaction 
maps from a Capture Hi-C approach to investigate the relationships between epigenetic 
dynamics and 3D genomic organization during monocyte-to-macrophage differentiation and 
immunological training. Our studies demonstrated that even stimuli as short as a few hours 
are able to significantly alter the epigenetic landscape at a collection of genomic regions. 
Moreover, these epigenetic alterations are strongly associated with gene regulation and 3D 
genomic organization, and confer to the cells the abilities to respond and survive when they 
experience similar environmental changes. 
Genome-wide study of epigenetic memory extended our understandings of transcriptional 
regulation beyond protein-coding regions, and allowed the systematic identification of a 
myriad of potentially functional genomic regions. This approach was initially used to annotate 
and interpret regulatory DNA elements including enhancers and promoters in a single cell 
type, or compare them with the elements in other cell types (Chen et al., 2016; Consortium, 
2012; Ernst et al., 2011; Roadmap Epigenomics Consortium et al., 2015; Stunnenberg et 
al., 2016). In our studies, we deployed this approach to track the chromatin changes during 
cellular responses and differentiation at the epigenetic level. We observed that the epigenetic 
landscape at promoter regions are largely unchanged, in contrast, epigenetic dynamics occur 
remarkably more often at enhancer regions especially the active marks such as DHS, H3K27ac, 
and H3K4me1. In addition, the potential target genes of these dynamic enhancers showed 
high enrichment in treatment or stimuli related gene ontology terms, and the expression 
of these gene is highly correlated with the active marks at the enhancers. This implies that 
enhancers play a vital role in gene regulation over short timescales. 
It is well established that an enhancer complies its function via the binding of TFs and 
other chromatin regulators of chromatin. The TF-binding DNA motifs allow us to predict 
the candidate TFs that directly bind to the DNA sequence of an enhancer. Moreover, the 
enrichment of DNA motifs at regions with epigenetic dynamics gives a hint for the master TFs 
in the processes. Using this approach in Chapter 4, we predicted EGR2 and MITF as the key 
regulators in monocyte-to-macrophage differentiation. These master players can be further 
examined by ChIP-seq using the antibodies against them or by functional studies such as 
genomic edit. In conclusion, the hypothesis-free epigenomic and transcriptomic approach 
147
Discussion
6
is a powerful and efficient tool in deciphering cell systems and importantly, it generates a 
number of testable hypotheses. 
Linking enhancers to their target genes
Identifying the target genes of enhancers is not a straightforward task, because an enhancer 
may regulate multiple genes and is frequently (very) distal from its target genes. Three 
approaches have been used to predict the linkages between enhancers and genes. Firstly, 
the simplest approach is to assign an enhancer to its nearest transcription start site, but it 
neglects the fact that enhancers do act over long genomic distances. Secondly, a widely used 
approach is using the information from epigenomic profiling to correlate the changes in DNA 
accessibility, histone modifications, or DNA methylation levels with gene expression across 
different cell types or cellular conditions (Andersson et al., 2014; Ernst et al., 2011; He et al., 
2014; Sheffield et al., 2013; Shen et al., 2012; Whalen et al., 2016; Yao et al., 2015). Thirdly, 
3C-based techniques are recently being used to predict the linkages by measuring chromatin 
physical contacts (Jin et al., 2013; Li et al., 2012; Rao et al., 2014; Sanyal et al., 2012; Tang 
et al., 2015; Zhang et al., 2013). The approach assumes that enhancers make more contacts 
with functionally relevant regions than with other genomic regions. In Chapter 2, 3, and 4, 
we deployed various 3C-based techniques. Our observations are in line with other studies in 
that either epigenomic-based or 3C-based approaches predict more than one target gene for 
most enhancers whereas less than half of the enhancers are linked to the nearest TSS (Jin et 
al., 2013; Li et al., 2012; Sanyal et al., 2012; Schoenfelder et al., 2015a; Zhang et al., 2013). 
Taken together, epigenomic-based and 3C-based approaches provide more reasonable and 
comprehensive information about the pairing of regulatory DNA elements and genes within 
the cell systems. 
The epigenomic-based approach to determine the respective targets relies on statistical 
associations. A few ChIP-seq and RNA-seq experiments are sufficient to provide the essential 
information to make the prediction for a cell system of interests. However, all of the association 
methods only provide predictions of putative target genes. Of note, these methods cannot 
predict the linkages between the regions that are separated by more than several million 
base-pairs. Because a limit for genomic distance is usually included in the prediction, 
otherwise, the entire genome is too large and too many regions could be predicted as the 
targets for individual regions. On the other hand, the 3C-based approach does not have this 
limitation, however, the technical noise may reduce their power especially when the two 
genomic regions are (too) far apart. 
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To answer whether 3C-based techniques are a suitable approach to identify enhancer-
promoter linkages, we need to go back to a fundamental question that is how enhancers 
regulate promoters. To answer it, two non-exclusive mechanistic models have been 
proposed: the ‘tracking’ model and the ‘looping’ model (Blackwood and Kadonaga, 1998). 
In the ‘tracking’ model, the transcriptional machinery containing RNA polymerase II (RNAPII) 
travels over the DNA between an enhancer-promoter pair; whereas in the ‘looping’ model, 
an enhancer directly interacts with its target promoters by physical contacts mediated by 
protein–protein interactions. The ‘tracking’ model has been shown to exist in sporadic cases 
in which the enhancers are located only a few kilo base-pairs upstream of the TSSs indicating 
this model may only apply to the enhancers of close proximity (Hatzis and Talianidis, 2002; 
Wang et al., 2005). The ‘looping’ model has been largely supported, because reduction 
of loop-associated proteins (Ren et al., 2011; Song et al., 2007), interruption of looping 
by altered insulators (Guo et al., 2015; Lupiáñez et al., 2015; Narendra et al., 2015; Nora 
et al., 2012; Ong and Corces, 2014) or genomic duplication (Franke et al., 2016) all affect 
transcriptional outcome. Therefore, using 3C-based techniques seem to be a reasonable 
approach to identify enhancer-promoter linkages, as these techniques capture the physical 
contacts between separated genomic regions. 
Nevertheless, experimental validation is essential to confirm the predicted enhancer–
promoter linkages, and in turn the validation result can also be used to improve the prediction. 
However, to date, relatively few enhancer–promoter pairs have been experimentally examined 
(Visel et al., 2007), whereas systematic validation experiments have been performed only in 
Drosophila but not in mammalian cells to support the predicted enhancer-promoter linkages 
(Kvon et al., 2014). 
The frequency of long-range chromatin communication
While the ‘looping’ model proposes the physical interactions between enhancers and 
promoters via their associated proteins, it also implicates that the functional chromatin 
communications such as enhancer-promoter contacts are likely more frequent than with 
other genomic regions. Since genome-wide 3C-based techniques detect population-
averaged crosslinking probabilities of chromatin, they provide a systematic way to estimate 
and compare the relative frequencies of physical contacts of chromatin between different 
genomic regions in a global way. It is shown that in pluripotent stem cells enhancers and 
promoters occupied by the pluripotency factors display higher relative frequencies of 
intrachromosomal and interchromosomal interactions, suggesting that the cell-type-specific 
transcription factors may play a key role in shaping genomic 3D architecture (de Wit et al., 
2013). However, this observation was based on interaction maps of low resolution (hundreds 
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of kilo base-pairs) which makes it not easy to determine the specificities of enhancer-
promoter contacts. In Chapter 3 and 5, our Capture-HiC experiments enabled us to perform 
a genome-wide detection of chromatin interactions from regions of interest at a resolution 
of a few kilo base-pairs. We observed that the interacting regions are highly enriched in the 
distal regulatory DNA elements of the corresponding cell types. This is in line with a deeply 
sequenced Hi-C study (Rao et al., 2014) and promoter Capture Hi-C studies (Javierre et al., 
2016; Mifsud et al., 2015; Schoenfelder et al., 2015b). In conclusion, high relative frequency 
of physical contacts to promoters is a key attribute of enhancers, and likely plays a role in 
exerting and modulating enhancer function. 
However, the existence of physical contacts between a distal regulatory DNA element 
and a promoter does not automatically guarantee that the element is actually involved in 
regulating the expression of that gene. Indeed, in Chapter 2, 4C-seq experiments showed 
that the chromatin interactions between inducible enhancers and target genes displayed 
significantly higher signals than background even before treatment, while these interactions 
were almost undetectable in P300 ChIA-PET experiments under the same cell condition. 
This observation as well as some other studies (Ghavi-Helm et al., 2014; Jin et al., 2013; de 
Wit et al., 2013) suggest that the interactions between distal regulatory DNA elements and 
promoters are likely pre-existing. It also implicates that without the required TFs, the enhancer 
is likely not activated for regulating the interacting gene. Interestingly, upon the treatment 
with TA and TNFa, the same interactions became detectable in CHIA-PET experiments and 
showed moderately but significantly higher signals in 4C-seq experiments compared with 
before treatment. In contrast to 4C-seq, ChIA-PET technique is designed to only capture the 
chromatin interactions mediated by a protein of interest. Hence, our study suggests that 
both chromatin physical contacts and TFs contribute to exerting enhancer function and 
regulating gene expression in which TFs may reinforce the physical contacts between the 
active enhancers and promoters. 
A different way of assessing enhancer-promoter contacts is by DNA fluorescent in situ 
hybridization (DNA FISH). In contrast to 3C-based techniques, DNA FISH measures physical 
distances of separated genomic loci in the 3D space of the nucleus. It is also able to depict 
the distribution of these distances within a chosen cell population. This technique is limited 
by the number of genomic loci that can be simultaneously monitored. Recently, an improved 
technique called HIPMap introduced a high-precision, high-throughput, automated pipeline 
for mapping spatial locations of genomic regions at much larger scale (Shachar et al., 2015). 
3D DNA FISH is often used to validate and support the chromatin interactions identified by 
3C-based experiments. The majority of the studies suggest that DNA FISH and 3C-based 
techniques give concordant results over a wide range of genomic and spatial distances 
(Andersson et al., 2014; Crane et al., 2015; Giorgetti et al., 2014; Kalhor et al., 2012; Li et 
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al., 2012; Rao et al., 2014), yet discordant result has been reported in a study in which 
the discrepancy is likely due to the changes in chromatin composition (Williamson et al., 
2014). DNA FISH and 3C-based techniques provide intrinsically different but complementary 
information (Giorgetti and Heard, 2016). In Chapter 3, we also deployed DNA FISH in an 
attempt to validate a selection of identified extremely long-range interactions (ELRIs), 
however, we were not able to observe significant difference in the distributions of the 
distances between the interacting loci pairs. This result might be due to the low accuracy of 
DNA FISH resulting from the technical issues such as the heating step for base-pairing probe 
and its target DNA (Giorgetti and Heard, 2016; Solovei et al., 2002). 
Long-range chromatin interactions are rare events. That is, an interaction between distant 
loci or loci on different chromosomes occurs infrequently in a cell, or in other words, such 
interactions occur only in a small number of the cells in a population at any given time. In 
contrast, loci that are close on the linear genome interact much more frequently, because a 
chromosome essentially is a large polymer which constrains the spatial distances between the 
nearby polymeric subunits. With the data from 3C-based techniques, the absolute frequency 
of a long-range interaction in a cell type can be estimated by calculating the ratio between the 
normalized read count for the interaction and the total read count for one of the interacting 
loci. This ratio for an interaction of more than 100 kb genomic distance is typically less than 
0.01, which means that in less than 1% of the time the two loci are close enough to make 
physical contact, or in other words, the physical contacts of the two loci are occurring in less 
than 1% cells if we take a snapshot of the same cell population. Such low value is in line with 
the observation from 3D DNA FISH experiments, that the interacting loci can only be observed 
being located in close proximity in a few cells (Fabre et al., 2015; Schoenfelder et al., 2015b; 
Vieux-Rochas et al., 2015). Also, the extremely long-range interactions identified in Chapter 3 
displayed low absolute frequencies in both Capture Hi-C and DNA FISH experiments. Hence, it 
remains unclear what the contribution of such low frequency of chromatin physical contacts 
is in gene regulation and how cells utilize it to regulate gene expression. 
Finally, it is possible that some promoter-interacting regions identified by 3C-based techniques 
do not show classical enhancer markers or other gene regulatory signatures yet function as 
enhancer or other types of regulatory DNA elements (Javierre et al., 2016; Rajagopal et al., 
2016). It is also possible that distal regulatory DNA elements impact gene expression not 
through physical interactions with their target genes but through the eRNAs transcribed from 
these regions, if the eRNAs have an appropriate lifespan. Because non-coding RNAs have 
been shown to be able to affect TFs, cofactors or signaling molecules thus indirectly influence 
gene expression (Li et al., 2016). 
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High-order structure of 3D genomic organization
The next question is how distal regulatory DNA elements are restricted to physically only or 
mainly interact with their own target genomic loci. The interactions identified by 3C-based 
techniques in a given cell type include not only the ones involved in gene regulation, but 
also the ones in maintaining the overall chromosomal structure. The extra information from 
3C-based techniques is especially useful for understanding high-level chromatin organization. 
With the extra information, 3C-based studies in line with DNA FISH studies revealed that the 
chromosomal structure is compartmentalized into multiple levels including the territories of 
individual chromosomes, the chromatin compartments of active and inactive regions at the 
scale of several Mb, and the topologically associating domains (TADs) of large self-interacting 
regions at the scale of several hundred kb (Bickmore and van Steensel, 2013; Gibcus and 
Dekker, 2013; Kalhor et al., 2012). Compartmentalization of chromosomes into structural 
domains is beneficial for chromatin communication. A domain is a relatively isolated structure, 
largely restricts interactions to occur between the loci within the domain, and prevents the 
access from other genomic loci. It also implies that the enhancers in a domain are largely 
constrained to affect the expression of target genes that also reside in the same domain.
Apart from chromosome territories, each chromosome can be classified into A and B 
compartments which contain relatively active and inactive chromatin, respectively. During 
stem cell differentiation (Dixon et al., 2015) and monocyte-to-macrophage differentiation 
(Chapter 5), A and B compartments were observed undergoing extensive switching, indicating 
that high-level chromatin structure is a cell-type specific signature. Indeed, converting somatic 
cells into induced pluripotent stem cells (iPSCs) effectively erased the somatic-cell-specific 
A/B compartment patterns, and established an embryonic stem-cell-like pattern (Krijger et 
al., 2016). However, only a subset of genes displayed differential expression in different cell 
types, hence it results in a subtle correlation between A/B compartment switching and the 
changes in overall patterns of gene expression (Dixon et al., 2015; Krijger et al., 2016). Taken 
together, the A and B compartments provide the first level of cell-type specific environment 
for individual genes, but do not suffice to determine the cell-type specific patterns of gene 
expression.
Each chromosome can be further divided into many topologically associating domains 
(TADs). In contrast to the high cell-type specificity of A/B compartments, TADs are largely 
invariant in different cell types (Dixon et al., 2015, also in Chapter 5). The switching of A/B 
compartment status during differentiation typically corresponds to a single or series of 
TADs, suggesting TADs behave as the basic units of the genome. However, the interaction 
frequency patterns within individual TADs can vary dramatically depending on the cell types. 
The changes in interaction frequency are positively correlated with the active marks (such 
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as DHS and H3K27ac) at the interacting regions and negatively correlated with repressive 
marks (such as H3K27me3) (Dixon et al., 2015). Hence, the internal interaction patterns of 
TADs are connected with the deposition of epigenetic marks within the TADs. In Chapter 
2, ChIA-PET experiments uncovered active genomic region centered interaction networks. 
P300 containing enhancers and the promoters of their target genes predominantly make 
contacts within segments of the TADs. It indicates the existence of sub-domains with in TADs, 
which is supported by a 3D map of the human genome at kilobase resolution (Rao et al., 
2014). Hence, the contacts of enhancers are restricted by the orchestrated domain-based 
hierarchical structure of the chromatin. 
A chromatin domain is likely formatted by a chromatin loop between two domain boundaries. 
CTCF, cohesin, condensin, and other architectural proteins are often found at boundaries, in 
which the orientation of CTCF-binding site relative to each other is a critical factor in setting 
up the loop (Acemel et al., 2016; de Wit et al., 2015; Dixon et al., 2012; Gómez-Marín et 
al., 2015; Rao et al., 2014; Tang et al., 2015; Van Bortle et al., 2014). Inversion of CTCF sites 
disrupts chromatin loops and consequently leads to the establishment of new chromatin 
loops that are in agreement with the new orientation (Sanborn et al., 2015). In Caenorhabditis 
elegans, it is shown that condensin plays a role in X chromosome dosage compensation by 
reshaping the X chromosomes into stronger boundaries with more regular spacing compared 
with autosomes. In Chapter 5, we observed a set of boundaries that display changes in 
boundary strength. However, the exact role of such changes in gene regulation needs further 
investigation. 
Although the domain structure provides an explanation about how distal regulatory DNA 
elements are restricted to interact with their target genomic loci, the mechanism of TAD 
formation remains incomplete and need further experimental supports (Dekker and Mirny, 
2016). Also, chromatin contacts do occur between domains and chromosomes (Chapter 3 as 
an example), especially that some of these contacts have been shown functionally important 
in gene regulation and development (Zhang et al., 2013). However, the principles behind 3D 
genomic organization and gene regulation are still far from clear. 
Enhancer, disease and epigenetic therapy
Given that enhancers play a vital role in orchestrating differentiation, development and 
environmental response, it is not surprising that many diseases are associated with 
enhancers. Genetic variants of enhancer-associated TFs (e.g. GATA factors (Lentjes et al., 
2016) and Hox factors (Quinonez and Innis, 2014)) and transcriptional coregulators (e.g. CBP 
(Iyer et al., 2004)) have long been linked to disease. These variants result in dysfunction of 
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the corresponding proteins thus likely affect many genes that are regulated by these proteins. 
Genetic variants of individual enhancer regions can also cause disease by altering enhancer 
activity and target gene expression (Emison et al., 2005; Gröschel et al., 2014; Kulozik et al., 
1988). Although genetic variants are an important component in many diseases, the role of 
epigenetic mechanisms should not be neglected in disease related to early life experience, 
diet, lifestyle and other environmental effects, as they are responsible for the integration of 
environmental cues into individual cells at the epigenetic level. Therefore, epigenetic therapy 
offers a potential way to directly influence related pathways in disease (Arrowsmith et al., 
2012; Kelly et al., 2010; Licht, 2015; Portela and Esteller, 2010; Wouters and Delwel, 2016).
In Chapter 4, we ‘perturbed’ normal monocyte-to-macrophage differentiation by exogenous 
signals to study innate immune memory, with the best-characterized outcomes being 
endotoxin tolerance and trained innate immunity (Netea et al., 2016). Exposure to high levels 
of LPS induces a tolerized macrophage phenotype, which is a major cause of sepsis-associated 
mortality. In contrast, trained immunity has beneficial effects through priming of macrophages 
for stronger responses to subsequent infection and can be induced by a variety of MAMPs, 
such as C. albicans (Quintin et al., 2012), Bacille Calmette-Gue ́rin (BCG) vaccine (Aaby and 
Benn, 2012), and BG (Saeed et al., 2014). Monocyte exposure to LPS induces and activates a 
group of enhancers that are associated with an inflammation response, showing discordance 
in time with accumulation of H3K4me1 while remaining at higher levels in LPS-Mfs compared 
to naive-Mfs and BG-Mfs. An epigenetic drug, bromodomain and extraterminal domain 
family inhibitor 151 (IBET151), was shown to be able to disrupt chromatin complexes which 
are responsible for the expression of key inflammatory genes in activated macrophages, by 
‘mimicking’ acetylated histones (Nicodeme et al., 2010). However, IBET151 was only effective 
in preventing tolerance when used to block the LPS-induced response via co-treatment with 
LPS, but was not able to reverse tolerance when administered after LPS. On the other hand, 
BG treatment after LPS exposure was able to reverse LPS-induced tolerance and to reinstate 
normal levels of cytokine release in so-called rescue-Mf’s. Further investigation of rescue-Mf’s 
at the histone modification level revealed that BG recovers H3K27ac at regions that are silent 
in LPS-Mf’s. This observation further supported the notion that the molecular mechanisms of 
chromatin remodeling that are induced by BG remain after the initial LPS response, however 
will be largely blocked by IBET151. Our findings show that the innate immune ‘training 
stimulus’ b-glucan outperforms the inflammation blocker IBET151 in reversal of macrophage 
tolerance. This is an important step towards understanding how the tolerized phenotype can 
be reversed in sepsis patients and ultimately provides a framework for future therapeutic 
developments in epigenetic therapy. 
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Back to genetics
While epigenetic memory shapes cell types and modulate cell functions, individuals do 
have genetic variations that may cause disease or increase disease susceptibility. Given that 
3D genomic organization plays a role in gene regulation, it is interesting to investigate the 
relationships between genetic variations, epigenetic memory, 3D genomic organization, and 
gene expression patterns. 
Genome wide association studies (GWAS) have identified thousands of single-nucleotide 
polymorphisms (SNPs) that are associated with particular diseases. Most SNPs are located in 
non-coding regions (Freedman et al., 2011), in which many of these regions are regulatory 
DNA elements such as enhancers, suggesting that many SNPs affect gene expression that 
lead to an increased risk of certain disease (Farh et al., 2015; Gjoneska et al., 2015; Maurano 
et al., 2012; Roadmap Epigenomics Consortium et al., 2015). This is further supported by the 
identification of expression quantitative trait loci (eQTL) and histone quantitative trait loci 
(hQTL) which alter the local chromatin state and enhancer activity (Astle et al., 2016; Chen 
et al., 2016; Grubert et al., 2015; Kasowski et al., 2013; Kilpinen et al., 2013; McVicker et al., 
2013; Waszak et al., 2015). However, QTLs represent a mixture of direct and indirect gene 
regulation that often cannot be easily distinguished due to the unknown enhancer-promoter 
linkages. Hence, integration of GWAS SNPs and QTLs with chromatin interaction map provide 
a good approach to interpret non-coding genetic variation (Javierre et al., 2016). 
Large-scale genetic variations are also linked with disease. It has been shown that the patterns 
of chromosomal rearrangements and translocations are highly correlated with the spatial 
proximity by the combined analyses of Hi-C and High-throughput genome-wide translocation 
sequencing (HTGTS) (Zhang et al., 2012). Analyzing patient cells and genetically modified 
mice with 3C-based methods further showed that deletions, inversions, or duplications can 
elicit pathogenic effects by changing the higher-order chromatin structure, depending on the 
size and position of the genetic variations (Franke et al., 2016; Lupiáñez et al., 2015). 
3D genomic organization and evolution
Given the significant contribution of 3D genomic organization in gene regulation, it is 
also important to consider whether and how 3D genomic organization influence genome 
evolution. 
The investigations in a large range of species including bacteria, yeast, plants, and mammals 
suggest that the form of TAD-like structures seems to be a common mechanism that cells 
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organize their genomes in 3D space (Hsieh et al., 2015; Le et al., 2013; Mizuguchi et al., 2014; 
Wang et al., 2015). Interestingly, apart from the high similarity between the linear genome 
sequences of mammals, syntenic genomic regions also display remarkable conservation in 
TAD organization (Dixon et al., 2012; Vietri Rudan et al., 2015). This conservation is likely 
dependent on the conserved CTCF binding sites, which together with cohesin determine 
the TAD boundaries. The conservation of 3D genomic organization extends beyond the 
TADs. Evolutionary related genomic regions that are distant in the human genome but are 
adjacent in the mouse genome were shown to have significantly more chromatin contacts 
than expected (Véron et al., 2011). In our study in Chapter 3, the extremely long-range 
promoter-promoter Interaction (ELRI) loci identified in primed mouse pluripotent stem cells 
largely overlap with the promoters of many homeobox genes. Interestingly, similar long-
range chromatin interactions have also been observed in Drosophila (Bantignies et al., 2011), 
whereas these homeobox genes are believed to be generated by genome duplication during 
metazoan evolution (Garcia-Fernàndez, 2005). Therefore, the 3D genomic organization is 
conserved at various levels. 
3D genomic organization is likely also linked with the morphological alterations during 
evolution. In the mouse genome, the HoxD gene cluster is flanked by two TADs. With this 
configuration, the HoxD genes can be regulated by the regulatory DNA elements in the 
anterior and posterior TADs on demand to form the appendages of the body such as limbs 
(Andrey et al., 2013). This seems to be conserved in vertebrates, however, the Hox cluster in 
the embryos of an invertebrate chordate called amphioxus is organized into a single TAD that 
includes long-range contacts mostly from the anterior side (Acemel et al., 2016). Interestingly, 
most of the regulatory elements within the vertebrate-specific posterior TAD are required 
for the formation of vertebrate-specific appendages (Lonfat et al., 2014; Montavon et al., 
2011). This example indicates that 3D genomic organization may facilitate the incorporation 
of newly emerged regulatory input to the existing regulatory information and contribute to 
the morphological alterations during evolution. 
In summary, 3D genomic organization is associated with evolution and may also contribute 
to the morphological alterations during evolution. However, further investigations in a larger 
number of species are required to infer the general roles of 3D genomic organization in 
evolution. 
Perspective
Our view of the roles of distal regulatory DNA elements and the principles guiding chromatin 
organization are becoming greatly expanded, and have led us to a more comprehensive 
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understanding of the genome and the cell systems. However, further studies are needed in 
many aspects. Firstly, what are the common features of active enhancers? Current studies 
identified a large number of enhancers based on epigenetic marks. However, it has been 
shown that only a subset of the H3K27ac marked enhancers in a cell type are validated to 
be functionally active using transgenic mouse assays (Nord et al., 2013). Thus, additional 
experiments are needed to gather the actual activities of enhancers in individual cellular 
contexts. Secondly, what is the nature of enhancer-promoter communication? This includes 
broad questions such as how enhancers regulate genes, how enhancers find their target genes, 
how frequently enhancers make contact with their targets, how the contact frequencies are 
translated into transcription, and what are the contributions of individual enhancers in a 
complex enhancer-promoter interaction network. Thirdly, many underlying mechanisms 
remain unclear, including the formation process of chromatin loops, the dynamics of 
chromatin physical contacts, and the cell-to-cell variability in chromosome folding and its 
role in gene regulation (Dekker and Mirny, 2016). 
To address these questions, further supports from experimental evidence are needed. 
However, our current understanding of the activities, functions, and corresponding phenotypes 
of regulatory DNA elements largely relies on time consuming one by one experimental 
methods. The promotion of high throughput functional assays such as massively parallel 
reporter assays (Kvon et al., 2014) and genome editing screenings (Shalem et al., 2015) would 
lead us to a more comprehension view of regulatory DNA elements. Our understanding of 
chromatin organization and its impacts on gene regulation is also largely limited, by current 
population-averaged measurement. A deeper understanding into the dynamics of chromatin 
organization and underlying mechanisms of chromatin physical contact will provide further 
mechanistic insights into gene regulation and its variability in individual cells. This may 
require improvement in experimental methods at single-cell level, and, which is even better, 
real-time in live cells. Using live-imaging methods and quantitative analysis, a recent study 
provides a nice start in understanding the associations between enhancer and transcriptional 
bursting (Fukaya et al., 2016). Ultimately, the up-coming fundamental understanding of the 
regulatory code and grammar will be beneficial for guiding the therapy of disease. 
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SUMMARY
How a genome governs phenotypic plasticity, has long been the subject of research. Gene 
regulation has been associated with the activities of regulatory DNA elements, epigenetic 
memory and 3D genomic organization. Here, we investigated the effects of chemical signals 
on chromatin re-organization, the differences in the chromatin organization of naïve and 
primed embryonic stem cells, and epigenetic memories, chromatin reorganization and 
reversal of tolerance in innate immune cells.
In Chapter 2, using circular chromosome conformation capture coupled with next generation 
sequencing (4C-seq) and high-resolution chromatin interaction analysis by paired-end tag 
sequencing (ChIA-PET) of P300, we investigated the impact of signal-dependent transcription 
factors glucocorticoid receptor (GR) and nuclear factor kappa-b (NF-κB) on gene regulation 
and three-dimensional (3D) chromatin organization. We observed agonist-induced changes in 
long-range chromatin interactions, and uncovered interconnected enhancer–enhancer hubs 
spanning up to one megabase. The vast majority of activated glucocorticoid receptor and 
nuclear factor kappa-b appeared to join pre-existing P300 enhancer hubs without affecting 
the chromatin conformation. In contrast, binding of the activated transcription factors to loci 
with their consensus response elements led to the increased formation of an active epigenetic 
state of enhancers and a significant increase in long-range interactions within pre-existing 
enhancer networks. De novo enhancers or ligand-responsive enhancer hubs preferentially 
interacted with ligand-induced genes. We demonstrate that, at a subset of genomic loci, 
ligand-mediated induction leads to active enhancer formation and an increase in long-range 
interactions, facilitating efficient regulation of target genes. Therefore, our data suggest an 
active role of signal-dependent transcription factors in chromatin and long-range interaction 
remodeling. 
In Chapter 3, we established Capture Hi-C with target-sequence enrichment of DNase I 
hypersensitive sites to assess the dynamics of 3D genomic organization during the transition 
between two states of pluripotency serum-to-2i interconversion of mouse embryonic 
stem cells. We detected extremely long-range intra- and inter- chromosomal interactions 
between a small subset of H3K27me3 marked bivalent promoters involving the Hox clusters 
in serum-grown cells. Notably, these promoter-mediated interactions are not present in 2i 
ground-state pluripotent mESCs but appear upon their further development into primed-like 
serum mESCs. Reverting serum mESCs to ground-state 2i mESCs removes these promoter-
promoter interactions in a spatiotemporal manner. H3K27me3, which is largely absent at 
bivalent promoters in ground-state 2i mESCs, is necessary, but not sufficient, to establish 
these interactions, as confirmed by Capture Hi-C on Eed-/- serum mESCs. Our results implicate 
170
Appendix
H3K27me3 and PRC2 as critical players in chromatin alteration during priming of ESCs for 
differentiation. 
In Chapter 4, we integrated time-resolved epigenomes and transcriptomes to study innate 
immune memory. We characterized the molecular events involved in LPS stimulated, beta-
glucan stimulated and normal monocyte-to-macrophage differentiation. We observed that 
LPS-treated monocytes fail to accumulate active histone marks at promoter and enhancers of 
genes in the lipid metabolism and phagocytic pathways. Transcriptional inactivity in response 
to a second LPS exposure in tolerized macrophages is accompanied by failure to deposit active 
histone marks at promoters of tolerized genes. In contrast, b-glucan partially reverses the 
LPS-induced tolerance in vitro. Importantly, ex vivo b-glucan treatment of monocytes from 
volunteers with experimental endotoxemia reinstates their capacity for cytokine production. 
Tolerance is reversed at the level of distal element histone modification and transcriptional 
reactivation of otherwise unresponsive genes. Our findings show that the innate immune 
‘‘training stimulus’’ beta-glucan can reverse macrophage tolerance ex vivo and move forward 
in understanding how the tolerized phenotype can be reversed in sepsis patients.
Lastly, in Chapter 5 we performed Capture Hi-C to investigate the dynamics of 3D genomic 
organization during monocyte-to-macrophage differentiation and immunological training. 
The monocyte-to-macrophage differentiation is associated with changes at epigenetic, 
transcriptional and 3D genomic organization levels. We demonstrate that despite the absence 
of cell division, this differentiation is associated with higher-order chromatin reorganization, 
including changes in A/B compartments, strengthening of TADs and their boundaries and 
a global gain of short-range interactions. While differentiation is associated with profound 
changes, immunological training does not cause spatial chromatin dynamics, suggesting that 
differentiation is the main driver of chromatin remodeling. 
In summary, our studies demonstrated that even stimuli as short as several hours are able 
to significantly alter the epigenetic landscape at a collection of genomic regions. Moreover, 
these epigenetic alterations are strongly associated with gene regulation and 3D genomic 
organization. Our findings provide important insights into gene regulation at epigenetic and 
3D genomic organization level. 
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Samenvatting
SAMENVATTING
Hoe het genoom met phenotypisch plasticiteit omgaat is al geruime tijd onderwerp van 
studie. Genregulatie is geassocieerd met de activiteit van regulatoire DNA elementen, het 
epigenetische geheugen en 3D genoom organisatie. In deze studie hebben we het effect 
van chemische signalen op de reorganisatie van het chromatine onderzocht, de verschillen 
in chromatine organisatie in naive stamcellen en op differentiatie-voorbereidde stamcellen, 
en het epigenetisch geheugen, chromatine reorganisatie en omkering van tolerantie in 
aangeboren immuuncellen.
In hoofdstuk 2, hebben we de impact van de signaal-afhankelijke transcriptiefactoren 
glucocorticoid receptor (GR) en nuclear factor kappa-b (NF-kB) op genregulatie en de 
drie-dimensionale (3D) chromatine organisatie onderzocht. We observeerden agonist-
geïnduceerde veranderingen in lange-afstands chromatine interacties, en ontdekten 
enhancer-enhancer interacties die reikten tot over een megabase. Het overgrote deel van 
de geactiveerde glucocorticoide receptoren en NFkB bleek zich te voegen bij reeds aanwezig 
P300 enhancer regionen zonder de conformatie van het chromatine te beïnvloeden. 
Binding van deze geactiveerde transcriptiefactoren op hun reeds bekende specifieke DNA 
bindingselementen leidde tot een verhoogde epigenetische activatie van enhancers en een 
significante toename in lange-afstands interacties binnen de reeds aanwezige enhancer 
netwerken. De novo enhancers of ligand-gevoelige enhancer gebieden interacteerden 
bij voorkeur met ligand-geïnduceerde genen. Wij demonstreerden dat, in bepaalde delen 
van het genoom, ligand-gemedieerde inductie leidt tot actieve enhancer formatie en een 
toename in lange-afstands interacties, dat efficiënte regulatie van target genen faciliteert. 
Onze data suggereert daarom een actieve rol van signaal-afhankelijke transcriptie factoren in 
de herstructurering van chromatine en lange-afstands interacties.
In hoofdstuk 3 hebben Capture Hi-C met verrijking van DNAse I gevoelige gebieden opgezet om 
de dynamiek van de 3D genoom organisatie tijdens de transitie tussen twee verschillende staten 
van pluripotentie in kaart te brengen. We detecteerden extreem lange-afstands interacties, 
inter- en intra-chromosomaal, in een klein gedeelte van de H3K27me3 gemarkeerde bivalente 
promoters, welke betrokken zijn bij de regulatie van de Hox clusters in serum-gegroeide 
cellen. In het bijzonder, deze promoter-gemedieerde interacties zijn afwezig in 2i mESCs maar 
verschijnen tijdens ontwikkeling naar op differentiatie-voorbereidde mESCs. Bij de omkering van 
2i naar serum condities verdwijnen deze promoter-promoter interacties in een tijdruimtelijke 
manier. H3K27me3, dat grotendeels afwezig is op bivalente promoters in 2i mESCs, is vereist, 
maar niet genoeg, om deze interacties tot stand te brengen, dat bevestigd werd door Capture 
Hi-C in Eed-/- serum ESCs. Onze resultaten impliceren dat H3K27me3 en PRC2 een kritische 
spelen bij chromatine veranderingen tijdens het voorbereiden van mESCs op differentiatie. 
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In hoofdstuk 4 hebben we het epigenoom en transcriptoom door de tijd gebruikt om het 
aangeboren immuunsysteem te bestuderen. We hebben de moleculaire gebeurtenissen tijdens 
LPS-stimulatie, beta-glycaan-stimulatie en normale monocyt-naar-macrofaag differentiatie 
gekarakteriseerd. We observeerden dat LPS-gestimuleerde monocyten niet in staat waren 
om actieve histon markeringen op de promoters en enhancers van genen betrokken bij vet 
metabolisme en phagocytose te accumuleren. Transcriptionele inactiviteit in reactie op een 
tweede blootstelling aan LPS in tolerante macrofagen gaat gepaard met het onvermogen 
om actieve histon markeringen af te zetten op de promoters van tolerante genen. Beta-
glycaan hief de LPS-gestimuleerde tolerantie daarentegen deels op. Belangrijk, een ex vivo 
beta-glycaan behandeling van monocyten van vrijwilligers met experimentele endotoxemia 
herintroduceert hun vermogen om cytokines te produceren. Tolerantie is omgekeerd op 
het niveau van histon modificaties op distale elementen en transcriptionele reactivatie van 
anders niet-reactieve genen. Onze bevindingen tonen dat de aangeboren immuunsysteem 
“training stimulus” beta-glycaan tolerante macrofagen ex vivo kan reactiveren en helpt ons te 
begrijpen hoe het tolerante fenotype in sepsis patiënten omgekeerd kan worden.
Tenslotte, in hoofdstuk 5 hebben we Capture Hi-C gebruikt om de dynamiek van 3D 
genoom herstructurering tijdens monocyt-naar-macrofaag differentiatie en immunologische 
training te onderzoeken. De differentiatie van monocyt naar macrofaag gaat gepaard met 
veranderingen op epigenetisch, transcriptioneel en 3D genoom organisatie niveau. We 
demonstreren dat, ondanks de afwezigheid van celdeling, differentiatie is geassocieerd 
met chromatine reorganisatie, inclusief A/B compartimenten, het versterken van TADs en 
hun grenzen en een globale toename van het aantal korte-afstands interacties. Hoewel 
differentiatie is geassocieerd met grondige veranderingen veroorzaakt immunologische 
training geen structurele veranderingen in het chromatine, suggererend dat differentiatie de 
belangrijkste oorzaak van chromatine herstructurering is.
Samenvattend, onze studies tonen aan dat stimuli, reeds met de duur van slechts enkele uren, 
in staat zijn significante veranderingen in het epigenetische landschap teweeg te brengen. 
Bovendien zijn deze veranderingen sterk geassocieerd met genregulatie en de 3D organisatie 
van het genoom. Onze bevindingen verschaffen belangrijke inzichten in genregulatie op het 
epigenetisch niveau en op het niveau van de 3D structuur van het genoom.
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